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ABSTRACT:

THE EMERGING ORAL PATHOGEN, FILIFACTOR ALOCIS, DISRUPTS
NEUTROPHIL FUNCTIONS TO ENHANCE SURVIVAL AND DYSREGULATE
INFLAMMATION

Irina Miralda Molina
April 15, 2020

Periodontitis is an irreversible, chronic inflammatory disease where pathogenic
microbial communities accumulate in the gingival crevice. Advances in cultureindependent techniques have facilitated the identification of new bacterial species in
periodontal lesions, such as the Gram-positive anaerobe, Filifactor alocis. Neutrophils are
a major component of the innate host response, and the outcome of their interaction with
F. alocis may be a determinant of oral health. Neutrophil functions typically protect the
host against periodontal disease, oral pathogens have adapted to evade or disarm neutrophil
microbicidal functions while promoting mechanisms that drive inflammation, which also
provides a source of nutrients for growth. This study has two main goals: to determine how
F. alocis interferes with microbicidal mechanisms to survive in neutrophils and to examine
how F. alocis contributes to the chronicity of periodontitis by promoting inflammation.
This dissertation characterizes human neutrophil global gene expression during
infection with F. alocis (Chapter 2). Challenge of human neutrophils with F. alocis resulted
in the differential expression of genes involved in multiple neutrophil effector functions
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such as chemotaxis, cytokine and chemokine signaling pathways, and apoptosis. F. alocis
challenge also affected the expression of components from the TNFα and MAPK kinase
signaling pathways. This resulted in transiently dampened p38 MAPK activation by
secondary stimuli TNFα. Functionally, the F. alocis-mediated inhibition of p38 activation
by TNFα resulted in decreased cytokine production but had no effect on priming of the
respiratory burst response, or the delay of apoptosis by TNFα. Since this modulatory effect
was characteristic of viable F. alocis only, this is an F. alocis’ mechanism to control
neutrophils and their functional responses.
I also examined neutrophil functional mechanisms in bone marrow neutrophils
from TLR2-/- mice (Chapter 3). I found that compared to WT, TLR2-/- neutrophils were
more efficient at killing F. alocis, but the increase in killing capacity was not due to a
difference in phagocytosis or production of ROS. Instead, it was due to an increase in
fusion of myeloperoxidase granules with the F. alocis phagosome. Meanwhile, F. alocis
promotes inflammation by inducing the release of pro-inflammatory cytokines through
TLR2 signaling. The TLR2 adaptor protein, MyD88, was also critical for cytokine
production, but the events downstream of MyD88 follow non-canonical signaling.
Apoptotic pathways were also showed significant changes in mRNA levels when
neutrophils are challenged with F. alocis. Neutrophils had prolonged lifespans and higher
functional capacity than unchallenged cells (Chapter 4). Despite their viability, F. alocischallenged cells were significantly efferocytosed by macrophages, which developed a proinflammatory profile (Chapter 5). Collectively, this data confirms that F. alocis interferes
with TLR2 signaling to promote its survival within neutrophils and promotes chronic
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inflammation by extending neutrophil lifespan and delaying the resolution of
inflammation.
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CHAPTER 1:
INTRODUCTION

Periodontal Disease: etiology and consequences
Periodontal diseases affect the integrity of one or several tissues of the
periodontium, which is comprised of the gingiva, periodontal ligament, cementum and
alveolar bone. The prevalence of the disease is high, affecting 42% of adults 30 years or
older in the USA alone, with older adults and those living under the poverty line being the
most susceptible to develop the disease [1]. The term periodontal disease usually refers to
the most common inflammatory disorders, gingivitis and periodontitis. Out of the two,
gingivitis is the mildest form of periodontal disease and can be easily reversed by effective
oral hygiene. On the contrary, periodontitis is an irreversible, chronic inflammatory disease
that causes the loss of connective tissue, alveolar bone, and eventually the loss of teeth [2].
Preventative and treatment measures are aimed at controlling or removing the periodontal
biofilm and include deep cleaning, antibiotics and surgery in severe cases [3]; but
unfortunately, their efficacy is transient since the infection almost always returns. Even in
cases where inflammation is resolved and some tissue is regenerated, it is impossible for
the lost tooth support to be restored.
The progression of periodontal disease into periodontitis is one of the most severe
and irreversible forms of the disease. This development depends on the disruption of
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periodontal host-microbe homeostasis due to a shift in the composition of microbial
populations in the oral cavity. Unlike some infectious diseases, periodontitis does not
develop from a monoculture infection, but rather the colonization of a heterotypic
community of organisms where the presence of one organism enhances the colonization or
virulence of others [4]. These interspecies interactions include one organism providing the
substrate for attachment and colonization of another, the utilization of released metabolic
by-products of one organism as a nutrient source by another organism, or the coordinated
break-down of complex substrates [5-8]. The physical interactions among organisms and
the diffusion of soluble factors that benefit the whole community results in interdependence
between the different bacterial species, each providing a discrete set of communityessential genes. This is explained by the current accepted model for the etiology and
pathogenesis of periodontitis, which is called the poly-microbial synergy and dysbiosis
(PSD) model [9, 10]. Under the PSD model, a perturbation of the symbiotic microbial
community will result in an increase in the diversity and number of microbial burden.
Ultimately, this gives rise to a dysbiotic microbial community that can adapt to and take
advantage of the inflammatory environment to enhance the population’s bacterial fitness
[10].
Under homeostatic conditions, colonizing bacteria initially assemble into
physiologically compatible communities that can communicate through sophisticated
signaling mechanisms. Any overgrowth or pathology is efficiently controlled by the host
inflammatory response, and the gingiva will return to its normal, mild inflammatory state.
However, changes in host immune competence, diet, or behaviors like smoking can affect
microenvironmental factors like inflammation, pH, redox potential or nutrient availability
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that can drive the selection and enrichment of specific pathogenic bacteria. While the
microbiota associated with healthy oral tissues is considered more generalist, the diseaseassociated microbiota is influenced by the traits of specialized microorganisms that have
an elevated virulence potential. In mouse models of the disease, the colonization of a
keystone pathogen, like Porphyromonas gingivalis, introduces pathogenicity that can
elevate the virulence of the entire microbial community, even if there are low numbers of
the keystone pathogen present [11]. It is important to note that it is the combination of
polymicrobial constituents and their cooperative functional genes that unite to shape and
stabilize the dysbiotic microbiota. As the dysbiotic community develops, they will
stimulate inflammatory responses that are poorly restrained by susceptible hosts and
ineffective at confining the bacterial community. The aggravated and dysregulated
responses of the immune system will contribute to tissue destruction that affords a source
of nutrients for the microbial community’s growth, and thus a continuous cycle of dysbiosis
and inflammation ensues.
Importantly, this cycle of dysbiosis and inflammation is not an isolated event.
Periodontitis has been linked to systemic inflammation and other adverse impacts on
systemic health, amongst them several comorbidities like cancers, rheumatoid arthritis,
cardiovascular disease, Alzheimer’s disease and other inflammatory conditions [12-15].
The link between these seemingly independent diseases has been explained through several
plausible mechanisms. First, locally produced pro-inflammatory cytokines from the oral
cavity can enter the bloodstream to induce inflammation in distal sites. For example, tumor
necrosis factor (TNF) α, interleukin (IL)-1β and IL-6 can cause an acute-phase response in
the liver that increases systemic levels of C-reactive protein, fibrinogen and serum amyloid
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A, that contributes to atherosclerosis or intra-uterine inflammation [16, 17]. Through
ulceration of the gingiva, periodontal bacteria can also enter the bloodstream and
disseminate to other organs. P. gingivalis has been detected in atherosclerotic lesions where
it supports a pro-atherogenic environment and Fusobacterium nucleatum has been detected
in the placenta where it drives inflammation-induced pregnancy complications [18, 19].
Finally, since large quantities of bacteria are swallowed daily, it has been proposed that
oral bacteria like P. gingivalis can alter the gut microbiota and drive increased gut
permeability to cause systemic inflammation [20]. Therefore, finding efficient treatments
against periodontitis may provide solutions against the exacerbation of many other
pathologies.

A moving target: Making an inventory of oral microbes in periodontitis
The microbial shift observed in the gingival crevice from a symbiotic microbiota
to a dysbiotic polymicrobial community has been tracked and refined throughout the years
as culture-independent techniques have advanced [4, 8, 21, 22]. Initial studies from the turn
of the 20th century, used the microbiological techniques available at that time to begin
characterizing the etiological agents responsible for periodontitis [23]. Those initial studies
discovered spirochetes, fusiforms and streptococci [23, 24] present in periodontal pockets.
Later, using microscopic techniques, Listgarten et al. [25, 26] showed the frequency of
each morphology type in the composition of the subgingival microbiota of patients from
different stages of oral disease. The development of immunological techniques and DNA
probes helped identify the microbial species present in the subgingival pockets [27].
However, high-throughput analysis of microbial communities from subgingival pockets
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became possible with molecular DNA-based technologies. Using community
fingerprinting techniques like restriction fragment length polymorphism [28], or
denaturing gradient gel electrophoresis [29], variation and shift in the composition of the
microbial community in periodontitis could be identified. The development of DNA-DNA
checkerboard hybridization helped to understand the specific association of oral bacteria
with health and disease [30]. Socransky et al. [31] described the presence of five microbial
communities in subgingival biofilms associated with health and different stages of
periodontitis. The 16S rRNA approach has revolutionized the identification of bacterial
taxa whether they are cultivable or ‘yet-to-be-cultivated’, in a mixed population and
showed diversity of the oral microbiota [32, 33]. Next generation sequencing technologies
further reformed the study of oral microbial diversity with existence of underappreciated
periodontal pathogens [34-38]. The pioneer traditional studies together with the more
advanced 16S rRNA gene comparative analysis identified presence of approximately 700
predominant taxa in oral microbiome of which approximately 1/3 is ‘yet-to-be-cultivated’
[39]. About 400-500 taxa were reported in the subgingival crevice alone [32, 37].
Taken together, the plaque analysis from periodontitis-diseased sites has revealed
the presence of P. gingivalis, Tannerella forsythia and Treponema denticola related with
disease severity [31, 40] whereas the presence of Aggregatibacter actinomycetemcomitans
has been associated with aggressive periodontitis [24]. F. nucleatum is a commensal
species in the oral cavity that increases in abundance in diseased individuals; however, it
has been associated with most types of periodontal diseases (chronic and aggressive
periodontitis, gingivitis, and endodontic infections) due to its highly synergistic
interactions with P. gingivalis and T. forsythia [41]. The microbes described above are the
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most well-studied periodontal pathogens and have their pathogenic credentials wellestablished. However, examining the microbial composition of the gingival crevice using
more advanced techniques revealed the complexity of the microbial communities. A
review comparing 41 published studies from 1999 to 2013, showed that 17 newly identified
species comprised of five Gram-positive (Eubacterium saphenum, Mogibacterium
timidum, Peptoanaerobacter stomatis, Filifactor alocis and Enterococcus faecalis), eight
Gram-negative and four not-yet-cultivable group have a moderate association with the
etiology of periodontitis [42].

Filifactor alocis: finding its place in dysbiotic periodontal community
The oral microbiome consists of about 700 predominant taxa [39] and out of these,
about 400-500 taxa have been reported in the subgingival cervice alone [32, 37]. Many of
these microbial species are “yet-to-be-cultivated,” but have been identified due to advances
in 16S rRNA gene sequencing technology. Filifactor alocis is one of these putative periopathogens identified by culture-independent techniques. Initially, F. alocis was identified
from the gingival sulcus in gingivitis and periodontitis patients, and named Fusobacterium
alocis [43], but this bacterium was later reclassified under the genus Filifactor [44].
Multiple studies have shown high incidence of F. alocis in the subgingival plaques
of periodontitis patients, but a complete absence or low number detection in healthy
patients [34, 45-47]. A study conducted on 490 subgingival plaques identified F. alocis as
the second most prevalent bacteria in chronic periodontitis, the third most prevalent
bacteria in generalized aggressive periodontitis, and low prevalence in the control subjects
resistant to periodontitis [48]. The occurrence of F. alocis has also been reported in
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endodontic infections [49-52] and peri-implantitis [53]. Moreover, a review comparing 41
published studies shows that there is consensus amongst published literature in regards to
F. alocis being one of the 17 newly identified species associated with the etiology of
periodontitis [42]. Due to the stark difference in colonization of healthy vs. diseased
tissues, F. alocis has been designated a top marker for generalized aggressive periodontitis
along with P. gingivalis, T. denticola and T. forsythia [54].
In the oral cavity, F. alocis forms biofilms close to apical and middle thirds of the
gingival pocket, which is in close proximity to soft tissue [48]. A comparison of the
subgingival microbiota in periodontitis patients showed that F. alocis is more prominent in
the fourth layer of plaque, which is characterized as a loose layer between the attached
biofilm and the soft tissue where some traditional pathogens like T. denticola are also found
[55]. When the biofilms and saliva of healthy adults were cultured for three weeks in
growth media that simulates the inflamed subgingival environment, there was an
enrichment of periodontal pathogens like P. gingivalis, F. alocis, and several
Peptostreptococcus and Treponema spp, which further establishes the classification of F.
alocis an inflammaphilic oral pathogen [56]. This finding also supports the idea that
inflammatory changes in the subgingival nutritional environment favors an increase in the
abundance of pathogenic bacterial species like F. alocis.
Characterization of the bacterial composition of different oral sites like saliva, the
supragingival area, or the subgingival area showed positive correlation and possible
synergistic interactions between F. alocis and eight oral pathogens including P. gingivalis
and T. forsynthia [57]. Further, in vitro studies showed that co-culture of F. alocis with P.
gingivalis enhanced biofilm formation [58] and this biofilm is heterotypic, with enhanced

7

P. gingivalis growth [59]. Similarly, F. alocis can also form biofilms with F. nucleatum
and A. actinomycetemcomitans [59]. Taken together, these studies demonstrate that F.
alocis is strongly associated with periodontitis, and that F. alocis is a key player in biofilm
formation.

Enduring inflammation: F. alocis survival mechanisms & virulence factors
F. alocis is a slow-growing, non-spore forming, obligate anaerobic rod that has
been classified as Gram positive and asaccharolytic, due to its metabolic preference for
specific amino acids like arginine [44, 60, 61]. F. alocis manufactures many proteins
involved in arginine and citrulline synthesis pathways such as arginine deiminase,
aminotransferases, arginine decarboxylase, and acetyl ornithine transferase, suggesting
that the nutritional requirement is adequately fulfilled by the byproducts of the disrupted
host tissue produced as the consequence of the chronic periodontal inflammation [21, 58,
61]. Also, arginine degradation helps increase the pH, which counteracts the acidic
conditions generated through carbohydrate metabolism in the mixed oral community [62].
One of the properties of F. alocis that plays a role in the bacterium’s survival in
periodontal tissues is its resistance to oxidative stress; in fact, its growth was stimulated in
media supplemented with hydrogen peroxide [58]. This is likely mediated through F.
alocis’ expression of superoxide reductase, which catalyzes the conversion of toxic
superoxides into hydrogen peroxide. Additionally, the presence of sialidase activity helps
F. alocis play the role of oxidative sink and stabilize the microbial community in the
inflammatory environment of periodontal pockets [62]. F. alocis’ contribution enhanced
P. gingivalis survival in hydrogen-peroxide-induced oxidative stress [62].
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Another important asset of F. alocis is the presence of different proteases. While
most of them are membrane bound, they play an important role in protein or peptide
modification and secretion. For example, a collagen peptidase was identified in the F.
alocis extracellular fraction that can contribute to tissue destruction in periodontitis [63].
F. alocis also expresses a cytoplasmic enzyme, acetyl-ornithine transaminase, that is
involved in arginine catabolism but also inhibits the activation of complement component
3 convertase (C3 convertase) when present on the bacterial surface. Because of the
discovery of this dual function, it was designated as F. alocis complement inhibitor,
FACIN [64]. FACIN, lipoproteins, autolysins, and another 28 proteins were detected in the
extracellular vesicles from F. alocis [65]. Outer membrane vesicles like these represent an
efficient mode of disseminating bacterial effector components that manipulate host cell
responses. To conclude, all these studies show that F. alocis has the arsenal to disrupt
normal host cell processes and shields itself and bystander bacteria from the hostile
environment of periodontitis.

F. alocis interactions with oral epithelium and monocytes
The inflamed environment of subgingival plaques favors the growth of
periodontitis-associated pathogens like F. alocis [56], which is further supported by the
finding that this bacteria is abundantly present in subgingival plaques [34, 46] . Since F.
alocis is mostly found in the deep layers of biofilm close to the soft tissue, it is constantly
interacting with host cells. Studies focusing on the interaction of F. alocis with gingival
epithelial cells have shown that this bacterium can adhere and invade epithelial cells [62,
66]. Upon contact with F. alocis, pro-inflammatory cytokines like TNF-α, IL-1β and IL-6

9

are secreted from epithelial cells and the bacteria induces apoptosis in oral epithelial cells
via activation of caspase 3 and suppression of MEK1/2 signaling pathway [66]. When F.
alocis is co-cultured with P. gingivalis and epithelial cells, the level of internalization of
both bacteria by epithelial cells increases more than in monoculture. Their uptake is
mediated through endocytic events, and electron microscopy showed that the endocytic
vesicles contained both pathogens. Ultimately, uptake of F. alocis and P. gingivalis leads
to change in epithelial cell morphology and cell death [58]. In human oral keratinocytes,
F. alocis induced apoptosis in time and dose-dependent manner through the action of the
recombinant F. alocis peptidase U32 that has collagenase activity and induces the
expression of pro-apoptotic genes like Apaf-1, caspase3 and 9 and cytochrome C [67].
F. alocis can also drive inflammation through the secretion of pro-inflammatory
cytokines and mediators from the epithelium and infiltrating monocytes. By activating
NOD1 in mesothelial cells, heat-killed F. alocis induces the expression of CXCL-1, an
inflammatory neutrophil chemokine [68]. Additionally, F. alocis causes increases in
matrix metalloproteinase (MMP)-1 gene expression and protein synthesis in fibroblastic
and monocytic cells that can further contribute to tissue damage in periodontitis [69]. F.
alocis also induces release of IL-8, IL-6, and TNF-α from human monocytes and human
oral epithelial cells in vitro; however, host behaviors can modify this response, since it was
reported that marijuana-derived cannabinoids suppress the F. alocis-mediated release of
pro-inflammatory cytokines by activating the CB2/PI3K axis signaling pathway [70].
Notably, recognition of the whole bacterium is not necessary to elicit pro-inflammatory
responses. Extracellular vesicles isolated from the culture of F. alocis induced the
expression of CCL1, CCL2 (MCP-1), CCL3 (MIP 1), CCL4 (MIP-1), CCL5
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(RANTES), CXCL1, CXCL10, ICAM-1, IL-1β, IL-1ra, IL-6, Il-8, Macrophage Migration
Inhibitory Factor (MIF), TNF-α and SerpinE in a human monocytic cell line and also
caused the expression of CXCL1, granulocyte-colony stimulating factor (G-CSF),
granulocyte-macrophage colony stimulating factor (GM-CSF), IL-6 and Il-8 in human oral
kerationocytes cell line [65]. Thus, F. alocis and its bacterial products can fuel a proinflammatory environment that benefits the asaccharolytic bacteria’s growth.

F. alocis presence in extra-oral diseases
In the past few decades, the link between dental bacteremia and systemic adverse
conditions has drawn much attention from researchers [71]. Recent developments in
culture-independent techniques has facilitated the detection and identification of microbial
species in extra-oral infectious sites [72]. The first in vivo study to address this with F.
alocis used a mouse subcutaneous chamber model, which showed that F. alocis infection
(1) triggered a local inflammatory response that included recruitment of neutrophils into
the chamber and proinflammatory cytokine production, and (2) can exit the inoculation site
and colonize distal organs like the spleen, liver, lung, and kidney where presence of the
bacteria caused significant damage to both proximal and distal tubular epithelial cells in
the kidney [73]. Corroborating the data from this mouse model, two case reports detected
the presence of F. alocis in extra-oral diseases. In the first report, a high concentration of
F. alocis was detected by 16S DNA analysis in the pleural fluid from a 65- year old patient
hospitalized for thoracic empyema [74]. The second study reported that 16S rRNA
sequencing identified F. alocis in the brain abscess fluid from an 85-year old patient
hospitalized for dysarthria and left side paralysis [75]. These studies strengthen F. alocis’
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potential for systemic dissemination and position the bacteria as a pathogen that can
colonize and drive inflammation in distal organs outside the oral cavity.

Neutrophil Effector Functions: The calm before the dysbiotic storm
Polymorphonuclear leukocytes, or neutrophils account for 40% to 60% of
peripheral blood leukocytes in humans and are the most abundant white blood cell present
in the gingival crevice or periodontal pocket [76, 77]. They play an essential role in the
innate immune response, as demonstrated by the development of life-threatening infections
or uncontrolled inflammation in individuals with severe neutropenia or genetic disruptions
of neutrophil anti-microbial capabilities [78-80]. While it is true that to effectively clear
invading organisms, neutrophils must be capable of mounting rapid, vigorous responses to
activating stimuli, uncontrolled or prolonged neutrophil activation uses antimicrobial
responses to injure normal host cells, leading to pathologic changes to tissues and organs
in autoimmune and inflammatory diseases like periodontitis [81]. Consequently, although
neutrophil activation is normally tightly regulated, oral pathogens have evolved
mechanisms to manipulate neutrophil functions to the bacteria’s advantage. To better
understand how the dysbiotic microbial community in the oral cavity disarms neutrophils
at every step of their lifespan, first it is important to appreciate these effector functions at
their optimal response. Thus, here I highlight normal neutrophil functions before discussing
how oral pathogens distort them.
Figure 1.1 depicts the different functions that neutrophils perform from circulation
to the site of infection, which will be described with more detail in this section. Circulating
neutrophils exist in a basal state, characterized by non-adherence, a round morphology,
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minimal transcriptional activity, and a limited capacity to respond to activating stimuli.
However, microbial invasion or tissue injury will release pathogen-associated molecular
pattern (PAMPs) or damage-associated molecular pattern (DAMPs) molecules that induce
sentinel immune cells to release pro-inflammatory cytokines. Those cytokines first modify
the adhesion molecules on endothelial cells to facilitate the capture of circulating
neutrophils [82]. Additionally, the cytokines from tissue-resident cells will affect the
adhesion receptor pattern of neutrophils by inducing the shedding of selectins and the
fusion of neutrophil secretory vesicles with the plasma membrane, which leads to increased
expression of integrins and other receptors that augment the responsiveness of neutrophils.
Transmigration through the endothelial cell layer occurs primarily at endothelial cell
junctions and is mediated by a number of adhesion molecules [83, 84]. Next, neutrophils
will release proteolytic enzymes like gelatinase to traverse the vascular basement
membrane and enter the extravascular space [85]. Once there, neutrophils detect the
intensity of chemotactic gradients and move with directionality first towards intermediate
chemoattractants (IL-8, leukotriene B4, and platelet activated factor) and then towards end
target chemoattractants (bacterial formylated peptides and complement fragments C5a and
C3a) [86, 87].
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Figure 1.1: Sequential steps of classic neutrophil recruitment and activation.

As professional phagocytes, neutrophils will rapidly and readily undergo the
receptor-mediated process of phagocytosis [88]. Phagocytosis occurs most efficiently by
the recognition of complement or IgG-opsonized particles, and while non-opsonized
phagocytosis can occur it is less efficient since neutrophils possess fewer non-opsonic
receptors than macrophages [89]. Once the particle is engulfed, production of reactive
oxygen species (ROS) and fusion of antimicrobial granules will contribute to the
phagosome’s maturation and lethality [88]. The complementary actions of the granule
proteases and ROS production will create a highly toxic environment that few microbes
can survive.
Reactive oxygen species (ROS) are generated through the conversion of molecular
oxygen to superoxide by the multi-component NADPH oxidase complex. The oxidase is
comprised of three membrane subunits (gp91phox/NOX2, p22phox, and Rap1A), and four
cytosolic proteins (p47phox, p67phox, p40phox, and Rac2). Spatial separation of the membrane
and cytosolic components maintains enzymatic inactivity in resting neutrophils. Upon
stimulation, the cytosolic components translocate to the membrane bound components to
form the catalytically active enzyme complex [90-92]. Notably, neutrophils have the
capacity to tailor their response depending on the type of stimuli they encounter.
Stimulation of neutrophils by a soluble stimulus, such as fMLF, triggers assembly and
activation of the NADPH oxidase at the plasma membrane and release of superoxide anions
towards the extracellular space. In contrast, if neutrophils encounter a particulate stimuli,
for example a bacterium, assembly and activation of the NADPH oxidase will take place
at the membrane of the bacteria-containing phagosome with release of superoxide anions
inside the phagosome [93-95].
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Neutrophil granules are divided into four classes based on granule density and
contents [96-99]. Secretory vesicles are created by endocytosis, while gelatinase (tertiary),
specific (secondary), and azurophilic (primary) granules are formed from the trans-Golgi
network during neutrophil maturation [100]. Like ROS production, the different neutrophil
granule subtypes can either be recruited to the bacteria-containing phagosome or stimulated
to undergo exocytosis and release their matrix content to the extracellular environment
[101]. Normally granule subsets undergo an ordered release based on stimulus intensity,
termed graded exocytosis [97, 98]. A weak stimuli induces mobilization of secretory
vesicles, and increasing stronger stimulation is required to mobilize gelatinase, specific,
and azurophil granules, respectively [102]. The diverse repertoire of proteins and receptors
present at the membrane of each granule subtype, as well as within the granule lumen,
highlights the important role each granule plays in the different neutrophil responses during
inflammation [103-105]. However, the antimicrobial efficacy of neutrophils on
intracellular and extracellular microorganisms is enhanced by the ability to combine both
oxygen-dependent and independent mechanisms.
Under homeostatic conditions, after their release from the bone marrow into
circulation, neutrophils are programmed to undergo apoptosis ~12-24 hours and are cleared
by macrophages in the liver, spleen, and bone marrow [106]. In tissues, neutrophil lifespan
is prolonged by cytokines (IL-1β, TNFα, GM-CSF, G-CSF, and interferon (IFN) γ),
microbial components, and the local environment [107]. Moreover intracellular pathogens
like Anaplasma phagocytophilum, Chlamydia pneumoniae, and Francisella tularensis can
promote neutrophil viability as a way to protect their replicative niche, whereas other
microbes like Streptococcus pyogenes, Staphylococcus aureus, and Pseudomonas
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aeruginosa accelerate apoptosis, trigger neutrophil lysis, or redirect cell death towards
necrosis to evade intracellular killing [89]. In addition to apoptosis pathways activated
through extrinsic receptor ligation or intrinsic mitochondrially-mediated pathways,
neutrophils can also undergo apoptosis through a process termed phagocytosis-induced cell
death (PICD), that is triggered by phagocytosis of complement- or antibody-coated
particles and bacteria, production of NADPH oxidase-derived ROS, and global changes in
gene expression [108, 109]. Apoptosis is a critical step to minimize tissue damage by
downregulating the phagocytic and proinflammatory capacity of neutrophils and
preventing release of neutrophil cytotoxic components into the extracellular space [110112]. Additionally, timely apoptosis and clearance of neutrophil corpses by macrophages
minimizes tissue damage because this process dampens pro-inflammatory cytokine
production and reprograms macrophages to a pro-resolution phenotype that favors
restoration of tissue homeostasis [113-115].

Neutrophils in the progression of periodontitis
Neutrophils are the most abundant white blood cell present in the gingival crevice
or periodontal pocket [77]. They are recruited into the periodontal pocket by following
chemotactic gradients produced endogenously by the junctional gingival epithelium and
serum-derived factors or exogenously by the microbial community. This chemotactic
gradient is comprised of pro-inflammatory cytokines like interleukin (IL)-8, IL-1b, and
chemokines like CXCL12 secreted by gingival epithelial cells, pro-inflammatory serumderived products like C5a, and microbial and biofilm derived chemotactic factors like Nformyl-met-leu-phe (fMLF) peptide, lipopolysaccharide (LPS) [116, 117]. As neutrophils
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migrate toward the crevicular fluid, they will form a protective wall between the bacterial
community and the junctional epithelium [118-120]. Here, neutrophil microbicidal
mechanisms will reduce the bacterial burden, but the host must strike a balance between
the protective and damaging effects of neutrophils since excessive neutrophil-driven
inflammation results in collateral tissue destruction.
Neutrophils are indispensable in the innate immune response against bacterial
infection and are critical for maintaining homeostasis in the oral cavity (reviewed in [121]).
This is best illustrated in patients with neutropenic diseases or genetic defects that affect
neutrophil function like Leukocyte adhesion deficiency type I (LAD-I syndrome),
Chediak-Higashi syndrome, and Papillon-Lefèvre syndrome, who develop severe
periodontitis (reviewed in [122, 123]). Nonetheless, despite their beneficial role in
homeostasis, neutrophils are implicated as the main immune cells responsible for the
progression of periodontitis [124, 125]. Under periodontal disease conditions, neutrophils
are supernumerary, hyperactivated, or display dysregulated functions. Neutrophil effector
functions are likely altered in periodontitis through products from the chronic inflammatory
environment that contribute to a primed and hyperactive phenotype [126, 127] or through
the manipulating mechanisms of periodontal pathogens, which will be the focus of this
section (Table 1.1).
Many studies have compared neutrophils from periodontitis patients to those of
healthy controls, and found that while periodontitis neutrophils had augmented phagocytic
capacity, they showed defects in chemotaxis, apoptosis and released significantly higher
quantities of reactive oxygen species (ROS), anti-bacterial enzymes, neutrophil
extracellular traps (NETs), and pro-inflammatory cytokines [128-131]. Together, this

18

results in the inefficient killing of microbial pathogens, unresolved inflammation, and the
destruction of the tooth supporting tissues via the release of tissue-degrading enzymes or
inflammatory and toxic molecules [132-134]. To better understand the interaction of
emerging periodontal pathogens like F. alocis on neutrophil functions, it is necessary to
know the context of how well-established pathogenic oral bacteria can obstruct normal
neutrophil functions to promote disease (Figure 1.2).

Figure 1.2: Mechanisms by established oral pathogens to disrupt neutrophil functions

Manipulation of Neutrophil Effector Functions by Periodontal Pathogens
Chemotaxis:
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As the bacterial burden increases during periodontitis progression, neutrophil
recruitment and accumulation also magnifies. Not only are neutrophils the predominant
immune cell isolated from various oral fluids, but neutrophil counts correlate with the level
of inflammation, the increasing depth of the periodontal pocket and the severity of chronic
periodontitis [117, 135-137]. Defects in chemotaxis greatly contribute to the high presence
of neutrophils in tissues, and pathogenic oral bacteria are known to modulate this
neutrophil function. A clinical study from Roberts et. al showed that peripheral blood
neutrophils from chronic periodontitis patients had reduced chemotactic capacity, velocity,
and accuracy towards IL-8 and fMLF gradients, which was partially recovered when the
patients received non-surgical therapy [138]. One of the most effective ways pathogenic
oral bacteria restrict neutrophil chemotaxis is indirectly, by interfering with the
chemotactic gradient. T. denticola can degrade IL-8 through the action of dentilisin, a
major outer membrane protease [139]. Additionally, T. denticola and P. gingivalis can both
suppress IL-8 production by gingival epithelial cells to cause local chemokine paralysis
[140, 141].
Alternatively, oral bacteria can disarm neutrophil migration by acting on the
neutrophil itself. The supernatant from sonicated organisms like F. nucleatum, A.
actinomycetemcomitans, and P. gingivalis can bind and antagonize neutrophil chemotactic
receptors to prevent the detection of the chemotactic gradient and thus, inhibit neutrophil
migration towards known chemoattractants [142, 143]. Microbial products like the Major
Sheath Protein (MSP) of T. denticola can also interfere with cytoskeletal signaling
pathways that mediate cell movement [144-148]. Pathogenic oral bacteria also employ
misdirection mechanisms: P. gingivalis can downregulate the expression of cell adhesion
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molecules like E-selectin and intracellular adhesion molecule (ICAM)1 that are required
for leukocyte extravasation [149-152], while leukotoxin from A. actinomycetemcomitans
enhances random migration of neutrophils [153].
When the neutrophil directed migration pattern is altered, they will become vagrant
cells and accumulate at the periodontal pocket and adjacent connective tissue. This
meandering neutrophil behavior is beneficial to the microbial community because it
decreases the chances of neutrophil-bacteria interaction while increasing the chances for
bacterial colonization. Paradoxically, the same periodontal bacteria can contribute to the
recruitment of neutrophils to the gingival tissue through the actions of their proteases.
Mirolysin and karilysin from T. forsythia and arginine-specific gingipain (RgpA) from P.
gingivalis can cleave complement component 5 (C5) to generate the anaphylatoxin C5a,
which strongly recruits neutrophils [154-156]. It has been shown that the concentration of
gingipains released by P. gingivalis is tailored to promote bacterial survival. At early
infection stages gingipains can be found at low concentrations, promoting cleavage of C5
and generation of C5a which stimulates neutrophil recruitment that will enhance tissue
destruction and provide nutrients for the dysbiotic community. However, when their
concentration increases once the biofilm has been formed in deeper periodontal pockets,
they inhibit the complement pathway to protect P. gingivalis and bystander bacteria from
complement and neutrophil killing [157].

Phagocytosis:
The insidious manipulation of neutrophils by oral pathogens continues at the level
of phagocytosis and microbicidal mechanisms. T. denticola and P. gingivalis efficiently
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block neutrophil phagocytic events by interfering with cytoskeleton pathways, which
provides protective advantages to other bacteria in the oral cavity [148, 158, 159].
Neutrophils treated with MSP from T. denticola had diminished incorporation of actin
monomers during de novo filament assembly, which resulted in decreased uptake of IgGcoated spheres [148]. Alternately, P. gingivalis activates PI3K-dependent signaling
pathways that suppress RhoA GTPase activity and actin polymerization, thus inhibiting the
formation and extension of lamellipodia necessary to form the phagocytic cup [158, 159].
While some oral bacteria like T. denticola, A. actinomycetemcomitans, and P. gingivalis
naturally avoid phagocytosis by neutrophils, the presence of complement and antibodies
can overcome this resistance [128, 160, 161]. The problem that arises is that T. denticola
and P. gingivalis proteases can degrade C3 or other upstream components of the
complement pathway to synergistically inhibit complement opsonization and killing [154,
157]. Additionally, despite the finding that patients with periodontitis have high serum IgG
levels against P. gingivalis, the lysine-specific gingipain K (Kgp) is able to cleave IgG1
and IgG3 at the hinge region, which separates the antigen binding region of the antibody
from the effector fragment, resulting in the inactivation of IgG-mediated opsonization
[162-164]. When neutrophils are not able to engulf the bacteria, they resort to extracellular
killing mechanisms that also drive inflammation.

ROS Generation:
Activation of neutrophils, either by a particulate or soluble stimulus, results in
assembly of the NADPH oxidase multi-component enzymatic complex and robust
production of ROS [165]. Generally, ROS produced from neutrophils contributes to
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bacterial killing and intracellular signaling; however, excessive ROS can have cytotoxic
effects on periodontal tissues through oxidative damage to DNA and proteins, interference
with cell growth and cell cycle progression, and induction of apoptosis of gingival
fibroblasts [166-170]. Indirectly, ROS can also induce alveolar bone resorption through
their role as intracellular signaling molecules in osteoclastogenic pathways [171]. Like
other effector functions, the normal ROS generation by neutrophils is compromised in the
context of periodontitis. Neutrophils isolated from subjects with periodontitis released
significantly more reactive oxygen species in the absence of stimulus when compared to
neutrophils from healthy controls [128], but this was not due to increased expression of
NADPH oxidase components [172]. When tested against individual oral bacteria in vitro,
neutrophils can mount an ROS response of varying degrees against T. denticola, T.
forsythia, F. nucleatum, A. actinomycetemcomitans, and P. gingivalis, although the extent
of ROS production heavily depends on the strain used, multiplicity of infection, and
opsonization [160, 173-177]. Once generated, ROS do not discriminate between host and
pathogen cells, and contribute heavily to disease progression since patients with
hyperactive ROS response are more susceptible to periodontitis [178, 179]. Notably,
patients with Chronic Granulomatous Disease (CGD), who cannot mount a respiratory
burst response, are not more susceptible to periodontitis, suggesting that ROS are not
critical for maintenance of periodontal health [180].
The contribution of ROS to periodontal destruction was highlighted in a clinical
study that treated chronic periodontitis patients with lycopene, an antioxidant [181].
Lycopene-treated patients had reduced oxidative stress and improved clinical parameters
like gingival inflammation, periodontal probing depth, and clinical attachment loss. This
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improved outcome could be observed up to 4 months after discontinuing antioxidant
treatment, suggesting that if ROS formation can be limited, the destruction of periodontal
tissues can also be restricted. The inefficacy of ROS against oral pathogens may be due, in
part, to bacterial virulence factors that confer protection for the entire bacterial community.
Several oral pathogens like A. actinomycetemcomitans, F. nucleatum, and P. gingivalis
express superoxide dismutase (SOD), which catalyzes the dismutation of superoxides into
hydrogen peroxide [182-185]. The master neutrophil manipulator, P. gingivalis also
expresses rubrerythrin (Rbr) and alkyl hydroperoxidase reductase (Ahp), which detoxify
hydrogen peroxide [186-188]. Additionally, through the proteolytic action of gingipains,
P. gingivalis can acquire heme deposits on its cell surface, which act as an oxidative sink
to further protect bacteria against the deleterious effects of ROS [189, 190]. Other
periodontal bacteria may be acting directly on neutrophils to control the ROS response, for
example F. nucleatum is able to inhibit fMLF-induced superoxide generation, although the
mechanism for this phenotype is still unknown [177].

Granule Exocytosis:
Cationic antimicrobial peptides are one of the very first lines of defense against
microbial invaders. In the oral cavity and gingival tissues, the extracellular defense is
predominantly mediated by release of human beta-defensins from epithelial cells and
neutrophil derived cathelicidin‐type peptide LL‐37 and alpha‐defensins found in the
neutrophil cytoplasm and granules [191]. The crevicular fluid from chronic periodontitis
patients contained significantly elevated quantities of LL‐37 and alpha‐defensins [192,
193]; regardless, periodontal pathogens have increased resistance to antimicrobial
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peptides, though this response seems to depend on the strain of bacteria tested [194-198].
The high resistance of periodontal pathogens to bactericidal activity of these peptides can
be partially explained through the action of bacterially derived proteolytic peptides. From
T. forsythia, miropin, and karilysin efficiently inhibited the activity of a broad range of
proteases (LL-37, neutrophil and pancreatic elastases, cathepsin G, subtilisin, and
trypsin) [199, 200], and gingipains from P. gingivalis directly cleaved multiple host
antimicrobial proteins, which conferred resistance against extracellular, non-oxidative
killing mechanisms [201-204]. Interestingly, the expression of these gingipains is increased
when P. gingivalis undergoes oxidative stress, suggesting there is a synergistic,
compounding attack against neutrophil mechanisms [205].
While neutrophil granule contents can be released into the extracellular matrix or
into a microbe-containing phagosome, most studies related to periodontal pathogens have
focused on the release of neutrophil granule contents in the context of tissue degradation.
A. actinomycetemcomitans, F. nucleatum, T. denticola, and P. gingivalis have all been
reported to induce the release of Matrix metalloproteinase 8 (MMP8), Matrix
metalloproteinase 9 (MMP9), elastase and lysozyme [173, 196, 197, 206-209]. The
exocytosis of neutrophil granules has also been confirmed in neutrophils isolated from the
oral cavity, since neutrophils from periodontitis patients express increased levels of
degranulation markers on their surface [210]. Elevated levels of neutrophil elastase,
plasminogen, and MMP9 were detected in periodontal ligament from chronic periodontitis
patients [211]. Zymographic analysis of these three proteinases was tested in vitro on
periodontal ligaments, and elastase was the only proteinase involved in the degradation of
collagen fibrils. Notably, the morphological features from the in vitro system were similar
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to that of the periodontal ligament in chronic periodontitis, which directly implicates this
neutrophil enzyme in the early destructive stages of periodontal disease [211]. Similarly,
bacterial proteases can also directly induce tissue degradation. Karilysin from T. forsythia
shares structural homology to human matrix metalloproteinases and can cleave elastin,
fibrinogen and fibronectin [212].
Host-derived protease inhibitors are produced locally as negative-feedback loops
to maintain homeostasis in oral tissues and regulate the activity of neutrophil proteases
[213]. Two of these protease inhibitors are secretory leukocyte protease inhibitor (SLPI)
inhibits neutrophil elastase activity and elafin targets elastase and protease 3 (PR3). Gene
expression of these protease inhibitors was significantly induced when gingival epithelial
cells were infected with P. gingivalis, but not T. forsythia, A. actinomycetemcomitans, or
F. nucleatum [214]. It has been suggested that P. gingivalis manipulates this system to
specifically dampen neutrophil antimicrobial responses since SLPI and elafin have no
inhibitory action against gingipains [215]. Paradoxically, gingipains will degrade SLPI and
elafin, supporting the notion that P. gingivalis sustains some level of inflammation to
maintain infection [214, 216]. Taken together, these studies show there is an additional
level of complexity where oral pathogens can interfere with the host regulation of
extracellular neutrophil granule protein activity to protect the microbial community while
still maintaining inflammation.

NET formation:
NETs represent an immune defense mechanism deployed by neutrophils to
immobilize and kill invading microbes or contain biofilms from disseminating into other

26

sites of the body [217]. However, as with all other neutrophil mechanisms, this function is
a double edged sword that has also been implicated in inflammation and induction of autoimmunity [218]. Confocal and electron microscopy of gingival biopsies and crevicular
exudates from patients with chronic periodontitis confirmed there was NET formation in
the oral cavity [219]. A later study found that neutrophils are attracted to the supragingival
biofilms, where they are stimulated to release NETs [220]. When individual oral bacteria
were tested against neutrophils, A. actinomycetemcomitans and F. nucleatum both induced
NET formation. F. nucleatum activated neutrophils through nucleotide oligomerization
domain (NOD) 1 and 2 and induced a time-dependent, robust release of NETs [221]. This
NETosis was independent of TLR stimulation and ROS production [176]. A.
actinomycetemcomitans was also able to induce NETosis through stimulation by the whole
bacterium as well as through stimulation with leukotoxin alone [153]. The presence of
serum and signaling through complement receptor (CR)1 enhanced NET release induced
by A. actinomycetemcomitans [222]. Contrasting reports have shown that P. gingivalis
does [223, 224] and does not [176] induce NET formation, though this conflicting data
may be mediated by bacterial strain differences. No studies have directly tested whether T.
forsythia or T. denticola can induce NET release from neutrophils. Regardless of whether
NETosis was induced by the oral pathogen, both A. actinomycetemcomitans and P.
gingivalis could be trapped by HOCl-produced NETs [176].
Despite initial trapping by NETs, several oral microbes like P. gingivalis,
Prevotella intermedia, and F. nucleatum, but not A. actinomycetemcomitans, express
nucleases with differing DNA degradation capacities [225, 226]. Additionally, P.
gingivalis expresses Porphyromonas peptidylarginine deiminase (PPAD), an enzyme that
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citrullinates histone H3, thereby facilitating the bacterial escape from NETs [227-230].
When neutrophils were cultured with P. gingivalis or purified Rgp gingipains, both
stimulants induced NETs that not only lacked bactericidal activity but instead stimulated
the growth of bacteria species otherwise susceptible to killing in NETs [224]. The
protection against killing by NETs was mediated through the proteolysis of bactericidal
components on the NETs. Taken together, some periodontal pathogens may be playing a
dual role in NETosis: they are the potent direct inducers of NETs formation but
simultaneously prevent bacterial entrapment and subsequent killing by NETs.

Bacterial Killing:
Neutrophils isolated from the crevicular fluid of periodontitis patients showed
decreased phagocytic activity and intracellular killing against A. actinomycetemcomitans
and P. gingivalis as compared to neutrophils from healthy controls, indicating that there is
a pervasive inhibition of bacterial killing during periodontitis [231]. When cultured under
anaerobic conditions, neutrophils were unable to eliminate P. gingivalis as tested by colony
forming units (CFU) [204]. P. gingivalis was also resistant to killing by neutrophil granule
contents, likely because P. gingivalis culture supernatant contains ginigipains that could
inactivate cathepsin G, elastase, bacterial-permeability increasing factor and defensins
[204, 232]. Addition of gingipain inhibitors to the P. gingivalis culture supernatant and
neutrophils, neutrophils regained their microbicidal capacity against the bacteria [233].
Neutrophils

were

also

able

to

significantly

kill

F.

nucleatum

and

A.

actinomycetemcomitans strain Y4 within an hour [128, 234, 235]. Other strains of A.
actinomycetemcomitans were able to resist intracellular microbidical mechanisms after an
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hour of challenge, which correlates with the levels of leukotoxin expression [236]. Notably,
exposure of neutrophils to nicotine severely dampens their ability to kill F. nucleatum and
A. actinomycetemcomitans, hinting at the severity of effects from host-driven susceptibility
[237]. Killing of T. denticola and T. forsythia has been reported by in vitro studies using
macrophages [238, 239], but to the best of our knowledge, no studies have examined
whether neutrophils can directly kill T. denticola or T. forsythia.
Whether the pathogenic bacteria can block killing by neutrophils on its own is not
as important in the case of the periodontal dysbiotic community because the protective
effects from one species could benefit others that do not have any virulence factors of this
type. Succinic acid, a metabolic, fatty acid byproduct of P. gingivalis and other Bacteroides
species, abolished neutrophil killing of Escherichia coli by decreasing neutrophils ability
to produce ROS [240, 241]. Similarly, when neutrophils were incubated with short chain
fatty acids derived from anaerobic bacteria, their ability to undergo granule exocytosis and
produce ROS was also diminished [242].
Out of the established periodontal pathogens, P. gingivalis’ survival around
neutrophils is the best characterized and depends on the cross-talk between two receptors
on the surface of neutrophils in vivo [158, 243]. While P. gingivalis directly activates
TLR2/1 receptors, the C5a formed by the gingipain-dependent cleavage of C5 will activate
the C5a receptor (C5aR1). The co-stimulation of these receptors results in the degradation
of the TLR adaptor protein MyD88 [158, 244]. This reroutes signaling through another
adaptor protein, MyD88 adaptor-like (Mal, also known as TIRAP). This is significant
because activation of the MyD88-dependent signaling pathway is associated with the
initiation of antimicrobial responses while Mal-dependent pathways activate PI3K and
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block phagocytosis, while still resulting in the release of pro-inflammatory cytokines.
Thus, by redirecting signaling through Mal instead of MyD88, P. gingivalis dismantles the
killing activity of neutrophil, but not the proinflammatory activity [122]. Nonetheless, little
to no literature is available to explain how some oral pathogens can survive within the
hostile environment of the neutrophil phagosome.

Cytokine Production:
The role of neutrophils as regulators of the immune response has gained increasing
recognition because of their capacity to transcribe, perform de novo synthesis, and release
different cytokines and chemokines [245-247]. Depending on the type of stimulation they
encounter, neutrophils can produce and release an array of different cytokines and
chemokines, which is significant in the amplification loop of the local immune response
[246-250]. Although each individual neutrophil may not produce quantities comparable to
other immune cells, in periodontitis where neutrophils accumulate in great numbers, the
collective release of cytokines and chemokines by neutrophils can especially play a role in
tissue damage. It is unknown whether T. forsythia or A. actinomycetemcomitans induce
direct cytokine production by neutrophils, but reports show that T. denticola, F. nucleatum,
and heat-killed P. gingivalis induce release of pro-inflammatory cytokine IL-1β [160, 251].
F. nucleatum and its LPS also induce robust release of IL-8 and TNFα from neutrophils
[131, 177]. LPS from A. actinomycetemcomitans stimulated the release of significantly
greater amounts of IL-1β, TNFα, and IL-8 than the response elicited by P. gingivalis-LPS
[252]. However, challenge of neutrophils with P. gingivalis results in the release of TNFα,
IL-8, and CCL2 [252, 253]. A noteworthy distinction is that the best practice for measuring
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neutrophil-derived cytokines is to test a neutrophil population that is as pure as possible
since contamination of even 0.01% of monocytes can skew the cytokine and chemokine
populations significantly [254, 255].

Apoptosis:
Signs of cell death are readily observed in gingival tissue [256, 257]. The gingival
tissues of chronic periodontitis patients show increased activity of caspase 3 and caspase
7, the executioners of apoptotic cell death [258]. Moreover, periodontal pathogens, such as
T. denticola, P. gingivalis, and T. forsythia, elicit the release of adenosine triphosphate
(ATP), uric acid, heat shock protein (HSP)60, and High Mobility Group Box (HMGB)1
from THP-1 derived macrophages, indicating the presence of pyroptotic cell death in
periodontal tissue [259]. Although cell death pathways in epithelial cells and macrophages
have been well studied after interaction with periodontal pathogens, there are only a few
publications that have addressed neutrophil viability after encounters with oral bacteria.
Transcriptionally, neutrophils from chronic periodontitis patients have significantly
upregulated pro-survival pathways [260]; however, most studies on periodontal bacteria
and neutrophil lifespan have only measured cell death at very short-timepoints (three hours
or less) post bacterial challenge. For example, F. nucleatum, P. gingivalis and T. denticola
did not induce lactate dehydrogenase (LDH) release from neutrophils after 1-hour
challenge with neutrophils [196]. Incubation of neutrophils with T. denticola for an hour
resulted in a mild increase in cell death only detected in neutrophils that phagocytosed
antibody coated T. denticola at a multiplicity of infection (MOI) of 100 bacteria per
neutrophil [160]. Under the same experimental set-up, F. nucleatum induced cell death in
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a MOI and antibody opsonization-dependent manner [160, 261]. The induction of
apoptosis persisted when neutrophils were treated with multiple strains of F. nucleatum
[177]. Uptake of antibody-opsonized A. actinomycetemcomitans after 1 hour of challenge
also resulted in the rapid cell death of neutrophils [236]. The induction of apoptosis after
such short timepoints suggests the neutrophils challenged with A. actinomycetemcomitans,
P. gingivalis, F. nucleatum, and T. denticola underwent phagocytosis-induced cell death
(PICD), which is linked to the production of ROS [108, 262]; however, since periodontal
bacteria can resist neutrophil phagocytosis, the probability of PICD may not occur very
often in vivo.
Compounding the length of neutrophil lifespan is the presence of several proinflammatory mediators that promote neutrophil longevity at sites of inflammation, such
as LPS, liopoteichoic acids (LTA), TNFα, C5a, IL-1α, granulocyte-macrophage colonystimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), and
interferon (IFN) γ, and render these granulocytes resistant to extrinsic ligand-induced
apoptosis (FS-7-associated surface antigen (FAS) and TNF) [263, 264]. Additionally, the
products of periodontal bacteria can also lead to changes in neutrophil survival. Neutrophil
challenge for 1-3 hours with MSP from T. denticola does not induce cell death [148] and
culture of neutrophils with the LPS from three different P. gingivalis strains delayed
apoptosis

in

a

dose-dependent

fashion

[265-267], but

leukotoxin

from

A.

actinomycetemcomitans directly lyses neutrophils [236, 268]. Notably, it is unknown
whether direct interaction with T. forsythia or products from the bacteria will affect
neutrophil lifespan.

32

Induction of neutrophil apoptosis is beneficial to the bacteria because it will prevent
neutrophil phagocytosis and microbicidal mechanisms from eliminating the bacterial
burden. However, when neutrophil apoptosis is delayed, the inflammophillic bacteria still
profit because inflammation worsens by two mechanisms: (1) collateral tissue damage
increases because neutrophils will accumulate and continue to release degradative
neutrophil enzymes and ROS, and (2) resolution of inflammation is delayed because
clearance of apoptotic cells though efferocytosis cannot take place, which is essential for
the initiation of tissue restoration mechanisms.

Neutrophils against emerging oral pathogens
Considering the identification of novel bacteria associated with periodontitis, there
is still a significant gap in our understanding of the role of these organisms in the disease
etiology. Without a full understanding of the pathogenic potential of abundant organisms
in the periodontal lesions, there is a substantial barrier to the development of new
approaches to prevent or ameliorate the disease. Since neutrophils are a key component of
host innate immunity that must be overcome by pathogenic periodontal bacteria, studies
on how neutrophils control or are thwarted by emerging oral pathogens afford vital
contributions to the scientific community.
So far, characterization of F. alocis’ interaction with neutrophils has demonstrated
that this putative oral pathogen can modulate neutrophil effector functions for its nefarious
purposes. Unlike many periodontal pathogens, F. alocis does not resist phagocytosis by
human neutrophils [269]. In fact, most neutrophils challenged with F. alocis rapidly
internalized the bacteria independent of viability or opsonization with complement. This is
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likely because viable F. alocis is capable of disrupting the neutrophil antimicrobial
response. After 4 hours of challenge, >50% of F. alocis remain viable inside neutrophils,
and electron microscopy analysis of F. alocis-infected neutrophils showed that electron
dense bacteria could still be found inside neutrophil phagosomes after 20 hours of coculture, suggesting a defect in the degradation and clearance of engulfed bacteria.
To dissect how F. alocis could actively remain viable despite the toxic capacity of
neutrophils, the progression of phagosome maturation was assessed by testing oxygen
dependent and independent mechanisms of intracellular killing against viable and heatkilled F. alocis. When the production of intracellular ROS was measured, heat-killed F.
alocis induced a robust ROS response that was four times greater than the amount of ROS
produced by neutrophils stimulated with viable F. alocis [269]. Furthermore, viable F.
alocis did not suppress the respiratory burst induced by a secondary stimulus like heatkilled Staphylococcus aureus; suggesting that inhibition of ROS production is not a global
effect, but rather a local phagosomal mechanism geared towards promoting survival. The
second, oxygen-independent arm of intracellular killing is mediated through the fusion of
pre-formed granules with the bacteria-containing phagosome. However, live F. alocis
could also control granule trafficking to the phagosome to prevent phagosome maturation.
Viable F. alocis phagosomes had decreased co-localization with key antimicrobial proteins
lactoferrin and elastase whereas twice as many heat-killed F. alocis phagosomes had
efficient co-localization [269]. Thus, F. alocis actively subverts elimination by neutrophil
by inducing a minimal respiratory burst response and preventing phagosome maturation.
As an inflammophilic bacteria, F. alocis still drives pro-inflammatory processes to
secure a source of nutrients for replication. F. alocis is recognized by neutrophils through
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ligation of TLR2, which triggers the exocytosis of three of the four neutrophil granule
subtypes through activation of both p38 MAPK and ERK1/2 [270]. The release of toxic
granules has implications for tissue degradation, which could be directly observed through
gelatin zymography of supernatants of F. alocis-stimulated neutrophils [269]. In addition,
neutrophils challenged with either live or heat-killed F. alocis, showed enhanced random
and directed migration towards IL-8; an effect that was dependent on the bacteria-induced
granule exocytosis [270].
Remarkably, F. alocis appears to play the role of referee and helps limit the
system’s overall inflammation. Specifically, F. alocis does not induce NET formation at
any bacterial dose or time tested; additionally, pre-treatment of neutrophils with F. alocis
significantly inhibits PMA-induced NETs [271]. F. alocis is recognized by TLR2/6
heterodimers and promotes the release of neutrophil-derived cytokines and chemokines but
to a lesser extent compared to another emerging oral bacterium, Peptoanaerobacter
stomatis [253]. Additionally, F. alocis induced significant release of anti-inflammatory
cytokine, IL-1ra, which was greater than the amount induced by P. gingivalis.

Dissertation Goals
Much work remains to fully understand the mechanism of how F. alocis contributes
to the progression of periodontitis. A large piece of that puzzle is to define how the putative
oral pathogen interacts with neutrophils. Based on published work, F. alocis follows a
similar pattern as described for other periodontal pathogens, to evade killing by neutrophils
while simultaneously promoting inflammation. Nonetheless, it was unknown how F. alocis
manipulates neutrophil functions. I hypothesized that F. alocis interferes with signaling
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pathways to block extermination by neutrophils while inducing a pro-inflammatory
environment, so I completed a transcriptome study of F. alocis-challenged neutrophils
(Chapter 2) and found that Toll-like receptor (TLR) signaling (Chapter 3), apoptosis
pathways (Chapter 4), and efferocytic clearing (Chapter 5) are affected in F. alocischallenged neutrophils.
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Table 1.1: Oral Pathogens’ Effects on Neutrophil
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ROS
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No Effect
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Induced
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Filifactor alocis

Induced

[143, 153]
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gingivalis

Extract from
Pg was
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chemotaxis
to other
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[236]
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CHAPTER 2:
WHOLE TRANSCRIPTOME ANALYSIS REVEALS THAT FILIFACTOR ALOCIS
MODULATES TNF-STIMULATED MAPK ACTIVATION IN HUMAN
NEUTROPHILS.

Introduction:
Periodontitis is a chronic inflammatory disease where inflammophilic pathogenic
bacterial communities accumulate at the gingival crevice. These dysbiotic microbial
communities induce a severe inflammatory response that fails to control bacterial growth
and contributes to the irreversible destruction of the tooth-supporting tissues [8].
Historically, periodontal research has focused on the pathogenic members of the ‘red
complex,’

which

includes

Porphyromonas

gingivalis,

Treponema

denticola, and Tannerella forsythia. However, recent human microbiome studies have
revealed many previously uncultured organisms with a strong correlation with periodontal
disease [36, 38]. One of these newly appreciated species is Filifactor alocis, a Grampositive anaerobic rod whose pathogenic potential and contribution to periodontal diseases
is emerging. F. alocis is consistently and abundantly found in periodontal active lesions
[49, 50, 57, 278-280]. Furthermore, F. alocis shares virulence characteristics with other
periodontal pathogens such as resistance to oxidative stress, biofilm formation, secretion
of proteases, and evasion of the immune system [48, 58, 59, 62, 73].
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Neutrophils constitute an overwhelming majority of the leukocytes recruited to the
oral cavity, where they are essential for maintaining homeostasis of periodontal tissues
[119, 281, 282]. Neutrophils can deploy several strategies to efficiently detect, detain and
destroy microbes. These include phagocytosis, release of antimicrobial enzymes or toxic
factors, generation of massive amounts of reactive oxygen species (ROS) and the discharge
of their nuclear material into neutrophil extracellular traps (NETs) [283]. However, oral
pathogens have evolved mechanisms to manipulate neutrophil functional responses to
prevent being killed while propagating inflammation [14, 282]. Previous work from our
laboratory has shown that despite efficient phagocytosis by neutrophils, F. alocis survives
within neutrophils by inducing minimal production of intracellular ROS and curtailing the
fusion of antimicrobial granules with its phagosome [275, 284]. However, in comparison
to the keystone oral pathogen, P. gingivalis, and another emerging oral pathogen,
Peptoanaerobacter stomatis, challenge with F. alocis resulted in a mild release of
neutrophil-derived pro-inflammatory cytokines, which resulted in limited recruitment of
monocytes and other neutrophils [253]. Thus, I hypothesize that F. alocis may modulate
neutrophil signaling events to interrupt pro-inflammatory cytokine production and alter
immune cell recruitment and communication.
The Mitogen-activated protein kinases (MAPKs) are evolutionarily conserved
regulators that carry out signal transduction for many cellular functional processes. MAPK
activation cascades are well characterized, and usually begin with the ligation of cell
surface receptors followed by activation of a relay cascade of phosphorylation of three core
kinases: MAP3K, MAP2K (MEK or MKK) and MAPK. Active MAPKs can phosphorylate
a variety of intracellular targets, including transcription factors, nuclear pore proteins,
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membrane transporters, cytoskeletal elements, and other protein kinases, so their activation
is subjected to spatiotemporal regulation by complex feedback and crosstalk mechanisms
[285, 286]. In human neutrophils, bacterial lipopolysaccharide (LPS) activates Toll-like
Receptor (TLR) 4 followed by downstream activation of MAPK signaling pathways and
the transcription factor regulator nuclear factor (NF)-κB; both of which can independently
regulate the production of inflammatory cytokines and chemokines [287, 288]. Both p38
MAPK and ERK pathways control transcription and translation of inducible cytokines in
neutrophils stimulated with LPS or TNFα [289]. Due to the relevant role that MAPK
signaling plays in regulation of immune responses, it is not surprising that some pathogens
have developed mechanisms to hijack this signaling cascade on immune cells [290, 291].
For example, Mycobacterium tuberculosis acetylates a MAPK phosphatase, DUSP16, to
increase phosphatase activity on Janus kinase (JNK) and limit inflammatory cytokine
production by bone marrow-derived macrophages [292]. Prior work from our group
showed that F. alocis initially activates both p38 MAPK and ERK1/2 through TLR2 [275];
however, it is unknown what the MAPK response is after F. alocis stimulation for longer
time points or how the cells respond to secondary stimuli after F. alocis challenge.
Few sequencing studies have tracked transcriptome changes in human neutrophils
during challenge with a bacterial pathogen [293-296]. Even fewer studies have measured
changes in the neutrophil transcriptome associated with challenge by putative oral
pathogens. Thus, I sought to characterize global changes at the gene expression level in
human neutrophils during infection with F. alocis. Analysis of whole-transcriptome by
RNA-based next-generation sequencing (RNAseq) shows that F. alocis challenge alters
the human neutrophil transcriptome by inducing significant changes in the expression of
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genes involved in various neutrophil effector functions. One of the findings of our RNAseq screen was that F. alocis challenge affected the expression of components in both the
TNF and MAPK kinase signaling pathways. This resulted in decreased p38 MAPK
activation by secondary stimuli TNFα, but not fMLF. Moreover, only live F. alocis limited
the TNFα-stimulated production of IL-8, demonstrating that this is one of the mechanisms
actively induced by the oral pathogen to control neutrophil functional responses.

Materials & Methods:

Human neutrophil isolation: Human donor recruitment, blood draws, and the use of the
materials required for this procedure were in accordance with the guidelines approved by
the Institutional Review Board of the University of Louisville. Neutrophils were isolated
from venous blood of healthy donors using plasma‐Percoll gradients, as described
previously [297]. Neutrophil populations were further enriched to obtain highly pure cells
(>99%) by negative magnetic selection using the Easy Eights EasySep Magnet and human
neutrophil enrichment kit (Stemcell Technologies, Vancouver, BC, Canada), as previously
described [298]. Cell purity was assessed by simultaneously staining with FITC‐
conjugated anti‐CD66b (clone G10F5; BioLegend, San Diego, CA, USA) and APC‐
conjugated anti‐CD16 (clone CB16; eBioscience, San Diego, CA, USA) antibodies and
determining the percentage of CD66b+CD16+ cells using BD Celesta flow cytometer (BD
Biosciences, San Jose, CA, USA). Both pure (>90–95%) and highly pure (>99%)
neutrophils were cultured in complete RPMI‐1640 medium (Sigma-Aldrich, St. Louis,
MO, USA) with 5% human serum (Atlanta Biologicals, Flowery Branch, GA, USA).
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Bacterial strains and growth conditions: F. alocis ATCC 38596 was cultured in brain heart
infusion (BHI) broth supplemented 5 mg/mL yeast extract, L-cysteine (0.05%) and
arginine (0.05%) for 7 days anaerobically at 37 °C as previously described [275, 276].
Serum opsonization was performed by incubating F. alocis at 37°C for 20 min in 10%
normal human serum (Complement Technology, Inc., Tyler, TX, USA). Heat killed F.
alocis was generated by incubation at 90 °C for 60 min. Non-viability was confirmed by
incubation in culture media at same conditions used for the live organism.

F. alocis challenge and RNA isolation: Highly pure (>99%) human neutrophils (10–20 ×
106 cells/mL) were unstimulated or challenged with opsonized F. alocis at a multiplicity
of infection (MOI) of 10, for 1, 3, or 6 h. The infection was synchronized by centrifugation
at 14°C for 4 min at 600×g. After each time point, the cells were harvested using Trizol
(Life Technologies, Carlsbad, CA, USA) and stored at -80°C until RNA extraction. RNA
was isolated from unstimulated and F. alocis challenged human purified neutrophils using
the hybrid method of Trizol and RNeasy minikit (Qiagen, Venlo, Netherlands). The
aqueous phase containing RNA was loaded on the Qiagen column for further purification
of RNA. The purified RNA quality was measured by running sample on Bioanalyzer.

Library Preparation: The isolated RNA was checked for integrity using the Agilent
Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA) and quantified
using a Qubit fluorometric assay (Thermo Fisher Scientific, Waltham, MA, USA). Total
RNASeq libraries were prepared following Illumina’s TruSeq Stranded Total RNA LT
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with Ribo-Zero Gold library preparation protocol (Illumina Inc., San Diego, CA, USA,
Cat# RS-122-2301). After depletion of ribosomal RNA, all samples were ligated with
Illumina adapters and individually barcoded. Absence of adapter dimers and consistent
library size of approx. 300 bp was confirmed using the Agilent Bioanalyzer 2100. Library
quantitation was performed by qPCR using the KAPA Library Quantitation Kit (Kapa
Biosystems, part of Roche Sequencing and Life Science, Wilmington, MA, USA) for
Illumina Platforms.

Sequencing run: 1.8 pM of the library pool was loaded with 1% PhiX spike-in on two
NextSeq 500/550 75 cycle High Output Kit v2 sequencing flow cells. Sequencing was
performed on the Illumina NextSeq 500 sequencer targeting 50M 1x75bp reads per sample.

Bioinformatic analysis: Each of four single-end raw .fastq files for each replicate was
concatenated into one single end .fastq file using the unix cat command. A total of sixteen
files representing four independent donors and four experimental conditions were
generated. Quality control (QC) of the raw sequence data was performed using FastQC
(version 0.10.1) [47]. The interquartile range remained above 30 (99.9% base call
accuracy) across the reads. The concatenated sequences were directly aligned to the Homo
sapiens reference genome assembly (hg38.fa) using tophat2 (version 2.0.13) [300],
generating alignment files in bam format. The alignment rate ranged from 88 to 93 percent
across the samples. Differential expression analysis between each treatment condition (1hr,
3hrs, and 6hrs) and the control condition was performed using cufflinks cuffdiff2 (version
2.2.1) [301, 302]. A q-value cutoff ≤ 0.05 with an absolute |log2FC| ≥ 1 was used to
determine differential expression.
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Reverse Transcription and quantitative real-time PCR (RT-qPCR): Total RNA isolated
from the different experimental conditions was followed by reverse-transcription into
cDNA using a High capacity RNA to cDNA kit (Applied Biosystems, Foster City, CA,
USA), while qPCR was carried out using SYBR®Green PCR Master Mix Applied
Biosystems, Foster City, CA, USA) on an Applied Biosystems StepOne Plus cycler with
stepone software V2.2.2. Sequences of the gene-specific primers (Integrated DNA
Technologies, Skokie, IL, USA) used in this study are listed in Table 2.1. Data were
calculated and expressed as mean normalized expression (MNE) units after GAPDH
normalization as previously described [303].

Western Blotting: Neutrophils (10 × 106 cells/mL) were cultured at 37°C, 5%CO2 in RPMI1640 with 5% heat-inactivated human serum and left unstimulated, stimulated with FSL
(100 ng/mL), challenged with either live or heat-killed F. alocis for 1, 3, 6, or 10 hours
followed by stimulation with fMLF (300 nM, 1 min) or TNF-α (10 ng/ml, 15 min). After
the different experimental procedures, cells were centrifuged at 6,000 ×g for 30 s and lysed
for 30 min on ice in ice-cold lysis buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1%
[vol/vol] Triton X-100, 0.5% [vol/vol] Nonidet P-40, 20 mM NaF, 20 mM NaVO3, 1 mM
EDTA, 1 mM EGTA, 5 mM phenylmethylsulfonyl fluoride [PMSF], 21 μg/ml aprotinin,
5 μg/ml leupeptin, and 4mM Diisopropyl fluorophosphates [DFP]). After protein
estimation using the Pierce BCA protein assay kit (Thermo Scientific, Waltham, MA,
USA), samples were adjusted to a concentration of 2 µg/µL. 16-20 µg/µL of total cell
lysates were separated by 12% SDS-PAGE and immunoblotted with antibodies for
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phospho-ERK1/2, total ERK1/2, phospho-p38 MAPK, total p38 MAPK, phospho-AKT,
total AKT, phospho-S6 (Cell Signaling Danvers, MA, USA), p47phox or p67phox (gift
from Dr. William M. Nauseef) all at 1:1000 dilution. The appropriate secondary antibodies
were used at 1:2000 dilution (Cell Signaling, Danvers, MA, USA). The ECL system
(Amersham Pharmacia Biotech, Little Chalfont, United Kingdom) or the SuperSignal West
Femto Maximum Sensitivity Substrate (Thermo Scientific,Waltham, MA, USA) was used
to visualize antigen-antibody reactions. Densitometric values of each band were calculated
using Image Lab software (BioRad, Hercules, CA, USA).

Superoxide Generation and Priming: Superoxide anion release was measured
spectrophotometrically at 550 nm as the superoxide dismutase‐inhibitable reduction of
ferricytochrome c as previously described [297]. Briefly, neutrophils (4 × 106cells/ml)
were cultured in RPMI supplemented with 5% heat inactivated human serum, and left
untreated or pre-treated with p38 inhibitor BIRB-796 (75 nM, added to media 60 min
before 6 and 10 hour timepoints; Sigma, St. Louis, MO, USA), or with opsonized F. alocis
(MOI 10) for 6 and 10 hours at 37 °C in a shaking waterbath. After this first pre-treatment,
TNFα (10 ng/ml, 10 min) were added to all the samples. Samples were run in duplicate,
one of the duplicates was used to detect basal superoxide levels in the presence or absence
of each pre-treatment, the other sample was used to measure TNF-priming by further
challenge with fMLF (300 nM) for 5 min. After stimulation of superoxide production, the
samples were centrifuged for 10 min at 600×g, 4 °C, supernatants were collected, and
optical densities were read.
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IL-8 Cytokine Measurement and Apoptosis: Neutrophils (10 × 106 cells/mL) were cultured
in RPMI + 5% heat inactivated human serum, and left untreated, or pre-treated with TAK1
inhibitor (5Z)-7-Oxozeanol (3 µM, added 30 min before 6 and 10 hour timepoints;
Cayman, Ann Arbor, MI, USA), or p38 inhibitor BIRB-796 (75 nM, added 60 min before
6 and 10 hour timepoints; Sigma, St. Louis, MO, USA), or opsonized F. alocis (MOI 10)
for 6 and 10 hours at 37 °C in an incubator with 5% CO2. After the pre-treatment, the
volume in the tube was divided evenly between two tubes, one of the tubes received TNFα
(10 ng/ml) and the other nothing. All tubes were returned to the incubator for 4 or 12 hours.
After the TNFα stimulation period, cells were centrifuged, their supernatants collected and
the pellets tested for apoptosis. 1% protease and phosphatase inhibitors were added to the
supernatants to protect them from degradation. IL-8 was measured in the supernatants
using a commercially available kit (Invitrogen, Carlsbad, CA, USA). Cells were processed
for Annexin V/7-AAD staining using the commercially available APC Annexin V
Apoptosis Detection Kit with 7-AAD (BioLegend, San Diego, CA, USA). Samples were
read on a BD FACSCelesta flow cytometer and analyzed using the FlowJo software
(Ashland, OR, USA).

Statistical Analysis: Unless otherwise noted, statistical differences among experimental
conditions and time points were analyzed by a repeating measures two-way ANOVA,
followed by Bonferroni post-tests using GraphPad Prism Software (Graphpad San Diego,
CA, USA). Differences were considered significant at the level P < 0.05. When a two-way
ANOVA was not applicable, one-way ANOVA followed by the post-hoc Tukey multiplecomparison test was used.
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Results:
F. alocis induces global changes in gene expression
To assess changes in gene expression after F. alocis challenge, whole transcriptome
by RNA-based next-generation sequencing (RNA-seq) was performed on human
neutrophils from 4 individual healthy donors that were either left unstimulated or
challenged with F. alocis for 1, 3 or 6 hours. All time points for each donor were mapped
onto a principal component analysis (PCA) plot to determine the variation in the dataset
(Figure 2.1A). All four donors clustered together for each experimental condition, showing
that donor variability is not a major contributor in our dataset. Contrastingly, the
transcriptional profile of F. alocis-stimulated neutrophils clearly separated from basal
conditions at each time point. Next, differential expression analysis was completed
between each treatment condition using the Tuxedo Suite Program cuffdiff2, where a pvalue cutoff ≤ 0.01 and a log fold change │log2FC│ ≥ 1 was utilized to compile a list of
differentially expressed genes (DEG) for further analyses. Volcano plots for each time
point showed that F. alocis challenge induced a time-dependent change in gene expression,
as the number of red colored dots, which represent the significant DEG, grew at each time
point (Figure 2.1B). On the volcano plots, the most significant DEG for each time point
were identified. Out of these highlighted DEGs, CAMK1G was upregulated and
TNFRSF12A was downregulated at all three time points compared to unstimulated cells.
The CAMK1G gene encodes a protein like calcium/calmodulin dependent protein kinase;
however, according to RefSeq, its exact function is unknown. TNFRSF12A, also known
as Fn14, is a weak inducer of apoptosis that can activate NF-kB signaling pathways,
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promotes oxidative stress, and is linked to high expression of matrix metalloprotease 9
(MMP-9) [304-307].
The number of DEG was determined for each time point and plotted based on
whether it was upregulated or downregulated compared to the basal control (Figure 2.1C).
The biggest change in transcriptome occurred early in the time course, with 624 genes
differentially expressed at one hour and a steep increase in the number of DEG between 1
and 3 hours (Figure 2.1D). At the 6-hour time point, the number increased only marginally
from 3 hours. Throughout the time course, the number of genes induced was roughly the
same as the number of repressed genes. While our DEG criteria is more stringent than other
studies, these global changes in gene expression appear to be unique to F. alocis as
compared to other transcriptome studies between neutrophils and bacterial challenge [293296]. To validate the RNAseq data, 2 upregulated genes, 2 downregulated genes and 2
genes with no change were selected for validation by quantitative PCR. Figure 2.1E shows
the Fragments Per Kilobase of transcript per Million mapped reads (FPKM) expression
values for all four donors from the RNAseq screen, while Figure 2.1F shows the mean
normalized mRNA expression by qPCR. Overall, the qPCR results validate the RNAseq
screen and provide confidence about the targets identified by the high throughput screening
analysis.

F. alocis affects neutrophil functional and biochemical processes
To reduce bias during the bioinformatic analysis, the list of DEG was uploaded into
two

separate

databases:

Database

for Annotation, Visualization

and

Integrated Discovery (DAVID) [308, 309] and MetaCore by Clarivate Analytics. In each
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database, I first identified the significant (p < 0.01) biological processes during challenge
with F. alocis. From the DAVID analysis, 37, 74, and 86 processes were identified for the
1-, 3- and 6-hour time points, respectively, and categorized by cell function (Table 2.2).
Significant process categories in every time point include biological processes related to
the inflammatory response, response to microbes, chemotaxis, signal transduction, gene
expression and transcription factor regulation, cytokine-mediated responses and
production, and apoptosis. However, as the time course progressed, there was a shift in the
affected processes. While cytokine-related processes were most prominent at the earlier
timepoints, biological processes related to phagosome maturation and metabolic processes
became significant at the later time points. Moreover, processes related to protein folding
only became significant at 6 hours post bacterial challenge.
Using MetaCore, 71 significant (p < 0.01) network processes were determined in
our data set. Since the MetaCore software automatically categorizes the processes by cell
function, I determined the frequency of each category (Figure 2.2A). Like the DAVID
analysis, most processes were involved with inflammation, signal transduction, the
immune response, and apoptosis. Cell function processes with a lower frequency include
protein folding, cytoskeleton, transcription, chemotaxis, and autophagy. Next, I plotted the
top 25 most significantly upregulated (Figure 2.2B) and downregulated processes (Figure
2.2C). Processes related to inflammation made up 4 out of the top 5 upregulated network
processes, but the significance of the inflammatory processes decreased as the time course
progressed. In fact, some of these inflammation processes from the upregulated list became
significant in the downregulated processes during the later time points, as is the case with
processes such as IL-6 signaling and neutrophil activation (Table 2.3). This suggests that
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F. alocis may be dampening inflammatory processes between 1 and 3 hours to prolong its
survival or provide protection to bystander species. Together, this data shows that F. alocis
challenge induces temporal changes in neutrophil functional mechanisms like cytokine
production, chemotaxis, vesicular trafficking and degranulation, as well as neutrophil
biochemical mechanisms like the regulation of signaling pathways and metabolism. This
coincides with previous data from our laboratory that shows that F. alocis affects
neutrophil cytokine production, chemotaxis, vesicle trafficking, and degranulation
functions [253, 284].
Based on previous work that demonstrated that F. alocis induces minimal
intracellular and extracellular ROS production [284], I looked at whether the components
of the NAPDH oxidase complex are affected during F. alocis challenge (Table 2.4). From
the RNAseq data, the only statistically significant results show that the expression of
CYBB (gp91phox subunit) increased in a time-dependent manner while the expression of
NCF1 (p47phox subunit) decreased by 6 hours of challenge, which was also validated by
qPCR (Figure 2.1F). While the minimal ROS activation at the early time points cannot be
attributed to modulation of gene expression by F. alocis, generation of ROS at later time
points may be inhibited by the expression of a member of the galectin family of
carbohydrate binding proteins, galectin 3. The increased expression of galectin 3, has
already been associated with inhibition of ROS production when human neutrophils were
challenged with Candida albicans [310]. In our dataset, both the FPKM expression as well
as the qPCR validation show a time dependent increase in galectin-3 mRNA expression
(Figure 2.1E-F), and when tested by western blot, F. alocis induced a time dependent
increase in galectin-3 protein expression (data not shown).

51

F. alocis challenge upregulates cytokine pathways and downregulates signaling pathways
Next, I identified pathways relevant to challenge with F. alocis. Using DAVID, the
list of DEG was mapped onto predefined pathways from the Kyoto Encyclopedia of Genes
and Genomes (KEGG) database. I limited our analysis to highly significant pathways with
a p value < 0.01, which resulted in 10, 26, and 33 pathways for the 1, 3, and 6-hour time
points, respectively (Table 2.5). The F. alocis-neutrophil transcriptome reinforced the
pathogenic potential of F. alocis by the number of significant pathways linked to pathogens
that subvert immune cells (Salmonella, Legionella, Helicobacter pylori, and Influenza A).
Similarly, pathways for cancers, rheumatoid arthritis, and inflammatory bowel disease
were significant for the F. alocis-challenged neutrophil transcriptome in both databases.
Oral bacteria continue to be linked to systemic malignancies like those listed above [311],
and although F. alocis has not been amongst the oral pathogens detected yet, these results
hint that it could play a role in the pathogenesis of these diseases.
Two major bacterial recognition receptor signaling pathways were identified in our
data set, NOD-like receptor and Toll-like receptor signaling. These receptor pathways align
with published data on F. alocis-induced cytokine production, where NOD1 is activated
during challenge with heat-killed F. alocis to produce IL-6 in monocytes [68], and TLR2/6
activation of neutrophils leads to the production and release of cytokines and chemokines
[253]. Using Metacore, I divided the significant pathways into the top 20 upregulated
(Figure 2.3A) and downregulated (Figure 2.3B) plots. The list of upregulated pathways
supports published data that shows initial contact with F. alocis results in the early
transcription and production of cytokines [253]. At 1 hour, cytokine-related pathways such
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as cytokine-cytokine receptor interaction, TNF signaling pathway, and chemokine
signaling pathway were also prominent pathways by KEGG analysis (Table 2.5). In both
databases, the NFκB signaling pathway was significant and upregulated, suggesting this
transcription factor is responsible for the cytokine and chemokine transcriptome response.
While many of the upregulated pathways were related to inflammation and cytokine
responses, the downregulated list was largely comprised of signal transduction pathways
(Figure 2.3B). The pathways were significantly affected at the later timepoints and include
signal transduction by MAPK, GPCR, Rho GTPases, PI3K, PTEN, AKT, and PKA. Out
of the list of 20 downregulated pathways, seven relate to MAPK signaling. To further
support this analysis, under the signal transduction biological process category, positive
regulation of ERK1 and ERK2 cascade and activation of MAPK activity are significant at
one hour, but at 3 and 6 hours, inactivation of MAPK activity becomes significant (Table
2.5). I focused on this pathway and determined if F. alocis is modulating MAPK signaling
in human neutrophils.

F. alocis challenge does not affect fMLF-stimulated MAPK signaling
Since G-protein coupled receptor (GPCR) and MAPK were both hits in our dataset,
western blots to evaluate ERK1/2 and p38 MAPK activation were performed on lysates
from human neutrophils pretreated with media or media containing F. alocis for 1, 3, 6,
and 10 hours followed by stimulation with the bacterial peptide N-Formylmethionineleucyl-phenylalanine (fMLF) (Figure 2.4A). Densitometry analysis of the western blots
bands for phosphorylated and total ERK1/2 showed that stimulation with F. alocis alone
has a time dependent increase in phosphorylation of ERK1/2 (Figure 2.4B). This suggests
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there is a bimodal response in the activation of ERK1/2 since it was previously published
that ERK phosphorylation peaks at 15 min and then decreases [275]. In the case of p38
MAPK, the levels of phosphorylated p38 MAPK are also increased in the F. alocis pretreated cells as compared to neutrophils cultured in media alone (Figure 2.4C). However,
the levels remain steadily elevated throughout the time course. This pattern of
phosphorylation for the MAPK is also observed, although at different magnitudes, when
neutrophils are pre-treated with heat-killed F. alocis (Figure 2.4D, E), or the TLR2/6
agonist FSL1 (Figure 2.4F, G). Despite the increased basal levels of phosphorylated
ERK1/2 and p38 MAPK in the viable and heat-killed F. alocis pretreated cells, when the
neutrophils are stimulated with fMLF after pre-treatment with F. alocis, the
phosphorylation of both ERK and p38 MAPK is comparable to that of cells cultured in
media + fMLF (Figure 2.4B, C). Contrastingly, cells pretreated with FSL1 showed
increased phosphorylation of ERK1/2 when stimulated with fMLF, which became
significant at 10 hours compared to media-cultured cells stimulated with fMLF alone
(Figure 2.4F). A similar trend was observed at the 10-hour time point with phosphorylation
of p38 MAPK but the data did not reach statistical significance when compared to fMLF
alone (Figure 2.4G).

F. alocis challenge dampens TNF-α-stimulated MAPK signaling
From the DAVID analysis, one of the KEGG pathways that was significantly
modulated by F. alocis at each timepoint was the TNF signaling pathway (Table 2.5).
Similarly, four of the upregulated pathways and one of the dowregulated pathways from
the MetaCore analysis involve TNF signaling (Figure 2.3A, B). Since it is well documented
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that stimuli like LPS and TNFα can activate the p38 and MEK/ERK pathways in
neutrophils [287, 312, 313] and high levels of TNFα are present in periodontitis active sites
[314, 315], I tested the effect of F. alocis pre-treatment on TNFα-induced MAPK signaling
cascade. Whole cell lysates from neutrophils pretreated with media or F. alocis followed
by stimulation with TNFα were immunoblotted for phosphorylated and total ERK1/2 and
p38 MAPK (Figure 2.5A). Densitometry analysis of the ERK immunoblots showed that
pre-treatment with F. alocis did not impact TNFα-driven phosphorylation of ERK1/2
(Figure 2.5B). However, the TNFα-driven phosphorylation of p38 MAPK was
significantly dampened in neutrophils pre-treated with F. alocis for 6 and 10 hours as
compared to neutrophils cultured in media alone (Figure 2.5C). This effect is dependent on
the bacteria being viable, because when the neutrophils were pre-treated with heat-killed
F. alocis before stimulation with TNFα, there was no decrease in the p38 phosphorylation
at 6 or 10 hours (Figure 2.5D). Additionally, ligation of TLR2/6 is insufficient to elicit the
phenotype observed (Figure 2.5E). This data shows that viable F. alocis modulates TNFαinduced activation of the MAPK signaling pathway by selectively interfering with the
phosphorylation of p38 MAPK, but not ERK1/2.
In human neutrophils, activation of p38 MAPK by TNFα results in the downstream
phosphorylation and activation of AKT [316]. Therefore, since the TNFα-induced
activation of p38 MAPK was affected when neutrophils were pre-treated with F. alocis,
the activation of AKT should also be compromised. To test this hypothesis, the lysates
from media or F. alocis pre-treated neutrophils stimulated with TNFα were immunoblotted
for phosphorylated and total AKT (Figure 2.6A). Densitometry analysis of the Western
blots demonstrated that TNFα-mediated phosphorylation of AKT was also dampened in F.
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alocis treated cells as compared to media-cultured neutrophils (Figure 2.6B). The reduced
AKT phosphorylation followed the timing of the decreased p38 MAPK phosphorylation
with the phenotype reaching statistical significance only at 6 and 10 hours. Like the p38
MAPK phenotype, the lowered AKT activation was dependent on interaction with viable
F. alocis (Figure 2.6C) and was not mediated solely through ligation of the TLR2/6
receptor (Figure 2.6D). Also downstream of p38 MAPK phosphorylation is the activation
of translation machinery such as the S6 ribosomal protein [287]. Thus, the phosphorylation
of S6 was tested in whole cell lysates from neutrophils pre-treated with F. alocis prior to
TNFα stimulation (Figure 2.7A). Densitometry analysis showed that the activation of S6
in response to TNFα was significantly dampened in neutrophils pre-treated with F. alocis
for 6 hours in comparison to media treated controls (Figure 2.7B). While this trend
continued in the 10-hour pre-treatment condition, it did not reach statistical significance.
Together, these results demonstrate that F. alocis actively modulates the TNFα signaling
pathway by dampening the activation of p38 MAPK and its downstream effectors, AKT
and S6 ribosomal protein.

Functional effects of F. alocis’ inhibition of TNFα-mediated p38 phosphorylation
TNFα stimulation can prime the ROS response of neutrophils, extend their lifespan
and induce cytokine production (reviewed in [127]). To determine if the interference of
TNFα signaling resulted in any phenotypic changes, these three TNFα-mediated functional
responses were tested on cells cultured with F. alocis for 6 and 10 hours prior to TNFα
stimulation. The RNA seq screen showed that the mRNA levels of some NADPH oxidase
components were affected; thus, before testing the ROS priming response, the protein
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expression of two of the subunits p47phox (NCF1) and p67phox (NCF2) was determined
(Figure 2.8). The RNAseq screen showed the gene expression of p67phox was unchanged
when the cells were challenged with F. alocis, but the gene expression of p47phox was
significantly decreased in F. alocis treated cells (Table 2.4). At the protein level, there was
no significant difference between media cultured neutrophils and those exposed to F. alocis
at any timepoint tested for either p47phox or p67 (Figure 2.8A-C). Stimulation with TNFα
also had no effect on either subunit’s protein expression in media cultured neutrophils or
those exposed to F. alocis, demonstrating that any changes observed in the ROS priming
response could not be due to differences in the availability of NADPH oxidase components.
The basal extracellular superoxide production was similar in cells cultured in media or in
media with p38 inhibitor BIRB-796 or F. alocis for 1, 6, and 10 hours (Figure 2.9A).
However, when BIRB-796 and F. alocis pre-treated cells were primed with TNFα followed
by stimulation with fMLF, the superoxide production was comparable to that of neutrophils
cultured in media prior to the TNFα priming. Thus, I conclude that inhibiting p38 activation
through a chemical inhibitor or F. alocis does not affect the ability of TNFα to prime
neutrophils’ ROS response.
In human neutrophils, TNFα stimulation activates MAPK kinase kinase, TAK1
(also known as MAP3K7), which leads to the downstream phosphorylation of ERK1/2 to
delay apoptosis and the phosphorylation of p38 to induce cytokine production (Figure 2.12)
[287, 316]. First, the effect of F. alocis- impaired p38 activation was tested on apoptosis.
Neutrophils were cultured in media or media with a TAK1 inhibitor (5Z)-7-Oxozeanol (30
min), a p38 inhibitor BIRB-796, (60 min) or F. alocis for 6 hours, followed by ± TNFα
stimulation for 12 hours (Figure 2.9B, Fig. 2.10). Based on Annexin V and 7-AAD
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staining, TNFα stimulation of cells cultured in media was able to decrease the number of
apoptotic cells compared to cells left in media alone. When TAK1 was inhibited by (5Z)7-Oxozeanol, neutrophils became apoptotic, especially when treated with TNFα.
Neutrophils pre-treated with BIRB-796 behaved similarly to media-cultured neutrophils,
where TNFα stimulation is pro-survival because inhibition of p38 does not affect the
TNFα-ERK1/2 mediated delay in apoptosis. Interestingly, pre-treatment of neutrophils
with F. alocis alone resulted in a decrease in apoptotic cells, which was not reduced further
with TNFα stimulation. Apoptosis was also assessed in cells pre-treated with F. alocis for
10 hours prior to the 12-hour stimulation with TNFα, and results matched the 6-hour pretreatment (Figure 2.11A-E). Together, this data reinforces the finding that only ERK1/2
signalling is important in TNFα-induced neutrophil survival and that F. alocis is selectively
inhibiting p38 MAPK.
TNFα stimulation can also induce the production of cytokines and chemokines,
such as interleukin (IL)-8. Thus, the release of IL-8 was tested in the supernatants of cells
cultured with media, (5Z)-7-Oxozeanol, BIRB-796, or F. alocis for 6 hours followed by
+/- TNFα stimulation for 12 hours (Figure 2.9C). As expected, TNFα stimulation of mediacultured neutrophils induced significant release of IL-8. Culturing the neutrophils with the
TAK1 and p38 inhibitors alone did not induce IL-8 production; however, TAK1 and p38
inhibition reduced the release of IL-8 by TNFα stimulation. Contrastingly, the F. alocis
pre-treatment alone caused robust release of IL-8, which significantly surpassed the IL-8
release of TNFα-activated, media-cultured cells. Despite the potent IL-8 production by F.
alocis alone, the further stimulation of F. alocis pre-treated cells with TNFα did not cause
significant, additional release of IL-8. To rule out the possibility that F. alocis treatment
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alone exhausted the neutrophils’ ability to produce IL-8, I also tested neutrophil IL-8
production after pre-treatment with heat-killed F. alocis, which show normal p38 activation
in response to TNFα stimulation (Figure 2.5D). Similar to viable bacteria, the heat-killed
bacteria induced significant IL-8 production from neutrophils, and this production was not
significantly enhanced with stimulation by TNFα (Figure 2.9C). This phenotype was also
observed when neutrophils were pre-treated for 10 hours with viable or heat-killed F. alocis
prior to TNFα challenge for 12 hours (Figure 2.11F), suggesting that despite a defect in
TNFα-mediated p38 phosphorylation by the viable bacterium, alternative pathways are
activated by F. alocis that result in maximal IL-8 production from neutrophils in the
timepoints tested. This observation raised the possibility that the inhibition of p38
phosphorylation by F. alocis subsides during the 12-hour TNFα stimulation period.
Therefore, I tested the phosphorylation of p38 in neutrophils pre-treated with media or F.
alocis for 6, 10 and 20 hours prior to TNFα stimulation for 15 min, and the inhibition of
p38 phosphorylation by F. alocis had dissipated by 20 hours, suggesting the MAPK
dampening by F. alocis is a transient effect (Figure 2.9D). Finally, to determine if IL-8
production is affected during the period of infection where p38 phosphorylation is
dampened, I shortened the TNFα stimulation to 4 hours (Figure 2.9E). Despite the shorter
stimulation period, TNFα still caused significant release of IL-8 from media cultured cells.
Both viable and heat-killed F. alocis induced significant IL-8 production on their own, but
their responses diverged after TNFα stimulation. While heat-killed F. alocis pre-treated
cells produced a greater amount of IL-8 upon addition of TNFα, viable F. alocis-treated
cells were incapable of generating more IL-8. Combined, this data demonstrates that viable
F. alocis blocks TNFα-mediated p38 activation to reduce transiently the production of pro-
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inflammatory cytokines, but this interference has no effect on other TNFα induced effector
functions like ROS priming or pro-survival response.

Discussion:

As executioners of the innate immune response, neutrophils are recruited to the
gingival tissue to provide the host with protection against infection. However, in active
periodontitis disease sites the interaction between neutrophils and the dysbiotic microbial
community results in dysregulated inflammation, which is detrimental to the host.
Composition analysis of the dysbiotic microbial community identified high concentrations
of emerging periodontal pathogens such as F. alocis. I recently demonstrated that F. alocis
survives within human neutrophils by inducing minimal ROS production and blocking
granule recruitment to the bacteria-containing phagosome [284]. Despite F. alocis causing
significant changes in the mRNA expression of different neutrophil-derived cytokines and
chemokines, lower levels of these inflammatory mediators are released when compared to
the response elicited by other oral pathogens [253]. Therefore, a systems biology-level
approach was used to define global changes in human neutrophil transcriptome modulated
by F. alocis. This unbiased approach provides insights into how this emerging oral
pathogen might undermine the innate immune system and contribute to disease
progression. Our results show that among the 71 significant biological process modulated
by F. alocis, the highest percent were related to inflammation, signal transduction, immune
response, and apoptosis. Furthermore, the KEGG pathway analysis revealed that uptake of
F. alocis significantly downregulated the expression of genes associated with signal
transduction pathways primarily the MAPK cascade and the TNFα signaling pathways. To
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the best of our knowledge, our results are the first to show that TNF-α-induced p38 MAPK
activation is significantly impaired in F. alocis-challenged neutrophils.
Research studies from the last 20 years have corrected the misconception that
neutrophils were unable to induce changes in gene expression because they are short-lived,
differentially terminated cells with a densely condensed nucleus [317-320]. Microarraybased approaches show that significant changes in neutrophil gene expression take place
after 3-6 h following microbial uptake [319]. Likewise, our results show a significant
increase in neutrophil DEGs from 624 genes up to 2671 following 1 and 3 h of F. alocis
challenge, respectively. By 6 h post bacterial challenge the number of DEGs continued to
rise up to 3489 with a similar number of upregulated (1739) and downregulated (1750)
genes. Interestingly, the transcriptome studies performed thus far on neutrophils following
bacterial interactions reveal common as well as pathogen-specific transcriptional profiles,
providing novel information about the potential pathogenic persona of the microorganism
studied [320]. For example, Anaplasma phagocytophilum induces minimal ROS
production by neutrophils and a microarray study following 1.5 up to 24 h post infection
shows that the inability to mount the response is not due to modulation of the genes
encoding for the different components of the NADPH oxidase [294]. F. alocis is
phagocytized by human neutrophils but induces minimal ROS production [284]. In contrast
to the transcriptional neutrophil profile elicited by A. phagocytophilum, our RNAseq and
qPCR results indicate a significant downregulation of the gene that encodes for one of the
cytosolic components of the NADPH oxidase, p47phox, and a significant time dependent
increase in the gene expression of galectin 3. P47phox together with p67phox and p40phox
form the triad cytoplasmic complex, in a 1:1:1 stoichiometric ratio, which is essential for
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NADPH oxidase activation [321]. Although the minimal ROS induced by F. alocischallenged neutrophils was monitored between 1 and 90 min and the significant decrease
in p47phox gene expression was observed at 6 h post infection, these pathogen-induced
changes in the transcript levels could leave neutrophils defective in mounting an
appropriate respiratory burst response. Furthermore, cytosolic galectin 3 acts as a negative
regulator of ROS production in both human and mouse neutrophils by modulating
complement receptor 3 signaling pathway during C. albicans infections [310]. Our results
show a time dependent increase in galectin 3 gene expression which could be one of the
strategies used by F. alocis to inhibit ROS production. The mechanisms by which F. alocis
modulates ROS production, both during early and late time points of infection, is an area
under investigation in our laboratory.
To mount an efficacious antimicrobial response inside the neutrophil phagosome,
the synergy between an optimal activation of the NADPH oxidase, and the fusion of the
different neutrophil granule subtypes with the bacteria-containing phagosome is essential
[321]. Microbial pathogens manipulate either one or both of these antimicrobial processes
to evade neutrophil killing [89]. The expression of CEACAM3-binding opacity (Opa)
proteins on Neisseria gonorrhoeae renders the organism susceptible to neutrophil killing.
The ability of N. gonorrhoeae to switch off the expression of Opa proteins, by phasevariation, prevents azurophilic granule fusion to the phagosome, thus promoting bacterial
survival [322]. During the phagocytic cup formation, effector proteins secreted by Yersinia
pseudotuberculosis prevent fusion of specific granules to the forming phagosome in human
neutrophils [323]. Our transcriptome results show that F. alocis challenge significantly
downregulated neutrophil processes and signaling pathways involved in the regulation of
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vesicle-mediated transport, neutrophil degranulation, and cellular pathways involved in
transport. This significant downregulation of vesicular trafficking and phagosome
maturation transcripts is consistent with our previous results that F. alocis inhibits specific
and azurophilic granule recruitment to the bacteria-containing phagosome [284]. The
mechanisms induced by F. alocis to modulate neutrophil vesicular trafficking to the
phagosome is an area of active investigation in our laboratories.
Neutrophils isolated from periodontitis patients and from healthy controls were
transcriptionally active following 3 h challenge with Fusobacterium nucleatum, which is
found in high numbers in the subgingival plaque from periodontitis patients [295]. In this
microarray study, F. nucleatum induced significant upregulation of genes encoding proinflammatory cytokines and chemokines, and it has been shown that this organism induces
the release of high levels of these inflammatory mediators from neutrophils [197]. In our
study I looked at the transcriptional response at 1, 3 and 6 hours while the microarray study
with F. nucleatum was performed only at 3 hours. However, our results show that at 1 h
post F. alocis challenge there is a significant increase in genes involved in proinflammatory cytokines such as IL-1β and IL-6 but those same signaling pathways were
significantly downregulated by 3 and 6 hours. F. alocis induces an early increase in both
gene expression and protein release of pro-inflammatory mediators such as IL-1β, TNFα,
CXCL1, CXCL8, CCL1, CCL2, and CCL3; but the levels released by human neutrophils
are significantly lower compared to the response elicited by P. gingivalis and P. stomatis
[253]. These results suggested that F. alocis might modulate the protein expression and/or
release of inflammatory mediators by neutrophils, and our current results confirm this
hypothesis since F. alocis pre-treatment limited the release of IL-8 from TNFα stimulation.
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An interesting observation from the RNAseq analysis was that F. alocis modulates
MAPK signaling pathways. Activation of the different MAPK pathways play a pivotal
role in several inflammatory and antimicrobial functional responses both in macrophages
and in neutrophils [291]. Pathogenic organisms have evolved different strategies to
modulate MAPK activation by releasing bacterial compounds into the host innate immune
cell that cause kinase inactivation by proteolysis, post-translational modification at active
enzymatic sites, as well as by induction of different phosphatases [290, 291]. Either
inactivation or sustained activation of the MAPK signaling pathways will lead to a
dysregulated immune response. F. alocis challenge induces an early activation of p38 and
ERK1/2 in human neutrophils that peaks between 15-30 min and decreases following 60
min of bacterial challenge [275]. I expanded our initial observation, and the data from the
present study revealed that F. alocis induces a second phase of MAPK activation in human
neutrophils beyond 60 min of bacterial challenge. Besides modulation of MAPK signaling,
RNAseq analysis showed that F. alocis also induced changes in gene expression associated
with GPCR and TNF signaling pathways. In the inflamed gingival crevice environment,
neutrophils infected with F. alocis will be also exposed to bacterial peptides, such as fMLF,
as well as to inflammatory cytokines such as TNFα. Our results show a similar degree of
fMLF-stimulated p38 and ERK1/2 phosphorylation in human neutrophils in the presence
or absence of F. alocis infection. However, when TNFα was used as the second stimulus,
F. alocis-challenged neutrophils showed a significant decrease in p38 MAPK activation.
This modulation of TNFα-induced p38 phosphorylation was not seen when neutrophils
were exposed to heat-killed F. alocis or the TLR2/6 agonist, FSL-1, prior to the cytokine
stimulation. Furthermore, the combination of F. alocis and TNFα had no impact on
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ERK1/2 activation by the pro-inflammatory cytokine. While many pathogenic organisms
can modulate MAPK signaling in innate immune cells as a mechanism to increase bacterial
virulence, this is the first time this observation has been shown for F. alocis.
In human neutrophils, TNFα stimulation results in activation of both p38 and
ERK1/2, which are involved in the production of inflammatory cytokines and chemokines
independently of NF-kB activation [316]. However, blocking TNFα-induced activation of
p38, but not ERK1/2, impaired both the transcription and translation of inflammatory
cytokines by human neutrophils [287]. Our results show that TNFα-induced activation of
p38 MAPK is impaired in neutrophils infected with F. alocis, the extent to which this
affects functional mechanisms was tested and is summarized in Figure 2.12. This
manipulation of MAPK signaling pathway by F. alocis limited the release of TNF-induced
chemokine IL-8 by neutrophils. This phenotype has been described for other periodontal
pathogens, which employ multiple mechanisms to manipulate IL-8 production and limit
the influx of neutrophils [282]. In human neutrophils, stimulation by TNFα also has a prosurvival response. It has been shown that activation of MEK and ERK1/2, which are
uncoupled in human neutrophils, participate in the pro-survival effect of TNFα [289]. A
previous study also showed that TNFα activated both p38 and ERK1/2 in human
neutrophils, but that only activation of ERK1/2 was necessary for TNFα-mediated
inhibition of caspase-3 activity and the pro-survival effect [324]. In our study, F. alocis
challenge did not affect TNFα-induced ERK1/2 activation, and when apoptosis was tested,
the pro-survival effect of the cytokine was not impaired. In fact, stimulation with F. alocis
alone had a pro-survival effect on neutrophils, which was also reflected in the RNAseq
analysis where F. alocis up-regulated anti-apoptotic signaling pathways in neutrophils.
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It has been shown that phagocytosis of pathogenic bacteria such as Staphylococcus
aureus and Streptococcus pyogenes induces changes in neutrophil gene expression
involved in the acceleration of apoptosis; whereas a different transcriptional profile, linked
to delay neutrophil apoptosis, is induced following A. phagocytophilum and Francisella
tularensis infection [294, 296, 320]. A microarray study showed that F. nucleatum induces
upregulation of anti-apoptotic genes in human neutrophils [295]. Similarly, our RNAseq
analysis identified several upregulated pro-survival and downregulated pro-apoptotic
differentially expressed genes in neutrophils after F. alocis challenge. Extending neutrophil
life span delays cell turnover and prevents resolution of inflammation contributing to
disease progression. The mechanisms utilized by F. alocis to delay neutrophil apoptosis is
an area under current investigation in our laboratory.
In conclusion, F. alocis induces significant changes in the human neutrophil
transcriptome. In particular, biological processes involved with inflammation, signal
transduction, vesicular trafficking, neutrophils activation, and apoptosis were significantly
regulated. Furthermore, these results show that F. alocis modulated both the TNF and
MAPK kinase signaling pathways. This resulted in decreased p38 MAPK activation by a
secondary stimulus i.e. TNFα, but not by fMLF. F. alocis, by selectively blocking p38
MAPK, but not ERK1/2, by the secondary stimulus TNF will potentially maintain a delay
of neutrophil apoptosis, while dampening the release of inflammatory mediators.
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Figure 2.1: Global changes in the transcriptome of F. alocis-challenged neutrophils
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Figure 2.1: Illumina RNA sequencing was performed on human neutrophils from 4
individual healthy donors that were either left unstimulated (Basal) or challenged with F.
alocis for 1, 3 or 6 hours. PCA analysis shows the variation between the four donors at
each timepoint (A). The Tuxedo Suite program cuffdiff2 was used to acquire a list of
differentially expressed genes (DEG) that were graphed in volcano plots (B). Genes that
had p ≤ 0.01 and log2 FC│ ≥ 1 are colored in red and genes with high fold changes are
labeled. For each time point, the average number of upregulated and downregulated
differentially expressed genes (DEG) was determined and plotted (C, D). Six genes (two
upregulated, two with no change, and two downregulated) were chosen to validate the
RNAseq data by quantitative qPCR analysis. From the RNAseq data, the fragments per
kilobase of transcript per million mapped reads (FPKM) for these six genes are plotted as
mean ± SEM from the four donors (E). From the qPCR analysis, the mean normalized
mRNA expression (MNE) from 5 independent experiments are plotted in (F) as MNE ±
SEM. One-way ANOVAs were performed on the expression levels from each gene to
determine statistical significance between the basal condition and each timepoint. * = p <
0.05, ** = p < 0.01, *** = p < 0.001.
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Figure 2.2: Biological processes affected during F. alocis challenge. Differentially
expressed genes (DEG) for each timepoint were uploaded into the MetaCore database and
analyzed for biological processes with a significant number of DEG. The frequency of each
cell function was tallied for all the 71 significant (p < 0.01) processes. The percentage of
each function are displayed as a donut graph (A). The top 25 upregulated (B) or
downregulated (C) network processes are graphed according to the –log of the p value for
each time point. The dotted line represents a p value of 0.01.
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Figure 2.3: Pathways affected during F. alocis challenge. Using the MetaCore database,
the top 20 upregulated (A) or downregulated (B) pathways in the transcriptome of F.
alocis-challenged neutrophils were determined. These pathways are graphed according to
the –log10 of the p value for each time point. The dotted line represents a p value of 0.01.
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Figure 2.4: F. alocis effect on fMLF-induced MAPK activation
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Figure 2.4: To assess whether F. alocis is interfering with MAPK signaling, human
neutrophils were cultured in media with or without F. alocis at an MOI of 10 for 1, 3, 6, or
10 hours followed by stimulation with fMLF for 1 min. Western blots of whole cell lysates
were probed for phosphorylated and total p38 and ERK1/2 (A) and quantified by
densitometry (B, C). Alternatively, neutrophils were cultured in media alone, media with
heat-killed F. alocis (D, E) or the TLR2/6 agonist FSL (F, G) for 1, 3, 6, or 10 hours before
fMLF stimulation. Densitometries are plotted as the mean ± SEM from 6 (B, C) and 4 (DG) independent experiments. Statistical differences among experimental conditions and
time points were analyzed by a repeating measures two-way ANOVA, followed by
Bonferroni post-tests. * = p < 0.05, ** = p < 0.01, *** = p < 0.001.
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Figure 2.5: F. alocis effect on TNFα-induced MAPK activation
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Figure 2.5: Human neutrophils were cultured in media with or without F. alocis at an MOI
of 10 for 1, 3, 6, or 10 hours followed by stimulation with TNF-α for 15 min. Western blots
with whole cell lysates were probed for phosphorylated and total p38 and ERK1/2 (A) and
quantified by densitometry (B, C). To determine if the decreased p38 phosphorylation at 6
and 10 hours was specific to the viable bacteria or a consequence of TLR 2/6 ligation,
neutrophils were cultured in media alone, media with heat-killed F. alocis (D) or the
TLR2/6 agonist FSL (E) for 6 or 10 hours before TNF-α stimulation. Western blots of
whole cell lysates were probed for phosphorylated and total p38. Densitometries are plotted
as the mean ± SEM from 3 independent experiments. Statistical differences among
experimental conditions and time points were analyzed by a repeating measures two-way
ANOVA, followed by Bonferroni post-tests. * = p < 0.05, ** = p < 0.01, *** = p < 0.001.
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Figure 2.6: F. alocis effect on TNFα-induced AKT activation. Whole cell lysates from
human neutrophils pre-treated with media alone or F. alocis (MOI 10) for 3, 6, or 10 hours
followed by TNF-α stimulation were probed for phosphorylated and total AKT (A) and
quantified by densitometry (B). Similarly, neutrophils were cultured in media alone, media
with heat-killed F. alocis (C) or the TLR2/6 agonist FSL (D) for 6 or 10 hours before TNFα stimulation. Densitometries are plotted as the mean ± SEM from 3 (B) and 4 (C, D)
independent experiments. Statistical differences among experimental conditions and time
points were analyzed by a repeating measures two-way ANOVA, followed by Bonferroni
post-tests. * = p < 0.05, ** = p < 0.01, *** = p < 0.001.
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Figure 2.7: Dampened p38 MAPK phosphorylation affects the activation of
translation machinery. Western blots for S6 ribosomal protein, S6, were performed on
whole cell lysates from human neutrophils cultured in media or with F. alocis for 3, 6, and
10 hrs, followed by no stimulation or TNFα stimulation for 15 min (A). The protein
expression of phosphorylated S6 was quantified by densitometry, normalized to β-actin,
and plotted as the mean ± SEM from three independent experiments (B).
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Figure 2.8: F. alocis challenge has no effect on the protein expression of NADPH
oxidase components. Western blots for NADPH oxidase components, p67phox and
p47phox, were performed on whole cell lysates from human neutrophils cultured in media
or with F. alocis for 1, 3, 6, and 10 hrs, followed by no stimulation or TNFα stimulation
for 15 min (A). The protein expression of p67phox (B) and p47phox (C) was quantified by
densitometry, normalized to β-actin, and plotted as the mean ± SEM from three
independent experiments.
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Figure 2.9: F. alocis effect on TNFα-induced functional responses
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Figure 2.9: The ability of TNFα to prime media, BIRB 796 or F. alocis pre-treated
neutrophils was assessed as the production of superoxide release (A). Cells were cultured
in media, pre-treated with F. alocis for 1, 6, and 10 hours, or the p38 inhibitor BIRB 796
(60 min) followed by TNFα alone or TNFα + fMLF. Results from three independent
experiments are shown as the mean ± SEM superoxide production from basal TNFα
stimulation or from cells primed with TNFα followed by fMLF stimulation. To test
apoptosis, neutrophils were cultured in media or pre-treated with the TAK1 inhibitor (5Z)7-Oxozeanol (30 min), BIRB-796 (60 min), or F. alocis for 6 hours followed by a 12-hour
TNFα stimulation (B). The apoptosis data are plotted as the mean ± SEM percent of early
apoptotic cells (Q3: Annexin V+, 7-AAD-) from three independent experiments. IL-8
production was also tested in neutrophils described above as well as neutrophils pre-treated
with heat-killed F. alocis for 6 hours prior to a 12-hour stimulation with TNFα (C). The
cytokine data are graphed as the mean ± SEM IL-8 release from 5 independent
experiments. The duration of F. alocis’ inhibitory effect on TNFα-mediated p38
phosphorylation was tested at 6, 10, and 20 hours (D). Normalized western blot
densitometries are summarized from 3 independent experiments. Finally, IL-8 production
was also tested in neutrophils cultured in media or pre-treated with live or heat-killed F.
alocis for 6 hours prior to a 4-hour stimulation with TNFα (E). Data is graphed as the mean
± SEM IL-8 release from 4 independent experiments. N.s. = no significance, * = p < 0.05,
** = p < 0.01, *** = p < 0.001.
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Figure 2.10: BIRB-796 and 6-hour F. alocis treatment do not inhibit TNFα prosurvival effect. Neutrophils were cultured in media (A) or media with TAK 1 inhibitor
(5Z)-7-Oxozeanol (B), p38 inhibitor BIRB-796 (C), or F. alocis MOI 10 (D) for 6 hours,
followed by +/- TNFα stimulation for 12 hours. Cells were stained for Annexin V and 7AAD and apoptosis was determined by flow cytometry. Flow cytometry scatter plots show
the cells that did not receive TNFα (red) and those that did (blue). Histograms for each
marker are shown to the side.
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Figure. 2.11: BIRB-796 and 10-hour F. alocis treatments do not inhibit the TNFα
functional effects.
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Fig. 2.11: The apoptotic status was tested in neutrophils cultured in media (A), media with
TAK 1 inhibitor (5Z)-7-Oxozeanol (B), p38 inhibitor BIRB-796 (C), or F. alocis MOI 10
(D) for 10 hours, followed by +/- TNFα stimulation for 12 hours. Cells were stained for
Annexin V and 7-AAD and apoptosis was determined by flow cytometry. Flow cytometry
scatter plots show the cells that did not receive TNFα (red) and those that did (blue).
Histograms with the mean fluorescence intensity for each marker are shown to the right of
each plot. Data is summarized as the mean ± SEM percent of early apoptotic cells (Q3)
from three independent experiments (E). The supernatants from these cells were tested for
IL-8 production (F). Data is graphed as the mean ± SEM IL-8 release from 4 independent
experiments.

82

Figure 2.12: Proposed working model. Normal TNFα signaling pathway in neutrophils starts
with ligation of TNFR and activation of TAK 1, which phosphorylates ERK1/2 to delay apoptosis
and phosphorylates p38 to induce cytokine production. However, challenge of neutrophils with
viable F. alocis results in decreased p38 activation by TNFα. Ultimately, this results in decreased
cytokine (IL-8) production, but does not interfere with the TNFα-mediated delay in apoptosis.
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Table 2.1: qPCR primer sequences used to validate RNAseq results
Gene
Galectin 3
NCF-1
GAPDH
CXCL5
CCL5
ASC
NOD2

qPCR Primer Sequence
Forward:

5′- CAGAATTGCTTTAGATTTCCAA-3′

Reverse:
Forward

5′-TTATCCAGCTTTGTATTGCAA-3'
5'-AAGATGGCAAGAGTACCGC-3'

Reverse

5'-TCTCGTAGTTGGCAATGGC-3'

Forward

5'-CTTTGGTATCGTGGAAGGACTC-3'

Reverse

5'-GTAGAGGCAGGGATGATGTTC-3'

Forward
Reverse
Forward

5'-TCTGCAAGTGTTCGCCATAG-3'
5'-CAGTTTTCCTTGTTTCCACCG-3'

Reverse

5'-TTTCGGGTGACAAAGACGA-3'

Forward

5'-CTCCTCAGTCGGCAGCCAAG-3'

Reverse

5'-ACAGAGCATCCAGCAGCCAC-3'

5'-TGCCCACATCAAGGAGTATTT-3'

Forward

5'-CTGAAGAATGCCCGCAAGGT-3'

Reverse

5'-GTCTCTTGGAGCAGGCGGATG-3'
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Table 2.2: Significant biological processes from DAVID analysis categorized by cell function

Inflammatory Response

1 Hour

3 Hour
P-value

Process

inflammatory response

1.40E-13

immune response

7.30E-08

positive regulation of
inflammatory response

9.30E-04

negative regulation of
inflammatory response

9.00E-03

inflammatory
response
regulation of
inflammatory
response
positive regulation of
inflammatory
response
negative regulation of
inflammatory
response
immune response

Response to Microbes
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Process

6 Hour
Pvalue
3.30E
-15

Process

1.10E
-04

innate immune response

8.50E
-06

5.50E
-04

negative regulation of
inflammatory response

1.50E
-03

3.60E
-03

positive regulation of
inflammatory response

1.60E
-03

6.70E
-03

regulation of
inflammatory response

1.50E
-02

Pvalue
2.90E
-06

Process
response to
lipopolysaccharide

Pvalue
1.30E
-03

inflammatory response

Pvalue
4.80E
-09

Process

P-value

Process

cellular response to
lipopolysaccharide

1.70E-04

transferrin transport

response to
lipopolysaccharide

1.60E-03

response to
lipopolysaccharide

3.60E
-05

response to muramyl
dipeptide

3.80E
-03

lipopolysaccharidemediated signaling
pathway

4.90E
-05

defense response

1.10E
-02

1 Hour
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Phagocytosis & Phagosome Maturation

Response to
Microbes
(cont.)

Process

3 Hour
P-value

6 Hour

cellular response to
lipopolysaccharide

Pvalue
3.70E
-04

response to muramyl
dipeptide

5.60E
-03

cellular response to
oxidative stress
phagosome
acidification
intracellular protein
transport
response to hydrogen
peroxide
regulation of
macroautophagy
macroautophagy

1.50E
-06

autophagy

2.80E
-03

endosome to
lysosome transport

5.40E
-03

Process

Process
lipopolysaccharidemediated signaling
pathway
cellular response to
lipopolysaccharide

Pvalue
1.80E
-02
1.70E
-02

actin cytoskeleton
organization
phagocytosis

1.10E
-02

3.20E
-04

phagosome acidification

6.00E
-03

7.70E
-04

response to hydrogen
peroxide
response to nitrosative
stress
cellular response to
oxidative stress
positive regulation of
autophagy
positive regulation of
xenophagy
negative regulation of
inclusion body assembly
transferrin transport

7.30E
-04

8.80E
-06

8.60E
-04
2.60E
-03

4.00E
-03

4.60E
-03
7.20E
-03
8.30E
-03
1.10E
-02
1.60E
-02
7.80E
-04

1 Hour
Process

Pvalue

Process

5.10E06
6.80E05
1.80E04

neutrophil chemotaxis

chemotaxis

2.70E04

cell chemotaxis

6 Hour
Pvalue

Process

Pvalue

4.70E05
1.30E04
6.00E04

leukocyte migration

leukocyte migration

2.50E03

neutrophil chemotaxis

3.80E03

5.50E04

positive regulation of cell
migration

5.90E03

positive regulation of
neutrophil chemotaxis

2.50E04

positive regulation of
neutrophil chemotaxis

1.40E03

monocyte chemotaxis

8.60E03

positive regulation of cell
migration

1.10E03

positive regulation of cell
migration

3.00E03

small GTPase mediated
signal transduction

2.90E05

small GTPase mediated
signal transduction

3.10E05

positive regulation of
ERK1 and ERK2 cascade

8.50E05

intracellular signal
transduction

5.70E04

signal transduction

6.10E05

positive regulation of
peptidyl-serine
phosphorylation

7.70E04

neutrophil chemotaxis
monocyte chemotaxis
lymphocyte chemotaxis
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Chemotaxis

3 Hour

chemotaxis
positive regulation of
neutrophil chemotaxis

granulocyte chemotaxis
chemotaxis

4.80E04
6.10E04
2.50E03

1 Hour
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Signal Transduction

Process

3 Hour
Pvalue

Process

6 Hour
Pvalue

signal transduction

8.40E04

positive regulation of JNK 5.70E04
cascade

G-protein coupled
receptor signaling
pathway
activation of MAPKKK
activity

2.30E03

signal transduction

5.50E03

intracellular receptor
signaling pathway

7.00E03

positive regulation of
peptidyl-tyrosine
phosphorylation

1.00E02

Process

Pvalue

intracellular signal
transduction

3.70E03

1.10E03

positive regulation of
GTPase activity

4.30E03

TRIF-dependent toll-like
receptor signaling
pathway
signaling

2.90E03

3.60Epositive regulation of
ERK1 and ERK2 cascade 03

6.10E03

inactivation of MAPK
activity

regulation of protein
phosphorylation

8.90E03

inactivation of MAPK
activity

7.00E03

positive regulation of
peptidyl-serine
phosphorylation
positive regulation of
TOR signaling

1.00E02

negative regulation of IkappaB kinase/NFkappaB signaling

7.70E
-05

1.00E
-02

1.40E02

1 Hour
Process

89

Gene Expression & Transcription Factors

negative regulation of
transcription from RNA
polymerase II promoter

3 Hour
Pvalue
1.70E05

positive regulation of
transcription from RNA
polymerase II promoter

2.50E05

positive regulation of
tyrosine phosphorylation
of Stat3 protein

4.20E05

Process

6 Hour
Pvalue

Process

positive regulation of
NF-kappaB
transcription factor
activity
positive regulation of IkappaB kinase/NFkappaB signaling

1.70E04

negative regulation of
gene expression

1.10E03

positive regulation of
NF-kappaB transcription
factor activity

positive regulation of
protein kinase B
signaling
positive regulation of
NF-kappaB import into
nucleus
regulation of I-kappaB
kinase/NF-kappaB
signaling
positive regulation of
transcription, DNAtemplated

2.30E03

positive regulation of IkappaB kinase/NFkappaB signaling
negative regulation of IkappaB kinase/NFkappaB signaling
regulation of I-kappaB
kinase/NF-kappaB
signaling
negative regulation of
NF-kappaB transcription
factor activity

negative regulation of
transcription from RNA
polymerase II promoter

1.00E02

2.70E03
3.00E03
1.00E02

Pvalue
1.10E02

8.40E04

7.10E03
8.30E03
1.70E02
1.80E02

1 Hour
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Cytokines

Process

3 Hour
Pvalue

Process

6 Hour
Pvalue

chemokine-mediated
signaling pathway

4.60E08

cellular response to
tumor necrosis factor

2.00E07

cellular response to
interleukin-1

6.60E07

chemokine-mediated
signaling pathway

3.00E05

cellular response to
interferon-gamma

2.60E05

8.30E05

tumor necrosis factormediated signaling
pathway

7.50E03

positive regulation of
interleukin-1 beta
secretion
cellular response to
interleukin-1
tumor necrosis factormediated signaling
pathway
regulation of tumor
necrosis factor-mediated
signaling pathway
negative regulation of
transforming growth
factor beta receptor
signaling pathway

cellular response to
tumor necrosis factor
positive regulation of
tumor necrosis factor
production

8.30E06

Process

Pvalue

interferon-gammamediated signaling
pathway
positive regulation of
interleukin-1 beta
secretion

2.90E06

8.00E04

4.10E03

negative regulation of
type I interferon
production
tumor necrosis factormediated signaling
pathway
positive regulation of
interferon-beta
production
cellular response to
tumor necrosis factor

4.30E03

cellular response to
cytokine stimulus

6.50E03

5.10E03

positive regulation of
interleukin-1 beta
production

6.50E03

1.60E05

4.10E04

3.90E05

3.40E03
6.00E03
6.40E03

1 Hour

Cytokines (cont.)

Process
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Protein Folding

3 Hour
Pvalue

6 Hour

positive regulation of
chemokine production

Pvalue
5.40E03

positive regulation of
interleukin-8 production

8.60E03

Process

Process

negative regulation of
transforming growth
factor beta receptor
signaling pathway
chemokine-mediated
signaling pathway

Pvalue
7.20E03

7.70E03

type I interferon signaling
pathway

7.20E03

response to unfolded
protein

1.40E08

protein folding

1.50E05

protein refolding

5.70E05
1.60E02
1.70E02
8.80E03

protein ubiquitination
protein maturation
chaperone-mediated
protein complex assembly
positive regulation of
protein phosphorylation

9.10E04

1 Hour

6 Hour

Pvalue
9.80E03

glycosphingolipid
metabolic process

Pvalue
2.40E04

3.90E03

cellular response to
starvation

1.50E03

cellular response to
glucocorticoid stimulus

1.10E03

2.80E03

cellular response to
corticotropin-releasing
hormone stimulus

1.50E03

positive regulation of
nitric oxide biosynthetic
process
cellular response to fatty
acid
UDP-Nacetylglucosamine
biosynthetic process
N-acetylneuraminate
catabolic process
positive regulation of
cholesterol homeostasis
ATP metabolic process

5.60E03

ATP hydrolysis coupled
proton transport
proton transport

6.30E03

Process

positive regulation of
nitric oxide biosynthetic
process
response to amino acid
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Metabolic Processes

3 Hour
Process

4.50E03

6.10E03
6.10E03
6.30E03

2.60E05

Process

glycosphingolipid
metabolic process

Pvalue
2.30E03

positive regulation of
tumor necrosis factor
production
GTP metabolic process

3.30E03

proteasomal ubiquitinindependent protein
catabolic process
glycogen biosynthetic
process

4.60E03

carbohydrate metabolic
process
phospholipid metabolic
process
regulation of
gluconeogenesis
inositol phosphate
metabolic process
ceramide biosynthetic
process
N-glycan processing

1.10E02

3.60E03

4.70E03

1.10E02
1.10E02
9.70E03
1.40E02
1.60E02

1 Hour
Pvalue

Process

6 Hour
Pvalue

Process

Pvalue

N-acetylneuraminate
catabolic process

1.70E03

positive regulation of
MHC class I biosynthetic
process

1.90E02

2.10E05

apoptotic process

3.70E07

Metabolic
Processes
(Cont.)

Process

3 Hour

2.00E05

apoptotic process

7.90E04

apoptotic process

1.60E04

apoptotic mitochondrial
changes

2.60E03

activation of cysteinetype endopeptidase
activity involved in
apoptotic process

1.70E03

positive regulation of
apoptotic process

1.90E04

extrinsic apoptotic
signaling pathway

1.20E02

necroptotic process

1.10E03

activation of cysteine-type
endopeptidase activity
involved in apoptotic
process

4.00E04

negative regulation of
extrinsic apoptotic
signaling pathway via
death domain receptors

1.80E03

activation of cysteine-type
endopeptidase activity
involved in apoptotic
signaling pathway

1.30E03

Apoptosis
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negative regulation of
apoptotic process

negative regulation of
apoptotic process

1 Hour
Pvalue

Miscellaneous

94

Apoptosis (Cont.)

Process

3 Hour

6 Hour

Process

Pvalue

Process

Pvalue

negative regulation of
cysteine-type
endopeptidase activity
involved in apoptotic
process

3.20E03

negative regulation of
extrinsic apoptotic
signaling pathway via
death domain receptors

6.60E03

intrinsic apoptotic
signaling pathway in
response to DNA
damage

5.30E03

regulation of extrinsic
apoptotic signaling
pathway via death domain
receptors

6.70E03

regulation of extrinsic
apoptotic signaling
pathway via death
domain receptors

5.40E03

negative regulation of
apoptotic process

1.10E02

activation of cysteinetype endopeptidase
activity involved in
apoptotic process

5.60E03

positive regulation of
apoptotic process

1.10E03

endoplasmic reticulum
calcium ion homeostasis

3.30E03

cell-cell adhesion

3.50E03

secretion by cell

1.60E02

positive regulation of
osteoclast differentiation

3.70E05

1.60Epositive regulation of
osteoclast differentiation 03

cell adhesion

8.10E03

positive regulation of
calcium ion transport

8.60E03

1 Hour
Process

3 Hour
Pvalue

Process

6 Hour
Pvalue

Process

Pvalue

proton transport

4.80E03
9.10E03
9.10E03

Miscellaneous

response to iron ion
negative regulation of
protein serine/threonine
kinase activity
negative regulation of
cysteine-type
endopeptidase activity
involved in apoptotic
process
positive regulation of
calcium ion transport

1.40E02

4.70E03
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Table 2.3: Genes involved in the Biological Process of Inflammation & Neutrophil activation by MetaCore

Input IDs

Network Object Name

ENSG00000142208

AKT(PKB)

ENSG00000012779

ALOX5

ENSG00000115966

1 Hour
Log2Fold
p-value
Change
-0.268394
0.56125

3 Hour
Log2Fold
p-value
Change
-1.35053
0.0029

6 Hour
Log2Fold
p-value
Change
-2.14563
0.00005

-0.235755

0.46905

-0.43537

0.17815

-1.30551

0.00025

AP-1

0.336876

0.41865

0.492399

0.23355

0.730992

0.0755

ENSG00000115966

ATF-2/c-Jun

0.336876

0.41865

0.492399

0.23355

0.730992

0.0755

ENSG00000143632

Actin

0.636624

1

-1.3805

1

-0.975943

1

ENSG00000164742

Adenylate cyclase

1.20705

1

0.372034

1

0.698685

1

ENSG00000164742

Adenylate cyclase type I

1.20705

1

0.372034

1

0.698685

1

ENSG00000078295

0.948255

1

0.638634

1

0.867516

1

0.214679

0.767

3.72654

0.00005

4.60815

0.00005

-0.906962

0.0755

-0.65237

0.1834

-1.09539

0.02525

0.704655

1

2.14178

0.0006

2.31121

0.0002

-4.53876

1

0.0994383

1

-2.46958

1

0.173814

1

0.654431

1

0.28185

1

-0.605382

0.2165

-0.429987

0.3534

-0.103959

0.83925

-15.5693

1

0.222025

1

2.16771

1

ENSG00000135046

Adenylate cyclase type
II
Adenylate cyclase type
III
Adenylate cyclase type
IV
Adenylate cyclase type
IX
Adenylate cyclase type
V
Adenylate cyclase type
VI
Adenylate cyclase type
VII
Adenylate cyclase type
VIII
Annexin I

0.240346

0.4812

-0.660925

0.0554

-1.59915

0.00015

ENSG00000120868

Apaf-1

-0.147656

0.73435

-0.852756

0.06645

-0.543003

0.23705

ENSG00000138071

Arp2/3

-0.085798

0.8165

-0.290621

0.39975

-0.611465

0.1097

ENSG00000015475

Bid

0.106129

0.8675

1.5263

0.0072

0.85196

0.169

ENSG00000138031
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ENSG00000129467
ENSG00000162104
ENSG00000173175
ENSG00000174233
ENSG00000121281
ENSG00000155897

1 hour
Input IDs

Network Object Name

3 hour

ENSG00000010671

Btk

Log2Fold
Change
-0.151721

p-value

97

0.0073

Log2Fold
Change
0.172335

ENSG00000106804

C5a

-0.670077

0.3237

ENSG00000197405

C5aR

0.291758

0.38

0.572423

0.49415

0.942053

0.25

-0.129738

0.7045

-1.24779

0.0008

ENSG00000108691

CCL2

2.84034

0.00005

1.91775

0.0006

0.95627

0.06905

ENSG00000135404

CD63

0.341514

0.49925

2.20922

0.00005

2.74768

0.00005

ENSG00000006210

CX3CL1

0.412438

1

0.807216

1

0.31547

1

ENSG00000168329

CX3CR1

-0.154489

0.76035

-0.579668

0.35505

-0.20214

0.6979

ENSG00000164305

Caspase-3

0.0872686

0.80205

0.340595

0.3449

0.796916

0.0377

ENSG00000064012

Caspase-8

-0.332073

0.4657

-1.05957

0.0224

-1.78981

0.00025

ENSG00000172757

Cofilin

-0.019265

0.96085

-0.29201

0.4632

-1.2949

0.00155

ENSG00000051523

Cytochrome b-558

-0.234277

0.64875

0.438144

0.3666

0.201541

0.6868

ENSG00000172115

Cytochrome c

0.401099

0.43565

-0.174956

0.7352

-0.420116

0.43985

ENSG00000168970

-0.649148

0.4939

-0.859994

0.3485

-1.22401

0.20455

ENSG00000007908

Cytosolic phospholipase
A2 beta
E-selectin

0

1

15.6737

1

14.7034

1

ENSG00000163735

ENA-78

2.78973

1

4.99307

0.0094

4.94474

0.0082

ENSG00000102882

ERK1 (MAPK3)

-0.31347

0.50515

-1.46191

0.0036

-1.83436

0.00085

ENSG00000100030

ERK1/2

0.111859

0.86515

-1.22384

0.04215

-2.03661

0.00205

ENSG00000100030

ERK2 (MAPK1)

0.111859

0.86515

-1.22384

0.04215

-2.03661

0.00205

ENSG00000168040

FADD

-1.82699

0.02235

-1.83039

0.0195

-2.24993

0.00495

ENSG00000171051

FPR

0.309293

0.4953

0.433394

0.33985

-0.117564

0.80285

ENSG00000171049

FPRL1

0.300916

0.7945

0.258945

0.80795

-0.704088

0.52475

ENSG00000060558

G-protein alpha-15

0.108801

0.77065

1.07998

0.00265

1.11406

0.0034

ENSG00000127955

G-protein alpha-i family

0.571501

1

-12.529

1

-2.51315

1

ENSG00000114353

G-protein alpha-i2

-0.334653

0.3361

-0.98326

0.004

-2.03799

0.00005

0.70195

Log2Fold
Change
-1.02335

6 hour
p-value

p-value
0.69585

1 hour
Input IDs

Network Object Name

98

0.6306

-0.003427

0.99495

0.695778

0.17615

0.279574

0.6152

0.162711

0.7157

0.776796

0.06805

0.653148

0.16675

GRO-1

3.37405

0.00005

1.8271

0.00005

1.77034

0.00005

ENSG00000081041

GRO-2

6.33583

0.00005

6.15229

0.00005

6.00946

0.00005

ENSG00000163734

GRO-3

4.37038

0.00005

3.77473

0.00005

4.35262

0.00005

ENSG00000144648

-1.48914

0.04105

-1.18726

0.09355

-1.35623

0.064

ENSG00000174775

Galpha(i)-specific
peptide GPCRs
H-Ras

-0.079523

0.88715

-0.100795

0.88615

-2.22536

0.00045

ENSG00000100906

I-kB

0

1

3.16244

0.00005

2.48684

0.00005

ENSG00000090339

ICAM1

2.80958

0.00005

2.10994

0.00005

1.37142

0.00605

ENSG00000108622

ICAM2

-0.172743

0.70855

0.353612

0.4279

-0.709392

0.13385

ENSG00000105371

ICAM4

2.97046

0.0036

2.5412

0.00365

2.49967

0.00435

ENSG00000111537

IFN-gamma

-0.411676

1

-1.57507

1

-1.43862

1

ENSG00000213341

IKK (cat)

0.0386051

0.9263

-0.201073

0.64655

-0.033242

0.93635

ENSG00000213341

IKK-alpha

0.0386051

0.9263

-0.201073

0.64655

-0.033242

0.93635

ENSG00000104365

IKK-beta

-0.24989

0.576

1.24499

0.0115

1.03277

0.0572

ENSG00000136634

IL-10

-0.882243

0.1873

-0.420915

0.48805

0.508715

0.52685

ENSG00000109471

IL-2

0

1

15.6737

1

0

1

ENSG00000134460

IL-2 receptor

1.67419

1

4.1224

0.0016

3.33951

0.0022

ENSG00000100385

IL-2R beta chain

0.432867

1

0.504894

1

1.06171

0.29405

ENSG00000113525

IL-5

0.242808

1

1.40525

1

1.79082

1

ENSG00000136244

IL-6

2.99727

0.08685

6.22286

0.0654

5.70078

0.0652

ENSG00000163464

IL8RA

-0.746133

0.023

-2.18534

0.00005

-1.99003

0.00005

ENSG00000180871

IL8RB

-0.329611

0.40595

-1.94377

0.00005

-2.21343

0.00005

G-protein alpha-q/11

ENSG00000078369

G-protein beta/gamma

ENSG00000177885

GRB2

ENSG00000163739

p-value

p-value

6 hour
Log2Fold
p-value
Change
0.202808
0.78065

Log2Fold
Change
-0.040169

ENSG00000088256

Log2Fold
Change
-0.383532

3 hour

0.9544

1 hour
Input IDs

Network Object Name

99

0.9694

-0.072381

0.8493

-0.199032

0.59635

-0.635927

0.10645

-0.277596

0.3734

-0.768094

0.01255

-2.11987

0.00005

JAK1

0.134832

0.66445

0.0062887

0.9844

0.463703

0.14465

ENSG00000175592

JunB/Fra-1

0.700587

0.10625

-1.95565

0.00005

-2.27314

0.00005

ENSG00000170345

JunD/c-Fos

0.540993

0.1754

-1.63712

0.00005

-0.447981

0.2341

ENSG00000106683

LIMK1

-0.488078

0.22955

-1.0831

0.00895

-2.07483

0.00005

ENSG00000182541

LIMK2

0.505974

0.16555

0.975505

0.0039

0.210261

0.54895

ENSG00000111144

LTA4H

-0.18693

0.6781

-0.627719

0.1415

-0.426102

0.3342

ENSG00000213903

LTBR1

-0.811739

0.26125

-1.3433

0.08285

-2.08177

0.0134

ENSG00000213906

LTBR2

-1.221

0.41905

-2.23305

0.17685

-3.13535

0.091

ENSG00000110514

MADD

0.0831299

0.8343

-0.649991

0.14525

-0.791325

0.04255

ENSG00000156575

MBPH

0.9458

1

1.26023

1

2.31847

1

ENSG00000169032

MEK1(MAP2K1)

-0.016729

0.9712

-0.019278

0.9619

-0.485772

0.3074

ENSG00000169032

MEK1/2

-0.016729

0.9712

-0.019278

0.9619

-0.485772

0.3074

ENSG00000126934

MEK2(MAP2K2)

0.0310253

0.9711

-0.818938

0.27245

-0.478587

0.58065

ENSG00000095015

MEKK1(MAP3K1)

0.0913193

0.7935

-0.773331

0.02555

0.30483

0.38005

ENSG00000109320

NF-kB

1.4494

0.00125

3.07581

0.00005

2.37882

0.00005

ENSG00000109320

NF-kB p50/c-Rel

1.4494

0.00125

3.07581

0.00005

2.37882

0.00005

ENSG00000109320

NF-kB p50/p50

1.4494

0.00125

3.07581

0.00005

2.37882

0.00005

ENSG00000109320

NF-kB p50/p65

1.4494

0.00125

3.07581

0.00005

2.37882

0.00005

ENSG00000077150

NF-kB p52/RelB

1.65511

0.00005

2.46764

0.00005

1.84765

0.00005

ENSG00000162924

NF-kB p65/c-Rel

1.09213

0.0241

1.97707

0.00005

1.74788

0.00025

ENSG00000173039

NF-kB p65/p65

0.805521

0.075

0.644145

0.14395

-0.831558

0.0612

ENSG00000109320

NF-kB1 (p50)

1.4494

0.00125

3.07581

0.00005

2.37882

0.00005

IP3 receptor

ENSG00000169896

ITGAM

ENSG00000160255

ITGB2

ENSG00000162434

p-value

p-value

6 hour
Log2Fold
p-value
Change
2.39845
0.00005

Log2Fold
Change
1.96326

ENSG00000150995

Log2Fold
Change
0.0169103

3 hour

0.00005

1 hour
Input IDs

Network Object Name

100

0.00005

1.65511

0.00005

2.46764

0.00005

1.84765

0.00005

0

1

3.16244

0.00005

2.48684

0.00005

2.0777

0.0001

2.61055

0.00005

2.19574

0.00005

-0.560321

0.4498

-1.84519

0.0133

-1.53898

0.0294

-1.19698

1

-0.310513

1

-0.99699

1

NOX1/p22-phox

-0.234277

0.64875

0.438144

0.3666

0.201541

0.6868

ENSG00000117592

NSGPeroxidase

0.215028

0.5748

-0.361838

0.3472

-0.453273

0.27595

ENSG00000174175

P-selectin

0.758977

0.2542

-1.2616

0.035

-1.26137

0.05625

ENSG00000116711

PA24A

0.253945

0.55755

-1.20128

0.007

-2.08999

0.00125

ENSG00000184381

PA2G6

2.83811

0.0049

3.50727

0.00005

3.8014

0.00005

ENSG00000149269

PAK1

0.184457

0.58715

0.554972

0.1074

0.320026

0.3308

ENSG00000180370

PAK2

0.0139468

0.9761

-0.652408

0.191

-0.826735

0.13585

ENSG00000005381

PERM

0.103196

0.84875

0.0038075

0.99585

-0.866344

0.11665

ENSG00000138308

PG12B

-1.56865

1

1.23723

1

1.1968

1

ENSG00000121879

PI3K cat class IA

0.205456

0.77335

-0.755579

0.2899

0.305876

0.6754

ENSG00000121879

0.205456

0.77335

-0.755579

0.2899

0.305876

0.6754

0.0572675

0.88035

-0.077703

0.83165

-0.313535

0.38125

-0.173014

0.60385

-1.013

0.00495

-0.900246

0.012

ENSG00000145675

PI3K cat class IA (p110alpha)
PI3K cat class IA (p110beta)
PI3K cat class IA (p110delta)
PI3K reg class IA

0.211027

0.69585

-0.252244

0.65605

0.199538

0.70535

ENSG00000117461;
ENSG00000278139

PI3K reg class IA (p55gamma)

0.178026

1

0.585365

1

14.7034

1

ENSG00000145675

PI3K reg class IA (p85)

0.211027

0.69585

-0.252244

0.65605

0.199538

0.70535

NF-kB2 (p100)

ENSG00000077150

NF-kB2 (p52)

ENSG00000100906

NFKBIA

ENSG00000146232

NFKBIE

ENSG00000006062

NIK(MAP3K14)

ENSG00000007952

NOX1

ENSG00000051523

ENSG00000051382
ENSG00000171608

p-value

p-value

6 hour
Log2Fold
p-value
Change
1.84765
0.00005

Log2Fold
Change
2.46764

ENSG00000077150

Log2Fold
Change
1.65511

3 hour

0.00005

1 hour
Input IDs
ENSG00000145675

Network Object Name

Log2Fold
Change
0.211027

3 hour
p-value

p-value

6 hour
Log2Fold
p-value
Change
0.199538
0.70535

0.69585

Log2Fold
Change
-0.252244

1.46031

0.26735

1.69027

0.1937

2.09423

0.1278

-15.5693

1

0.278206

1

1.61796

1

1.46251

1

1.31425

1

0.964295

1

101

ENSG00000105647;
ENSG00000268173
ENSG00000101333

PI3K reg class IA (p85alpha)
PI3K reg class IA (p85beta)
PIB4

0.65605

ENSG00000154229

PKC-alpha

ENSG00000166501

PKC-beta

-0.026308

0.9484

-0.464389

0.27455

-0.237803

0.5807

ENSG00000163932

PKC-delta

-0.006682

0.9835

0.907419

0.0052

0.385075

0.2377

ENSG00000067606

PKC-zeta

-0.239774

0.5907

-1.19652

0.0118

-1.3945

0.00325

ENSG00000069764

PLA2

-0.049767

1

-0.496008

1

-0.257958

1

ENSG00000069764

PLA2G10

-0.049767

1

-0.496008

1

-0.257958

1

ENSG00000123739

PLA2G12

0.859792

0.40245

-2.39237

1

-1.85832

1

ENSG00000117215

PLA2G2D

14.5678

1

15.6737

1

14.7034

1

ENSG00000100078

PLA2G3

0

1

15.6737

1

14.7034

1

ENSG00000105499

PLA2G4C

1.65877

0.00005

3.85692

0.00005

4.54325

0.00005

ENSG00000182621

PLC-beta

0.320995

0.55995

0.0635368

0.91035

-0.749371

0.16965

ENSG00000182621

PLC-beta1

0.320995

0.55995

0.0635368

0.91035

-0.749371

0.16965

ENSG00000137841

PLC-beta2

-0.617107

0.1306

-1.58707

0.00005

-2.59408

0.00005

ENSG00000149782

PLC-beta3

-0.41557

0.38635

0.297363

0.50225

0.0303082

0.9445

ENSG00000075651

PLD1

0.655048

0.2572

2.88132

0.00005

2.86643

0.00005

ENSG00000129219

PLD2

-0.420784

0.36975

-1.13418

0.02485

-1.84026

0.0017

ENSG00000186951

PPAR-alpha

-0.263617

0.63005

0.456419

0.449

0.30982

0.57365

ENSG00000124126

PREX1

-0.044813

0.88785

0.193453

0.5318

0.25828

0.40825

ENSG00000110876

PSGL-1

-0.636731

0.0715

-1.4926

0.00005

-1.76971

0.00005

ENSG00000067900

ROCK

0.0737406

0.82895

-0.68744

0.03295

-0.369869

0.2781

ENSG00000067900

ROCK1

0.0737406

0.82895

-0.68744

0.03295

-0.369869

0.2781

1 hour
Input IDs

Network Object Name

102

0.60285

-0.058633

0.89405

0.336282

0.4181

0.142861

0.73685

-0.215299

0.5043

0.527082

0.09755

0.35238

0.2695

1.38866

0.0004

2.56647

0.00005

2.03533

0.00005

0.181352

0.6135

0.393

0.24965

-0.143086

0.7032

1.73729

1

0.477101

1

1.04811

1

SNAP-23

0.0824211

0.86715

-0.476283

0.29665

0.236652

0.60175

ENSG00000185338

SOCS1

-0.443341

0.63635

0.356888

0.62995

2.23929

0.009

ENSG00000156735

SODD

-0.259028

0.69995

-1.92762

0.01045

-0.945209

0.15885

ENSG00000168610

STAT3

0.318497

0.2861

-0.182545

0.5424

-0.518398

0.0822

ENSG00000106089

Syntaxin 1A

-1.49897

0.00725

-3.17114

0.00005

-3.77

0.00005

ENSG00000103496

Syntaxin 4

0.915306

0.02265

1.76622

0.00005

1.55602

0.00005

ENSG00000135823

Syntaxin 6

-0.697353

0.1095

-1.36091

0.00095

-1.18491

0.0033

ENSG00000079950

Syntaxin 7

0.0715859

0.92885

0.412041

0.5591

1.35408

0.05435

ENSG00000067182

TNF-R1

-0.474593

0.3514

-0.90111

0.04775

-1.00755

0.06335

ENSG00000028137

TNF-R2

-0.1768

0.5946

1.24355

0.00035

0.729701

0.03695

ENSG00000232810

TNF-alpha

4.0306

0.00005

2.77055

0.00005

1.15677

0.00165

ENSG00000226979

TNF-beta

0.273582

0.5725

1.24517

0.00705

0.212522

0.6612

ENSG00000102871

TRADD

-0.849765

0.05665

-1.15573

0.0059

-0.85951

0.0678

ENSG00000127191

TRAF2

-0.070513

0.94135

0.0796205

0.93035

0.548455

0.5636

ENSG00000131323

TRAF3

0.0651305

0.87575

2.40231

0.00005

2.67965

0.00005

ENSG00000263620;
ENSG00000220205
ENSG00000141968

VAMP2

-0.26636

0.79795

-1.81689

0.57355

1.47089

0.0633

VAV-1

-0.055979

0.8732

1.09768

0.0008

0.702089

0.03485

ENSG00000134215

VAV-3

0.187493

0.6775

0.512374

0.2545

-0.061412

0.896

ROCK2

ENSG00000136238

Rac1

ENSG00000128340

Rac2

ENSG00000160271

RalGDS

ENSG00000067560

RhoA

ENSG00000196218

Ryanodine receptor 1

ENSG00000092531

p-value

p-value

6 hour
Log2Fold
p-value
Change
-0.3473
0.4248

Log2Fold
Change
-0.493979

ENSG00000134318

Log2Fold
Change
0.228265

3 hour

0.3389

1 hour
Input IDs

Network Object Name

0.7201

-0.072381

0.8493

-0.199032

0.59635

-0.635927

0.10645

-0.495397

0.1884

-0.793995

0.03005

-0.218374

0.55605

c-Jun/Fra-1

0.700587

0.10625

-1.95565

0.00005

-2.27314

0.00005

ENSG00000170345

c-Jun/c-Fos

0.540993

0.1754

-1.63712

0.00005

-0.447981

0.2341

ENSG00000177606

c-Jun/c-Jun

-0.495397

0.1884

-0.793995

0.03005

-0.218374

0.55605

ENSG00000132155

c-Raf-1

0.127627

0.7162

-0.041701

0.8997

0.248827

0.4648

ENSG00000116711

cPLA2

0.253945

0.55755

-1.20128

0.007

-2.08999

0.00125

ENSG00000165168

gp91-phox

0.530715

0.25785

1.60592

0.00045

1.62704

0.00055

ENSG00000007171

iNOS

ENSG00000051523

p22-phox

ENSG00000185386

VTI1B

ENSG00000169896

alpha-M/beta-2 integrin

ENSG00000177606

c-Jun

ENSG00000175592

p-value

p-value

6 hour
Log2Fold
p-value
Change
-0.284376
0.6871

Log2Fold
Change
-1.13439

ENSG00000100568

Log2Fold
Change
-0.23661

3 hour

0.0526

103

-15.5693

1

-12.529

1

2.07421

1

-0.234277

0.64875

0.438144

0.3666

0.201541

0.6868

p38 MAPK

-2.27641

1

-0.431726

1

-1.38824

1

ENSG00000112062

p38alpha (MAPK14)

-0.02206

0.96605

-0.716459

0.1727

-1.45325

0.006

ENSG00000185386

p38beta (MAPK11)

-2.27641

1

-0.431726

1

-1.38824

1

ENSG00000156711

p38delta (MAPK13)

-0.134623

0.79435

0.596537

0.19465

0.422063

0.37635

ENSG00000188130

p38gamma (MAPK12)

0.45834

1

0.110895

1

-0.029106

1

ENSG00000100365

p40-phox

0.05836

0.8683

-0.397913

0.2401

0.112339

0.7651

ENSG00000116701

p67-phox

-0.011738

0.97455

0.542507

0.11335

0.447425

0.1847

ENSG00000015475

tBid

0.106129

0.8675

1.5263

0.0072

0.85196

0.169

Table 2.4: Fold change of Components of NADPH Oxidase Complex compared to basal
ENSEMBL
GENE

GENE SYMBOL|DESCRIPTION

1 hr

3 hr

6 hr

ENSG00000165168

CYBB|cytochrome b-245, beta polypeptide

1.4

3.04* 3.09*

ENSG00000051523

0.9

1.4

1.1

ENSG00000158517

CYBA|cytochrome b-245, alpha
polypeptide
NCF1|neutrophil cytosolic factor 1

1.3

1.2

0.32*

ENSG00000116701

NCF2|neutrophil cytosolic factor 2

1.0

1.5

1.4

ENSG00000100365

NCF4|neutrophil cytosolic factor 4, 40kDa

1.0

0.8

1.1

ENSG00000128340

RAC2|ras-related C3 botulinum toxin
0.9
1.4
substrate 2 (rho family, small GTP binding
protein Rac2)
ENSG00000116473
RAP1A|RAP1A, member of RAS
1.1
0.8
oncogene family
Note: Asterisk denotes p value <0.05 compared to basal unstimulated conditions

1.3

0.9

Table 2.5: KEGG pathways significantly enriched for differentially expressed genes
during challenge with F. alocis
Time Point

1h

3h

3h

DEG Count
19

Description
Cytokine-cytokine receptor interaction

P-value
5.40E-09

13

TNF signaling pathway

2.50E-08

10

Rheumatoid arthritis

3.50E-06

9

NF-kappa B signaling pathway

2.70E-05

8

Salmonella infection

1.50E-04

6

Legionellosis

9.20E-04

6

NOD-like receptor signaling pathway

1.10E-03

9

Transcriptional mis-regulation in cancer

2.40E-03

9

Chemokine signaling pathway

4.60E-03

10

MAPK signaling pathway

9.10E-03

26

Rheumatoid arthritis

2.30E-08

19

Legionellosis

1.50E-07

29

Lysosome

4.10E-07

26

TNF signaling pathway

1.40E-06

18

NOD-like receptor signaling pathway

1.50E-06
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6h

6h

22

NF-kappa B signaling pathway

5.70E-06

40

Cytokine-cytokine receptor interaction

4.00E-05

17

Epithelial cell signaling in Helicobacter pylori infection

8.50E-05

19

Salmonella infection

1.20E-04

22

Toll-like receptor signaling pathway

1.30E-04

30

Chemokine signaling pathway

6.40E-04

20

Chagas disease (American trypanosomiasis)

8.00E-04

13

Vibrio cholerae infection

9.00E-04

28

Influenza A

1.00E-03

23

Measles

1.30E-03

34

Endocytosis

2.70E-03

24

Phagosome

2.80E-03

13

Apoptosis

4.40E-03

20

Epstein-Barr virus infection

5.30E-03

13

Inflammatory bowel disease (IBD)

5.70E-03

17
26

Inflammatory mediator regulation of TRP channels
Herpes simplex infection

6.40E-03
8.70E-03

10

Sphingolipid metabolism

0.014

12

Pancreatic cancer

0.017

32

HTLV-I infection

0.018

27

Viral carcinogenesis

0.019

22

Legionellosis

2.70E-07

46

Chemokine signaling pathway

1.20E-06

20

Apoptosis

1.80E-05

30

Lysosome

1.20E-04

32

Measles

1.20E-04

37

Influenza A

4.40E-04

24

Estrogen signaling pathway

9.10E-04

22

Rheumatoid arthritis

1.00E-03

40

Viral carcinogenesis

1.40E-03

16

NOD-like receptor signaling pathway

1.60E-03

45

Endocytosis

1.80E-03

29

Insulin signaling pathway

2.50E-03

24

TNF signaling pathway

2.70E-03

26

Sphingolipid signaling pathway

2.90E-03

8

Other glycan degradation

3.00E-03

26

Epstein-Barr virus infection

3.60E-03

17

Epithelial cell signaling in Helicobacter pylori infection

4.00E-03

24

Toxoplasmosis

4.00E-03
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23

Chagas disease (American trypanosomiasis)

4.10E-03

23

Toll-like receptor signaling pathway

5.20E-03

13

Sphingolipid metabolism

6.80E-03

16

Pancreatic cancer

7.30E-03

33

Tuberculosis

8.20E-03

21

Phosphatidylinositol signaling system

9.10E-03

21

Inflammatory mediator regulation of TRP channels

9.10E-03

14

Non-small cell lung cancer

0.011

17

Pertussis

0.012

19

Prostate cancer

0.013

13

Vibrio cholerae infection

0.015

25

Platelet activation

0.016

16

Leishmaniasis

0.016

27

Hepatitis B

0.018

11

Bladder cancer

0.018
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CHAPTER 3:
THE TLR2 TANGO: FILIFACTOR ALOCIS MANIPULATES NEUTROPHIL
SIGNALING TO PREVENT KILLING WHILE PROMOTING INFLAMMATION

Introduction
One of the primary roles of neutrophils is host defense against microbial challenge.
However, their efficient antimicrobial activity hinges on the recognition of microbial
invaders and firing of the complex intracellular signal transduction pathways that link
neutrophil functional processes [325]. This process is initiated through the ligation of cell
surface receptors called pattern recognition receptors (PRR), which recognize general
microbial structures. There are several PRR, including C-type lectins, NOD-like, RIG-like,
and Toll-like receptors (TLR), but in this thesis the focus will be on TLRs.
Toll-like receptors belong to the IL-1R/TLR family of receptors and are
characterized by leucine-rich repeats on their extracellular domains. Out of the 13 TLR
members in the family of receptors, TLR1 to -9 are conserved in mouse and humans, while
neutrophils express all tested TLR except TLR3 and 7 [325-330]. Generally, TLR1, -2, -4,
-5 and -6 are present on the neutrophil cell surface, while TLR, -8 and -9 are in intracellular
endocytic compartments. Regardless of its cellular localization, TLRs mediate the
recognition of microbial components defined as pathogen-associated molecular patterns
(PAMPs). These microbial components include triacyl lipopeptides (TLR1 ligand),
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peptidoglycan (TLR2 ligand), bacterial lipopolysaccharide (LPS, TLR4 ligand), flagellin
(TLR5 ligand), diacyl lipopeptides (TLR6 ligand), bacterial CpG DNA (TLR9 ligand), and
viral single-stranded RNA (TLR8 ligand) [331]. TLR4 is regarded as the major receptor
for recognizing LPS from Gram-negative bacterial species while TLR2 recognizes the
lipopeptides, lipoteichoic acids (LTAs), and peptidoglycans of Gram-positive bacterial
species. Albeit at lower levels than monocytes, neutrophils express both TLR2 and -4 on
their surface and can upregulate the expression of TLR2 after exposure to several bacterial
species [109, 332]. F. alocis is a non-flagellated, Gram-positive bacterium that has been
shown to activate TLR2, but not TLR4 [275].
Once microbial PAMPS are recognized, a complex signal transduction cascade is
initiated to elicit antimicrobial and inflammatory functions. As shown in Figure 3.1, once
TLR2 binds with its ligand, the adaptor protein MyD88-like adaptor protein (Mal, also
called TIRAP) is recruited to the receptor’s cytoplasmic tail to facilitate the recruitment
and bridge the binding of myeloid differentiation primary-response protein 88 (MyD88) to
the TLR2 receptor. Once at the cytoplasmic tail of the receptor, MyD88 forms a complex
called the Myddsome with several IL-1 receptor-associated kinase (IRAK) -1, -2 and -4
[333]. IRAK4 is the first recruited to MyD88, where IRAK4 will auto-phosphorylate its
central kinase domain and activate IRAK1 and IRAK2 through phosphorylation [334]. The
Myddsome assembly induces the association and activation of E3 ubiquitin (Ub) ligase
TNF receptor-associated factor 6 (TRAF6), which facilitates the activation of transcription
factor, interferon regulatory factor (IRF) -5 [335], or associates with the TGF-𝛽 activated
kinase 1 (TAK1) complex comprised of TAK1, TAK1-binding protein 1 (TAB1), and
TAB2/3. Downstream of the TAK1 complex is the initiation of the MAPK and NF-𝜅B
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pathways, which culminate in the activation of several transcription factors like AP-1,
CREB, and NF- B (comprising subunits p50 and p65) [334].

FIGURE 3.1: Toll-like Receptor (TLR) signaling cascades. Adapted from [334].

Activation of TLR2 results in multiple phenotypic and functional changes in
neutrophils. First, TLR2 ligation can increase adhesion and chemotaxis in neutrophils.
Stimulation of human neutrophils with the TLR2 agonist, Pam3CysSerLys4 (PAM3CSK4),
resulted in the shedding of L-selectin (CD62L), upregulation of CD11b, and
downregulation of chemotactic receptors, CXCR2 and CXCR1, on the plasma membrane
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[327, 336]. This was also the case in our hands, where neutrophil interaction with F. alocis
through TLR2 ligation resulted in defects in neutrophil chemotaxis [275]. However, TLR2
agonists also induce neutrophil activation. PAM3CSK4 stimulation increased phagocytosis
of opsonized latex beads, induced ROS production and primed formyl methionyl leucyl
phenylalanine (fMLF)-induced ROS production as well [327, 336]. Granule exocytosis can
also be induced through ligation of TLR2. Previous publications from our laboratory have
also showed that F. alocis induces granule exocytosis through ligation of TLR2 [275].
TLR2 agonists also induce the production and release of cytokines and chemokines from
neutrophils through the phosphoinositide 3-kinase (PI3K) and the protein kinase B (Akt)
signaling pathway [327, 336, 337]. Literature on TLR2 stimulation and apoptosis has
yielded conflicting results, but overall, it appears that TLR2 stimulation has some prosurvival effects [338, 339].
For greater versatility and specificity, TLR2 forms heterodimers with TLR1 and
TLR6. TLR2/1 recognizes triacylated lipopeptides and TLR2/6 recognizes diacylated
lipopeptides

and zymosan from

Saccharomyces

cerevisiae

[338, 340, 341].

Experimentally, synthetic and microbe-derived specific ligands for TLR2/1 (PAM3CSK4)
and TLR2/6 (FSL-1, MALP-2) are available, but much of the information known about
TLR2 signaling in human neutrophils has been conducted with the TLR2/1 agonist. What
is known using the TLR2/6 agonist, FSL-1, is that TLR2/6 ligation also increases CD11b
expression, induces exocytosis of specific granules, can prime ROS generation and induces
cytokine release [342, 343]. Previous work showed that F. alocis activates TLR2/6 in
HEK293 cells [253], but this has not been proven in human neutrophils.
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Pathogenic bacteria have evolved elaborate strategies to block intracellular
signaling pathways that activate the host immune response. In fact, virtually every step of
the TLR2 signaling pathway can be inhibited through bacterially derived proteases,
acetyltransferases, kinases/phosphatases, deubiquitinases, proteins that act as TIR mimics,
etc. (Reviewed in [344]). Additionally, bacteria have also developed ways to activate
signaling pathways at different stages of infection to their advantage. For example, the oral
pathogen, P. gingivalis, evades clearance by neutrophils and promotes a pro-inflammatory
environment by stimulating cross-talk between TLR2/1 and C5aR that results in the
degradation of MyD88 [158, 244]. This reroutes signaling through Mal, which activates
the PI3K pathway instead of the MAPK pathway and increases the release of proinflammatory cytokines while decreasing the efficiency of neutrophil microbicidal
mechanisms. Ultimately, this results in the impaired clearance of systemic bacteria.
Little to nothing is known about the TLR signaling cascade elicited or influenced
by F. alocis, whose pathogenic potential continues to be defined. However, based on the
impaired neutrophil effector functions previously observed, it is clear that F. alocis has
devised a mechanism to escape killing by the immune system while stimulating
inflammation. In this exploratory chapter, I sought to determine the initial steps of
neutrophil intracellular signaling after challenge with F. alocis, and to determine how the
bacteria modulates intracellular signaling to control neutrophil functions. Our data shows
that F. alocis signals through TLR2/6 in human neutrophils, and that the oral bacterium
induces cytokine release through TLR2 and MyD88 dependent pathways. However, F.
alocis is modulating TLR2 signaling to survive within neutrophils by inhibiting phagosome
maturation. Our results are the first to delineate the F. alocis strategies to control neutrophil
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effector functions by interrupting intracellular signaling and will enhance our
understanding of how oral bacteria undermine the innate immune system.

Materials & Methods
Neutrophil isolation: Human donor recruitment, blood draws, and materials required for
this procedure were in accordance with the guidelines approved by the Institutional Review
Board of the University of Louisville. Neutrophils were isolated from venous blood of
healthy donors using plasma‐Percoll gradients, as described previously [297].

Mouse strains: Bone marrow neutrophil isolations were completed on legs from male and
female mice between 8 to 12 weeks of age. TLR2-/- and C57BL/6 control mice were
originally obtained from the Jackson Laboratory and bred in the University of Louisville
animal facilities. MyD88-/- and wild-type albino C57BL/6J mice (B6(Cg)-Tyrc-2J/J) were a
gift from Dr. Jonathan Warawa and bred in-house. The procedures used for our animal
studies were reviewed and approved by the University of Louisville Institutional Animal
Care and Use Committee.

Bone Marrow Neutrophil isolation: Mice were sacrificed by CO2 and the tibia and femur
were extracted and cleaned from excess flesh. The ends of each tibia and femur were
clipped with dissecting scissors and the bone marrow cells were flushed with PBS
supplemented with 1% glucose and 0.1% bovine serum albumin (PBS-BG) using a syringe
with 22G needle. The pooled bone marrow was then separated by gentle pipetting with the
22G needle followed by filtration through a sterile 70-µm nylon cell strainer to remove cell
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clumps and bone particles. For assays where cytokines were measured, positive selection
was performed using the MACS mouse Anti-Ly-6G MicroBead Kit (Miltenyi Biotec Inc.,
CA, USA) according to manufacturer’s instructions. For all other experiments, a percoll
density gradient protocol by the Mócsai laboratory was used [345, 346]. Briefly, the red
blood cells from the bone marrow prep were lysed hypotonically using a 0.2% NaCl
solution. Osmolarity was restored with 1.6% NaCl and after a wash, cells were resuspended
in PBS-BG and carefully pipetted on a 62.5% Percoll gradient and cells were centrifuged
for 30 min at 1000xg, brake off. A loose pellet of neutrophils will form at the bottom of
62.5% gradient. By flow cytometry analysis after staining for Ly6G and CD11b, 80% or
more of the cells will be neutrophils.

Bacterial strains and growth conditions: F. alocis ATCC 38596 was cultured in brain heart
infusion (BHI) broth supplemented 5 mg/mL yeast extract, L-cysteine (0.05%) and
arginine (0.05%) for 7 days anaerobically at 37 °C as previously described [275, 276].
Serum opsonization was performed by incubating F. alocis at 37 °C for 20 min in 10%
normal human serum (Complement Technology, Inc., Tyler, TX, USA). Heat
killed F.alocis was generated by incubation at 90 °C for 60 min. Non-viability was
confirmed by incubation in culture media at same conditions used for the live organism. P.
gingivalis ATCC 33277 was cultured anaerobically at 37 °C in trypticase soy broth
supplemented with yeast extract (1 mg/mL), hemin (5 µg/mL) and menadione (1 µg/mL)
as previously described [253].

113

Extracellular respiratory burst response: Human neutrophils (4 x 106 cells/mL) were
pretreated with PAM3CSK4 (1 µg/mL, Invivogen), FSL-1 (100 ng/mL, Invivogen), or
opsonized F. alocis for 30 mins at 37°C, followed by stimulation with fMLF (300 nM) for
5 min. After stimulation, the samples were centrifuged for 10 min at 600 x g and 4 °C, and
supernatants

were

collected.

Superoxide

anion

release

was

measured

spectrophotometrically at 550 nm as the superoxide dismutase-inhibitable reduction of
ferricytochrome c as previously described [297].

Granule exocytosis: Human neutrophils (4 × 106 cells/ml) were unstimulated (basal), pretreated with TLR6 neutralizing antibody (50 ug/mL, Invivogen) or Rat IgG isotype control
(50 ug/mL, Invivogen) for 60 minutes and/or TLR2 neutralizing antibody (50 g/ml; clone
TL2.1; BioLegend) or isotype control IgG2a kappa (50 g/ml; clone MOPC-173;
BioLegend) for 30 minutes. Then, cells were stimulated with FSL-1 (100 ng/mL,
Invivogen), or F. alocis (MOI 10) at 37 °C for 30 min. Exocytosis of specific granules and
secretory vesicles was determined by measuring the increase in plasma membrane
expression of membrane-associated receptors using antibodies: FITC-conjugated anti
human CD66b (Biolegend, clone G10F5) and PE-conjugated anti-human CD35
(Biolegend, clone E11), respectively. After treatment, the samples were washed with 0.5%
sodium azide, fixed with 1% paraformaldehyde, and analyzed by flow cytometry using a
BD FACSCalibur.

BacLight assay: As previously described [284, 322], the two DNA dyes, membranepermeable Syto9 (stains all bacteria) and membrane-impermeable propidium iodide (PI)
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(stains only nonviable bacteria), were used to determine bacteria viability associated with
mouse neutrophils. Bone marrow neutrophils (1 x 106 cells/mL) were allowed to settle on
poly-L-lysine-coated coverslips for 30 minutes, followed by challenge with opsonized F.
alocis (MOI 10) that was centrifuged at 600 x g for 4 min at 14 °C to synchronize
phagocytosis. Following challenge of 1 hour in a cell culture incubator at 37°C, mixed dye
solutions (AlexaFluor 670-Phallodin, 5 µM Syto9, 30 µM PI in 0.1 MOPS
(morpholinepropanesulfonic acid) (pH 7.2)–1 mM MgCl2) were added to samples. Z-stack
confocal images were acquired within 30 min using a Fluoview FV1000 confocal
microscope and analyzed by FV-10ASW software. Quantification was performed by
counting the total viable and nonviable bacteria both intracellularly from 100 neutrophils
in 3 independent experiments.
Phagocytosis assay and Myeloperoxidase staining: Bone marrow neutrophils (1 x 106
cells/mL) were allowed to settle on poly-L-lysine-coated coverslips for 30 minutes,
followed by challenge with opsonized F. alocis (MOI 10) that was centrifuged at 600 x g
for 4 min at 14 °C to synchronize phagocytosis. After an hour of challenge, cells were fixed
with 4% paraformaldehyde, 10 min at room temperature. Extracellular bacteria were
stained using F. alocis antibodies (1:1000) and Alexa Fluor 647-labeled (1:1000)
secondary antibodies for 1 hour each and antibodies were fixed in place with 4%
paraformaldehyde for 10 min, room temperature. Cells were permeabilized and blocked
with 3% bovine serum albumin with 0.02% saponin. Then, intracellular F. alocis was
stained using F. alocis antibodies (1:1000) and Alexa Fluor 488-labeled (1:1000)
secondary antibodies for 1 hour each. For experiments where myeloperoxidase was stained,
the same protocol as above was followed, except cells were blocked with 4% goat serum
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and incubated with a FITC-labeled mouse myeloperoxidase antibody (1:50, Hycult
Biotech) overnight. Z-stack confocal images were acquired using a Fluoview FV1000
confocal microscope and analyzed by FV-10ASW software. Quantification for
phagocytosis was performed by counting 100 neutrophils and determining the number of
neutrophils that had intracellular F. alocis. Quantification for myeloperoxidase was
performed by counting 100 infected neutrophils and determining the number of neutrophils
that had F. alocis that co-localized 50% or more with the myeloperoxidase.

F. alocis Colony Forming Units: F. alocis was co-cultured with isolated bone marrow
neutrophils at a MOI of 10 in RPMI + 5% fetal bovine serum in a 37°C, 5% CO2 incubator.
At the end of each timepoint, F. alocis and neutrophils were centrifuged (6000g, 2 min, 4
°C) to pellet all bacteria and immune cells. The pellets were lysed for 1 minute in 0.02%
saponin and serially diluted in sterile PBS. These dilutions were plated in duplicate 10 µL
drop aliquots on anaerobic BHI plates (BHI media (7.4g/200ml), L-cysteine (0.1g/ 200ml),
yeast extract (1g/200ml), agar powder (3g/200ml), 0.05% arginine and 5% sheep blood).
The plates were transferred into an anaerobic chamber and allowed to grow for 72 hours.
Colonies that grew were counted and Gram stained.

Intracellular ROS generation: ROS generation time courses with BMN were monitored by
luminol chemiluminescence. Plate 50 L of a 2 × 106 BMN/ml stock in triplicate and
incubate with luminol (125 M) with superoxide dismutase (15 nM) for 10 minutes.
Stimulate with opsonized zymosan (2 mg/mL), viable or heat-killed F. alocis (MOI 10).
After a short centrifugation to synchronize phagocytosis, plates were placed in a
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Spectramax L Luminometer (Molecular Devices) and readings were taken every minute
for the duration of 90 minutes. Single timepoint measurements of the phagocytosisstimulated respiratory burst response in human neutrophils was measured by 2′, 7′dichlorofluorescein (DCF, 5 μM) and analyzed by a BD FACSCalibur flow cytometer as
previously described [284]. In experiments with the MyD88 inhibitor (ST-2825, Med
Chem Express), 1-25 M were tested, but all subsequent experiments used a pre-treatment
of 20 M for 60 minutes.

Murine Bone Marrow Neutrophil Lysis & Western Blotting: After incubation in RPMI1640 + 5% fetal bovine serum or with viable or heat-killed F. alocis (MOI 10) for 4 or 24
hours in a 37 °C, 5%CO2 incubator, 2 × 106 cells/mL were lysed directly into 50 L of
SDS-sample buffer. 5 µL of the total cell lysates were separated by 12% SDS-PAGE and
immunoblotted with antibodies for F. alocis (1:1000) or −actin (1:1000, Cell Signaling,
Danvers, MA, USA). The appropriate secondary antibodies were used at 1:2000 dilution
(Cell Signaling, Danvers, MA, USA). The ECL system (Amersham Pharmacia Biotech,
Little Chalfont, United Kingdom) or the SuperSignal West Femto Maximum Sensitivity
Substrate (Thermo Scientific,Waltham, MA, USA) was used to visualize antigen-antibody
reactions. Densitometric values of each band were calculated using Image Lab software
(BioRad, Hercules, CA, USA).

Intracellular staining of IB After stimulation with FSL-1 (100 ng/mL), live or heatkilled opsonied F. alocis, human neutrophils (2 × 106 cells/mL for each timepoint) were
fixed with 4% paraformaldehyde, permeabilized and blocked with 0.02% saponin in 3%
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BSA for 1 hour. Primary antibodies for IB (1:800, Cell signaling) were incubated with
cells overnight followed by 3 washed with PBS. An alexa fluor 488 secondary antibody
(1:1000, Life Technologies) or FITC-IgG1 isotype control mAb (1:1000, Cell Signaling)
was incubated with the cells for 1 hour. After washing 3 times with PBS, cells were read
on a BD FACSCalibur flow cytometer.

Cytokine collection from bone marrow neutrophils: Highly pure (99%+) bone marrow
neutrophils (1 x 106 cells/mL) were allowed to settle in the wells of a 96 well plate for 30
minutes in RPMI 1640 + 5% fetal bovine serum, followed by challenge with opsonized F.
alocis or non-opsonized P. gingivalis (MOI 10) that was centrifuged at 600 x g for 4 min
at 14 °C to synchronize phagocytosis. After 24 hours, supernatants were collected from the
wells, centrifuged (10000g for 5 min) to remove any bacteria or cells and transferred to
sterile microcentrifuge tubes with 1% protease and phosphatase inhibitors. Supernatants
were stored at -80 °C until analyzed by multiplex assays.

Human Neutrophil Western Blotting: Human neutrophils (10 × 106 cells/mL) were cultured
at 37 °C, 5% CO2 in RPMI-1640 + 5% heat inactivated human serum and left unstimulated,
stimulated with FSL-1 (100 ng/mL), or challenged with live F. alocis for 3, 6, 10, or 20
hours. Then, cells were centrifuged at 6,000 ×g for 30 s and lysed for 30 min on ice in icecold lysis buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% [vol/vol] Triton X-100,
0.5% [vol/vol] Nonidet P-40, 20 mM NaF, 20 mM NaVO3, 1 mM EDTA, 1 mM EGTA,
5 mM phenylmethylsulfonyl fluoride [PMSF], 21 μg/ml aprotinin, 5 μg/ml leupeptin, and
4mM Diisopropyl fluorophosphates [DFP]). After protein estimation using the Pierce BCA
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protein assay kit (Thermo Scientific, Waltham, MA, USA), samples were adjusted to a
concentration of 2 µg/µL. Unless otherwise noted, 20 µg/µL of total cell lysates were
separated by 12% SDS-PAGE and immunoblotted with antibodies for MyD88,
phosphorylated IRAK4, total IRAK4, and −actin (1:1000, Cell Signaling, Danvers, MA,
USA). The appropriate secondary antibodies were used at 1:2000 dilution (Cell Signaling,
Danvers, MA, USA). The ECL system (Amersham Pharmacia Biotech, Little Chalfont,
United Kingdom) or the SuperSignal West Femto Maximum Sensitivity Substrate (Thermo
Scientific,Waltham, MA, USA) was used to visualize antigen-antibody reactions.
Densitometric values of each band were calculated using Image Lab software (BioRad,
Hercules, CA, USA).

Results
F. alocis challenge induces differential gene expression in the TLR2 pathway
Using the Metacore software, a list of genes involved in the TLR2/TLR4 signaling
pathway was compiled to assess the pattern of differential gene expression (Figure 3.2 A).
The expression of two genes (iNOS and TAB2) was downregulated and upregulated so
much that they were plotted separately (Figure 3.2 B). Overall, there is a pervasive
downregulation of genes in this pathway. Many of the signaling intermediates from the
MAPK pathway like ERK1/2, p38, NIK, and MEK4 and -6 show downregulation.
Moreover, proteins involved in the initial signaling mechanisms of TLR were also
downregulated, like TLR6 and 1, Mal, MyD88, and Tab 1. Out of the proteins that were
upregulated, many of them relate to inflammatory processes like IL-12beta, IL-6, IRF5,
NF-B, and TNF It is interesting that TAB2 is so highly upregulated because in addition
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to its role in the transduction of TLR2 signaling, it is also involved in the pathway that
senses bacterial double stranded DNA [347]. The inducible nitric oxide synthase (iNOS)
system is more developed in mice than in humans, but it can be found in human neutrophils
in azurophilic granules and phagosomes, and have been proposed to have roles as signaling
molecules and in bacterial killing [348-351]. In our dataset the expression of iNOS was
increased over the time course tested, but the biological significance of this increase in
gene expression remains to be examined. Taken together, I conclude that challenge of
human neutrophils with F. alocis results in significant changes to the expression of
components in the TLR2 signaling pathway.

Human neutrophils recognize F. alocis through TLR2/6
Previous work from our laboratory showed that F. alocis activates TLR2/6 in
HEK293 cells [253], but this has not been demonstrated in human neutrophils yet.
Neutrophils can undergo a sequential activation process called priming that results in
phenotypic changes enhancing the cell functional responses [352]. Whitmore et al. noted
that while stimulation with FSL-1, a TLR2/6 ligand, could prime the neutrophils from all
their human donors, only a subset of these donors could be primed with the TLR2/1 agonist,
Pam3CSK4 due to a single nucleotide polymorphism on TLR1 [342]. Based on this work,
I compared the priming capabilities of F. alocis in donors who had low or high priming
response to Pam3CSK4 (Figure 3.3A). Priming was measured as the ability to generate
extracellular superoxide by the colorimetric reduction of ferricytochrome c as previously
described [353]. As Whitmore reported, in our hands, Pam3CSK4 only primed a subset of
donors, which are color coded as high priming, whereas FSL-1 could prime all donors.
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Neutrophils primed by F. alocis produced a significantly higher superoxide concentration
than Pam3CSK4 low primers, suggesting that F. alocis is recognized through TLR2/6, like
FSL-1 (Figure 3.3A). Notably, F. alocis-primed neutrophils still produced significantly
lower amounts of superoxide than the FSL-1-primed neutrophils, which could be due to
the affinity of the receptor for either one of the ligands and the strength of subsequent
downstream signaling. To strengthen this observation, I tested granule exocytosis, which
is another neutrophil function that has been linked to TLR2 signaling [275, 342, 343].
Human neutrophils were pre-treated with media, neutralizing antibodies for TLR2 and -6,
or corresponding antibody isotype controls, followed by stimulation with FSL-1 or F.
alocis. When the release of secretory vesicles (Figure 3.3B) and specific granules (Figure
3.3C) was assessed, both FSL-1 and F. alocis stimulated exocytosis, but this was
significantly decreased when the cells were pre-treated with the neutralizing antibodies for
TLR2/6 while the isotype control had no effect. In conclusion, this data strongly suggests
that human neutrophils use the heterodimer receptors TLR2/6 to recognize F. alocis, and
that F. alocis-induced neutrophil degranulation depends on TLR2/6 activation.

F. alocis modulates TLR2 signaling to survive within neutrophils
Data published by our group as well as the data presented in this thesis so far,
strongly indicate that F. alocis can manipulate neutrophil functional responses. Thus, I
wanted to assess if F. alocis was modulating the TLR2 signaling pathway to interrupt
neutrophil functions and favor its survival. To do this, the functional responses were
compared between bone marrow neutrophils (BMN) from WT or TLR2-/- mice.
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First, the microbicidal capacity of these BMN was assessed using several methods.
The first of these, BacLight, is a confocal microscopy-based assay that uses the dyes Syto9
to label all bacteria and propidium iodide to label dead bacteria that have compromised cell
membranes as previously shown in neutrophils [284, 322]. Figure 3.4A shows
representative images from the BacLight assay on WT or TLR2-/- BMN that were
challenged with F. alocis for 1 hour. Like the data observed in human neutrophils, BMN
were also not able to completely eliminate intracellular F. alocis within the first hour of
challenge (Figure 3.4B). Moreover, TLR2-/- BMN were able to kill F. alocis slightly better
than their WT counterparts (15-20% decrease), suggesting that F. alocis is manipulating
TLR2 signaling to remain viable in neutrophils. Notably, this difference was not due to
discrepancies in phagocytosis between the mouse genotypes (Figure 3.4C-D). Using F.
alocis antibodies to differentiate between intracellular (green) or extracellular
(magenta/white) bacteria (Figure 3.4C), there was no difference in the number of BMN
that phagocytized F. alocis (Figure 3.4D). The disparity in F. alocis killing was also tested
by colony forming units (CFU) (Figure 3.4E). After 1 hour of challenge, the F. alocis that
was cultured with TLR2-/- BMN produced significantly fewer CFU than the bacteria
cultured with WT cells. By 4 hours, TLR2-/- BMN still had slightly fewer CFU, but the
difference between the genotypes was not statistically significant. This data demonstrates
that TLR2 is not involved in the phagocytosis of F. alocis, which is to be expected since
TLR2 is not a phagocytic receptor. The data also points to the idea that while TLR2
signaling is required for the maximal intracellular survival of the oral pathogen, but that
there are likely other mechanisms at play since the killing capacity of neutrophils was not
completely restored in the TLR2 null mice.
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TLR2 signaling is involved in phagosome maturation but not ROS generation
To determine why TLR2-/- BMN are able to eliminate F. alocis more efficiently
than WT BMN, differences in neutrophil microbicidal mechanisms were measured in both
of these genotypes. Intracellular ROS generation was detected during a time course luminol
assay, which is represented in Figure 3.5A. Based on the quantification of the area under
the curve, it is possible to observe that similar to human neutrophils, BMN were able to
quickly generate ROS in response to opsonized zymosan and heat-killed F. alocis, but
viable F. alocis induced minimal ROS production (Figure 3.5B). This trend was the same,
regardless of whether the cells expressed TLR2. This suggests that both the robust ROS
generation induced by heat-killed F. alocis, as well as the dampened ROS response by the
viable bacteria, are independent of TLR2. In the case of opsonized zymosan, host cells
recognize the yeast particle through TLR2/6, opsonic receptors, and C-type lectin receptors
such as dectin-1[354]. Signaling through these other receptors is responsible for the ROS
production observed with zymosan and in the case of F. alocis, other PRR may be involved
in the ROS response.
Oxygen independent microbicidal mechanisms are characterized by the deposition
of granule antimicrobial proteins into the phagosome to establish a hostile, non-physiologic
environment. Myeloperoxidase (MPO) is found in azurophilic granules and is a key
enzyme in the development of a noxious phagosome due to its catalytic activity. As a
measure of phagosome maturation and granule fusion with the phagosome, I evaluated the
co-localization of MPO with F. alocis phagosomes from WT and TLR2-/- BMN after 1
hour of challenge by confocal microscopy (Figure 3.6A). Fewer than 40% of F. alocis
phagosomes in WT BMN co-localized with MPO, and while TLR2-/- BMN had a
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significantly greater number of MPO+ F. alocis phagosomes, a majority of phagosomes
remained negative for MPO (Figure 3.6B). This partial increase in MPO fusion with the F.
alocis phagosome may be the reason for the marginal increase in F. alocis killing. As a
measure of total bacterial degradation, I collected whole cell lysates from WT and TLR2-/BMNs that were untreated or challenged with viable or heat-killed F. alocis for 4 and 24
hours (Figure 3.6C). The F. alocis antibody did not considerably detect proteins in
untreated cells from either WT or TLR2-/- BMNs, suggesting that the bands detected by
the antibody in the other conditions corresponded solely to F. alocis and not homologous
sequences in neutrophil proteins. The densitometry analysis of these western blots
demonstrated that in WT BMN, there is a time-dependent decrease in F. alocis proteins,
indicating degradation of F. alocis (Figure 3.6D). This degradation process started earlier
and progressed much faster in WT BMN that were challenged with heat-killed F. alocis,
indicating that much like in human neutrophils, viable F. alocis is actively delaying the
maturation of its phagosome in BMNs. In TLR2-/- BMNs, there was more degradation of
F. alocis proteins at the earlier timepoint tested, but by 24 hours WT and TLR2-/- BMN
had comparable levels of F. alocis proteins. The enhanced degradation of heat-killed F.
alocis compared to viable bacteria was similar between WT and TLR2-/- BMN. Taken
together, this data demonstrates that viable F. alocis requires TLR2 signaling to actively
delay the recruitment of azurophilic granules to its phagosome.

TLR2 signaling activates F. alocis pro-inflammatory cytokine production
TLR2 stimulation results in the activation of the MAPK and NF-B pathways.
Although F. alocis activation of MAPK through TLR2 and the production of cytokines in
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response to F. alocis has been shown [253, 275], the activation of NF-B or the role TLR2
plays in cytokine production had not been determined. The activation of NF-B was
determined indirectly by measuring the amount of IB In naïve cells, the inhibitory
IB is bound to NF-B to prevent its inadvertent activation. Upon stimulation, IB will
be phosphorylated, ubiquitinated and degraded by the proteasome, freeing the now active
NF-κB subunits to translocate into the nucleus and perform their effector functions [355].
IB was quantified by flow cytometry in human neutrophils that were untreated (basal)
or stimulated with FSL-1, F. alocis or heat-killed F. alocis for a short time course
experiment (Figure 3.7A). Within 15 minutes of stimulation, the cellular stores of
IB began to be depleted, and by 30 minutes of challenge with all three stimulants,
intracellular IB was significantly degraded compared to the basal expression. The
kinetics of activation of NF-κB by F. alocis was comparable to the TLR2/6 agonist, FSL1, and since F. alocis challenge quickly induced IB degradation regardless of viability,
I conclude that viable F. alocis is not inhibiting the activation of NF-κB at the initial stages
of infection.
Subsequently, the role of TLR2 in F. alocis-induced cytokine (Figure 3.7B) and
chemokine (Figure 3.7C) production was directly determined by using WT and TLR2-/BMN. When challenged with F. alocis, WT BMN significantly released all proinflammatory cytokines and the anti-inflammatory cytokine, IL-10 (Figure 3.7B).
Similarly, F. alocis induced significant release of chemokines, such as CCL2, CCL3, CCL4
and KC which are involved in monocyte and neutrophil chemotaxis, respectively by WT
BMNs (Fig 3.7C) However, the release of all these cytokines and chemokines was
abrogated in TLR2-/- conditions, indicating that TLR2 signaling is essential to produce
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cytokines and chemokines in F. alocis infection. In conclusion, this data indicates that F.
alocis manipulates TLR2 signaling to prevent microbicidal mechanisms, but requires this
signaling pathway to induce cytokine and chemokine release.

Role of MyD88 in antimicrobial responses against F. alocis challenge
MyD88 is the canonical adaptor protein for signaling pathways downstream of
TLRs. As a central node of inflammatory pathways and a bottleneck for multiple neutrophil
functional responses, it is a prime target for manipulation by pathogens. Burns et al.
conducted in vivo infections with P. gingivalis that proved that while TLR2-mediated
production of pro-inflammatory cytokines was independent of MyD88, MyD88 signaling
was required for controlling bacterial load [244]. Thus, I explored the possibility that F.
alocis was manipulating TLR2 signaling like P. gingivalis and assessed the role of MyD88
in F. alocis challenge.
Initially, the role of MyD88 was tested in the phagocytosis of F. alocis by confocal
microscopy as previously shown. Both WT and MyD88-/- BMN phagocytized the oral
pathogen to a similar extent after 1 hour of challenge (Figure 3.8A). Analysis of the killing
capacity of these BMN by BacLight demonstrated that F. alocis was able to survive equally
well in WT and MyD88-/- BMN (Figure 3.8B). Around 80% of the intracellular F. alocis
was viable after an hour of culture with WT or MyD88-/- BMN (Figure 3.8C). Preliminary
experiments by CFU also confirmed this finding (Figure 3.8D). Together, this data shows
that MyD88 is not required for the internalization or intracellular survival of F. alocis.
Next, the ROS generation by WT and MyD88-/- BMN was tested. Using a time
course luminol based assay, it appeared that there was a slight decrease in MyD88-/- BMN’s
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ability to produce ROS in response to F. alocis (Figure 3.9A). However, when the area
under the curve was combined from several mice, there was no significant difference in the
ROS generation between mouse genotypes (Figure 3.9B). In human neutrophils, I
confirmed this data by optimizing the use of a MyD88 inhibitor (ST2825). Figure 3.9C
shows the dose response curve where FSL-1 was used as the agonist and the readout was
ROS production. The chosen concentration, 20 M, which reduced the FSL-1 ROS
production by half, was tested in human neutrophils against viable and heat-killed F. alocis
(Figure 3.9D). However, pre-treatment of neutrophils with the MyD88 inhibitor had no
effect on the minimal production of ROS by viable F. alocis. In contrast to the results from
MyD88-/- BMNs, the MyD88 inhibitor decreased ROS generation by heat-killed F. alocis.
Overall, this data shows that MyD88 is not involved in the minimal ROS production by
viable F. alocis.
Since the killing capacity of MyD88-/- BMNs was equal to WT, I expected the F.
alocis phagosome maturation to be similar between genotypes. By confocal microscopy,
after 1 hour of challenge, less than 40% of F. alocis phagosomes had co-localized with
myeloperoxidase in both WT and MyD88-/- BMNs (Figure 3.10A-B). This suggests that F.
alocis does not interfere with neutrophil signaling through MyD88 to delay the maturation
of the phagosome at early timepoints. However, MyD88 may be playing a role in
phagosome maturation at longer timepoints. The whole cell lysates from WT and MyD88/-

BMNs that were challenged with live or heat-killed F. alocis for 4 and 24 hours were

processed for western blots to determine the degradation of F. alocis (Figure 3.10C). In
WT BMN, both viable and heat-killed F. alocis were degraded in a time-dependent
manner, albeit heat-killed F. alocis was degraded to a greater extent (Figure 3.10D). In the
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case of MyD88-/- BMN, heat-killed F. alocis was degraded with similar kinetics as in WT
BMN, but viable F. alocis in MyD88-/- BMN was not degraded as much as in WT cells by
24 hours of culture. These results indicate that while MyD88 signaling may not play a role
in the initial phagosome maturation, it may be essential to the degradation of the oral
pathogen at longer timepoints, though this finding requires more characterization.

Role of MyD88 in inflammatory responses to F. alocis challenge
The dogma in the field is that MyD88 signaling predominantly leads to the
production of inflammatory cytokines (e.g., TNF, IL-6, IL1) and chemokines (e.g., CC motif ligand 4, CCL4) [356], however, Burns et. al reported that P. gingivalis challenge
results in MyD88 independent cytokine release [244]. Therefore, I challenged WT and
MyD88-/- BMNs with F. alocis or P. gingivalis for 24 hours and measured the resultant
cytokine release (Figure 3.11). In WT mice, both P. gingivalis and F. alocis induced the
release of pro-inflammatory cytokines (G-CSF, IL-1, and TNF) and chemokines (IL17, CCL2, CCL3, CCL4, and CCL5). Interestingly, F. alocis induced significantly less
anti-inflammatory IL-10 than P. gingivalis, but greater release of pro-inflammatory
immune cell recruitment cytokines like IL-17, CXCL10, CCL3, and CCL4. In our hands,
both F. alocis and P. gingivalis required MyD88 signaling to induce the release of all
cytokines and chemokines. In the case of P. gingivalis, this could be explained by strain
differences between the studies. Therefore, in our system, MyD88 did not play a large role
in antimicrobial functions, but it was critical for F. alocis-induced inflammation.

F. alocis may be inducing non-canonical MyD88 signaling
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Burns et. al showed that P. gingivalis causes the degradation of MyD88 to block
MyD88-dependent antimicrobial mechanisms [244], so I tested whether this was taking
place in our system by measuring the levels of MyD88 in F. alocis-challenged human
neutrophils (Figure 3.12A). The normalized densitometry of MyD88 showed that although
levels of MyD88 steadily decreased as the time course progressed, there was no difference
in the MyD88 protein expression between untreated (basal) or F. alocis-challenged human
neutrophils (Figure 3.12B). Together with our functional analysis of MyD88-/- BMNs, these
results demonstrate that F. alocis is not inducing the same mechanism as P. gingivalis
strain ATCC strains 381 and 53,977. P. gingivalis infection leads to the degradation of
MyD88 to inhibit bacterial killing and promotes inflammation through MyD88independent cytokine production. However, F. alocis challenge did not change MyD88
abundance and required MyD88 to be present for cytokine production.
Downstream of MyD88 signaling is the activation of IRAK4 by phosphorylation,
a key step in the canonical TLR signaling pathway. To continue evaluating the F. alocis
activation of TLR2 signaling, western blots for the phosphorylation of IRAK4 were
performed on human neutrophils that were stimulated with the TLR2/6 agonist, FSL-1, or
F. alocis (Figure 3.12C). FSL-1 stimulation resulted in the transient phosphorylation of
IRAK4 that started after 5 min of challenge, and peaked at 30 min. To our surprise, F.
alocis did not induce phosphorylation at any point in the 90-minute challenge (Figure
3.12D). This response suggests that F. alocis is inducing non-canonical signaling from
neutrophils, but its full impact on neutrophil functional responses will need more testing.

Discussion
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Periodontal pathogens have evolved mechanisms to escape killing by the immune
system while stimulating inflammation; however, much of the current literature on the
signaling interactions between periodontal pathogens and the innate immune system
centers around long-established pathogens such as P. gingivalis [357]. The results shown
here characterize how F. alocis may be modulating TLR2 signaling to block or induce
neutrophil effector functions. Moreover, this is the first study to assess the functional
mechanisms of murine neutrophils against F. alocis, which will be useful in the context of
animal models.
In addition to species differences, one of the concerns of these experiments was that
since the mouse neutrophils were isolated from the bone marrow, they would be less
responsive than human cells, which are fully differentiated when isolated from peripheral
blood. However, the responses of wild-type bone marrow neutrophils (BMN) showed
similar trends as their human cell counterpart. When challenged with F. alocis, both mouse
and human neutrophils phagocytize F. alocis efficiently but are unable to eliminate the
intracellular oral pathogen. This is because F. alocis blocks neutrophils’ phagosome
maturation in both species by inducing minimal ROS generation and inhibiting the fusion
of azurophilic granules. Therefore, mouse neutrophils provided a suitable model to study
F. alocis challenge, especially neutrophils with genetic modifications. Early signaling
through TLR2 is associated with neutrophil migration, phagocytosis, cytokine production,
and direct microbicidal functions like the generation of reactive oxygen species, and
granule exocytosis [327, 358]. Previous work from our laboratory showed that TLR2
ligation by F. alocis has a direct impact on neutrophil migration and granule exocytosis
[275], but it was unknown if TLR2 played a role in phagocytosis or killing of F. alocis.
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Although TLR2 is not a phagocytic receptor, ligation of TLR2 will activate
signaling pathways that enhance the efficiency of phagocytosis and inflammatory
responses in macrophages [359, 360]. However, in our experimental system, TLR2 did not
have an effect on phagocytosis of F. alocis. A caveat to this finding is the fact that
phagocytosis was synchronized to increase the interaction between cells and used
complement opsonized bacteria, which already initiates an efficient mechanism of uptake.
I also did not observe a difference in the ROS generation between WT and TLR2-/neutrophils, which is consistent with a study that used human neutrophils, TLR2 blocking
antibodies and Paracoccidioides brasiliensis [361].
Studies of mice deficient in either TLR2 or MyD88 have found that loss of either
of these proteins results in impaired ability to clear several types of bacteria, fungi and
parasites from infected macrophages or mice [362-368]. This defect was attributed to
decreased phagocytosis, defective phagosome maturation, or decreased oxidative burst,
suggesting that both TLR2 and MyD88 are indispensable in innate immune defense against
pathogens. However, when TLR2 is absent, neutrophils lose their ability to generate
cytokines, but can kill and degrade viable F. alocis more efficiently due to a partial
restoration of myeloperoxidase recruitment to the phagosome. Also, MyD88 did not affect
phagocytosis, killing, ROS generation or degradation at early timepoints.
I speculate that F. alocis may be modulating the TLR2 pathway to block
antimicrobial mechanisms, but when TLR2 is not available, a redundant pathway is
activated to enhance elimination of F. alocis. It has previously been shown that TLR2 and
TLR9 can synergize to enhance immune responses [369, 370], but it has not been assessed
whether TLR9 is involved in F. alocis-induced signaling. TLR9 can be activated by
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unmethylated CpG containing DNA from bacteria or mitochondria [371], so while F.
alocis may not be recognized by its DNA after lysis by the neutrophil phagosome, TLR9
could still be activated. Notably, TLR9 signaling is MyD88-dependent but IRAK-4
independent [372], hinting at a possible role in the neutrophil response against F. alocis.
Surprisingly, the phosphorylation of IRAK4 was absent in F. alocis challenge but appeared
normally after FSL-1 stimulation. While more experiments are needed to determine if this
response has biological significance in the context of periodontitis and is actively caused
by the viable bacterium, defective IRAK4 signaling has substantial implications for disease
progression in other pathologies. For example, the kinase activity of IRAK4 is a
prerequisite for mounting innate immune responses against intracellular bacteria like
Listeria monocytogenes, Pseudomonas aeruginosa, S. aureus or Mycobacterium
smegmatis [373, 374]. IRAK4 and TLR9 have also both been linked to neutrophil granule
movement [375, 376].
Alternatively, F. alocis could be inducing crosstalk between TLR2 and another
receptor or signaling pathway that is disrupted when TLR2 is not present. F. alocis and
other oral pathogens are notorious for disrupting the complement system [64, 377]. P.
gingivalis, evades clearance by neutrophils and promotes a pro-inflammatory environment
by stimulating cross-talk between TLR2/1 and C5aR that results in the degradation of
MyD88 [158, 244]. This reroutes signaling through another adaptor protein, MyD88
adaptor-like (Mal, also known as TIRAP), which activates the PI3K pathway instead of the
MAPK pathway and increases the release of pro-inflammatory cytokines while decreasing
the efficiency of neutrophil microbicidal mechanisms. The TLR2-PI3K signaling resulted
in the bacterial phagosome escaping lysosomal degradation, so ultimately, this results in
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impaired clearance of systemic bacteria. However, when I tested this possibility in our
system, F. alocis challenge did not cause MyD88 to be degraded, and cytokine production
was completely dependent on MyD88 expression, indicating that the mechanism of
pathogenicity is not the same between both of these oral pathogens. Nonetheless, at this
time I cannot rule out the possibility that PI3K activation or complement receptor cross
talk is happening during F. alocis infection.
Similarly, complex mechanisms regulate signaling by TLR2 from multiple cellular
locations. TLR2 and its heterodimer partners, TLR1 and -6, can be found on phagosomes
containing zymosan particles, Chlamydia, and Borrelia species [378-381]. TLR2
heterodimers employ several accessory molecules like mannose binding lectin (MBL) and
CD36, that can synergize with TLR2/6 to recognize new ligands and drastically increase
the inflammatory responses downstream of TLR2 ligation [379, 382-384]. Through the
actions of these accessory molecules, TLR2/6 will be internalized in the process of
phagocytosis and can continue to signal from the phagosome, especially to enhance the
production of cytokines and phagosome maturation in macrophages [366, 378, 385].
Although they could be playing a role in F. alocis modulation of signaling, I have not
assessed either one of these accessory proteins.
Overall, I demonstrate that like other oral pathogens, F. alocis is blocking
microbicidal mechanisms in neutrophils while promoting inflammation through the release
pro-inflammatory cytokines; a phenotype that hinges on signaling from TLR2 and MyD88.
As the first study to delineate the F. alocis strategies to control neutrophil effector functions
by interrupting intracellular signaling and demonstrates that this topic is a rich source of
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knowledge that will enhance our understanding of how oral bacteria undermine the innate
immune system.
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Figure 3.2: F. alocis induces changes in gene expression of genes in TLR signaling
pathway.
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Figure 3.2: (A) Heatmap shows the differential expression of genes in the TLR2 Signaling
Pathway from MetaCore. Gene expression data was generated from Illumina RNA
sequencing performed on human neutrophils from 4 individual healthy donors that were
either left unstimulated or challenged with F. alocis for 1, 3 or 6 hours. (B) From the list
of genes from A, the two genes plotted had extremely large changes in gene expression
and are plotted separately.
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FIGURE 3.3: F. alocis is recognized by TLR2/6 heterodimers.
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FIGURE 3.3: (A) Human neutrophils were incubated with buffer (basal), PAM3CSK4
(TLR2/1 agonist), FSL-1 (TLR2/6 agonist), or F. alocis (MOI 10:1) or followed by fMLF
stimulation. Superoxide release was measured by spectrophotometer as the colorimetric
reduction of ferricytochrome C. Dotted line indicates the cut-off used for high and low
priming donors. Data shows the mean ± superoxide release from 7 total high and low
priming donors. A two-way ANOVA with Bonferroni post hoc tests was performed.
Human neutrophil were untreated or pre-treated with TLR2/6 blocking antibodies or
isotype controls before stimulation with FSL-1 for 30 min or F. alocis for 60 min. Then,
cells were analyzed by flow cytometry for expression of (B) secretory vesicles (CD35) or
(C) specific granules (CD66b) as a measure of granule mobilization. Data are plotted as
the average mean channel fluorescence from 4-7 independent experiments. A one-way
ANOVA with Tukey post-hoc tests was performed on graphs B and C. * = p > 0.05, **=p
> 0.01, ***= p > 0.001.
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FIGURE 3.4: F. alocis survival is partially linked to TLR2 signaling.
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FIGURE 3.4: Bone marrow neutrophils (BMN) were isolated from WT or TLR2-/- mice
and challenged with F. alocis (MOI 10) for 1 hour followed by staining with BacLight
dyes, Syto9 and Propidium Iodide (PI), to determine bacterial viability. (A) Representative
images show the BMN cortical actin (Blue), the syto9-labeled F. alocis (green), and PIlabeled non-viable bacteria (red/yellow/orange). Yellow arrows point to intracellular viable
F. alocis while white arrowheads point to intracellular, non-viable F. alocis. (B) The
viability of intracellular F. alocis was assessed in Z-stacks from 100 infected cells. Data
are plotted as the mean ± SEM of the % viable F. alocis from 3 mice each over two
independent experiments. (C) BMN from WT or TLR2-/- mice were challenged with viable
F. alocis (MOI 10) for 1 hour. Following incubation, cells were fixed and differentially
stained for extracellular (purple or white bacteria, white arrow) or intracellular (green
bacteria, yellow arrow) bacteria using anti-F. alocis antibodies. (D) 100 neutrophils from
2-3 mice in a single independent experiment were assessed for phagocytosis of F. alocis
and graphed as the % F. alocis+ cells ± SEM. (E) BMN from WT or TLR2-/- mice were
challenged with F. alocis (MOI 10) for 1 and 4 hours followed. The total pellets of this
interaction were plated in duplicates and grown anaerobically for 72 hours. Data are shown
as the average ± SEM of colony forming units from 3 mice completed over 2 independent
experiments. An unpaired student’s T test was used to determine statistical significance in
B and D. A two-way ANOVA with Bonferroni post-hoc tests were used to determine the
significance of E. * = p > 0.05, **=p > 0.01, ***= p > 0.001.

140

FIGURE 3.5: F. alocis induces minimal ROS generation from both WT and TLR2-/bone marrow neutrophils. BMN from WT and TLR2-/- mice were left unstimulated
(basal) or stimulated with opsonized zymosan or F. alocis in the presence of luminol, and
the light output was measured each minute during a 90-minute kinetic experiment. (A)
Shows a representative kinetic output curve for one experiment. (B) Shows the area under
the curve from 3 independent experiments where each dot is a mouse. A two-way ANOVA
with Bonferroni post-hoc tests was used to determine the statistical significance of B. No
differences were detected between mouse strains, so the lines indicate significance between
the conditions for both mice. * = p > 0.05, **=p > 0.01, ***= p > 0.001
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FIGURE 3.6: F. alocis modulates TLR2 signaling to block phagosome maturation.
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FIGURE 3.6: (A) BMN from WT and TLR2-/- mice were challenged with F. alocis for 1
hour. Staining shows myeloperoxidase (MPO, azurophilic granules, red), extracellular F.
alocis (purple/white), and intracellular F. alocis (green). The phagosomes of 100 infected
neutrophils from 3 mice of each genotype were assessed for 50% co-localization of
intracellular F. alocis and myeloperoxidase. Yellow arrows show MPO negative
phagosomes while the white arrows indicate MPO positive phagosomes. (B) Data show
the average % of F. alocis phagosomes that co-localized with myeloperoxidase ± SEM
from 3 mice in one independent experiment. An unpaired student’s T test was used to
determine statistical significance. (C) The representative western blot shows the whole cell
lysates from WT and TLR2-/- BMN that were left untreated (UT), challenged with F. alocis
(Fa), or heat-killed F. alocis (HK Fa) for 4 or 24 hours and probed for F. alocis and β actin.
(D) Shows the mean normalized densitometry ± SEM of F. alocis proteins from * mice
completed over 3 independent experiments. A two-way ANOVA with Bonferroni post-hoc
tests was used to determine the statistical significance. * = p > 0.05, **=p > 0.01, ***= p
> 0.001
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FIGURE 3.7: F. alocis activates NF-κB and induces the production of cytokines
through TLR2.
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FIGURE 3.7: (A) Activation of NF-κB was tested indirectly by intracellular staining of
human neutrophils for IkBα after no stimulation (untreated) or stimulation with LPS, or F.
alocis (MOI 10). Data shows the mean channel fluorescence (MCF) ± SEM of IκBα in
samples from 4 independent experiments. Asterisks denote significance compared to basal
levels of IκBα. WT and TLR2-/- BMN were untreated or challenged with F. alocis for 24
hours. Supernatants were collected and tested for the presence of cytokines (B) and
chemokines (C) using a multiplex assay. Data shows the cytokine & chemokine production
by neutrophils from 5-10 animals, conducted over 3-4 experiments. Error bars show SEM.
Two-way ANOVAs with Bonferroni post-hoc tests were completed on all plots to
determine statistical significance. * P <0.05; ** P <0.01; *** P<0.001.
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FIGURE 3.8: MyD88 signaling is not required for F. alocis viability.
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FIGURE 3.8: (A) BMN from WT or MyD88-/- mice were challenged with viable F. alocis
(MOI 10) for 1 hour. Following incubation, cells were fixed and differentially stained for
extracellular or intracellular bacteria using anti-F. alocis antibodies. 100 neutrophils were
assessed for phagocytosis of F. alocis over the course of 3 independent experiments. Data
are graphed as the % F. alocis+ cells ± SEM from 5-6 mice. (B) Representative images
show BMN from WT or MyD88-/- mice that were challenged with F. alocis (MOI 10) for
1 hour and then the viability of F. alocis was verified as described in Figure 4.4A. Yellow
arrows point to intracellular viable F. alocis while white arrowheads point to intracellular,
non-viable F. alocis. (C) The viability of intracellular F. alocis was quantified from Zstacks of 100 infected cells. Data are plotted as the mean ± SEM of the % viable F. alocis
from 2 mice in one independent experiment. (D) CFU were plated from an inoculum of F.
alocis that was cultured either with WT or MyD88-/- mice for 2 hours from a single
experiment with one mouse per genotype. An unpaired student’s T test was used to
determine statistical significance in A and C.
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FIGURE 3.9: F. alocis induces minimal ROS generation from both WT and MyD88/-

bone marrow neutrophils.
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FIGURE 3.9: BMN from WT and MyD88-/- mice were left unstimulated (basal) or
stimulated with opsonized zymosan or F. alocis in the presence of luminol, and the light
output was measured each minute during a 90-minute kinetic experiment. (A) Shows a
representative kinetic output curve for one experiment. (B) Shows the area under the curve
from 4-5 independent experiments where each dot is a mouse. A two-way ANOVA with
Bonferroni post-hoc tests was used to determine the statistical significance of B. No
differences were detected between mouse strains, so the lines indicate significance between
the conditions for both mice. (C) Human neutrophils were pre-treated with increasing
concentrations of ST-2825, a MyD88 inhibitor for 60 minutes, followed by stimulation
with FSL-1 for * minutes. The decrease in ROS production was measured via flow
cytometer. Data are plotted as the average mean channel fluorescence ± SEM from 3-4
independent experiments. Numbers above each condition indicate the average inhibition
by the concentration shown. A one-way ANOVA with Tukey post-hoc tests was used to
determine the statistical significance of C. (D) Using 20 µM of the MyD88 inhibitor as pretreatment, human neutrophils were stimulated with viable or heat-killed F. alocis and tested
for ROS generation. Data are plotted as the average mean channel fluorescence ± SEM
from 3-5 independent experiments. An unpaired student’s T test was used to determine
statistical significance between the pairs of conditions. * = p > 0.05, **=p > 0.01, ***= p
> 0.001
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FIGURE 3.10: F. alocis phagosome maturation requires MyD88 at long timepoints.
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FIGURE 3.10: (A) BMN from WT and MyD88-/- mice were challenged with F. alocis for
1 hour. Staining shows myeloperoxidase (MPO, azurophilic granules, red), extracellular F.
alocis (purple/white), and intracellular F. alocis (green). Yellow arrows show MPO
negative phagosomes while the white arrows indicate MPO positive phagosomes. (B) The
phagosomes of 100 infected neutrophils from 2 mice of each genotype were assessed for
50% co-localization of intracellular F. alocis and myeloperoxidase. Data show the average
% of F. alocis phagosomes that co-localized with myeloperoxidase ± SEM from 2 mice in
one independent experiment. An unpaired student’s T test was used to determine statistical
significance. (C) The representative western blot shows the whole cell lysates from WT
and MyD88-/- BMN that were left untreated (UT), challenged with F. alocis (Fa), or heatkilled F. alocis (HK Fa) for 4 or 24 hours and probed for F. alocis and β actin. (D) Shows
the mean normalized densitometry ± SEM of F. alocis proteins from 5 mice for each
genotype completed over 2 independent experiments. A two-way ANOVA with
Bonferroni post-hoc tests was used to determine the statistical significance. * = p > 0.05,
**=p > 0.01, ***= p > 0.001
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FIGURE 3.11: F. alocis-induced cytokine production is MyD88-dependent. WT and
MyD88-/- BMN were untreated or challenged with P. gingivalis or F. alocis for 24 hours.
Supernatants were tested for cytokines and chemokines using a multiplex assay. Data
shows cytokine & chemokine release from 5 mice, conducted over 2 experiments. Error
bars show SEM. Two-way ANOVAs with Bonferroni post-hoc tests were completed on all
plots to determine statistical significance. * P <0.05; ** P <0.01; *** P<0.001.
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FIGURE 3.12: F. alocis does not affect MyD88 protein levels and does not activate
IRAK4.
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FIGURE 3.12: (A) Western blot showing MyD88 expression in human neutrophils
cultured in media or stimulated with F. alocis for 3, 6, 10 or 20 hours. (B) Pooled
normalized densitometry from 4 independent experiments was plotted ± SEM. A two-way
ANOVA with Bonferroni post-hoc tests determined statistical significance. (C)
Phosphorylation of IRAK4 in whole cell lysates from human neutrophils cultured in media
or stimulated with F. alocis for 3, 6, 10 or 20 hours. (D) Normalized densitometry from 2
independent experiments was pooled and plotted ± SEM. A two-way ANOVA with
Bonferroni post-hoc tests determined statistical significance for B and D. * = p > 0.05,
**=p > 0.01, ***= p > 0.001.
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CHAPTER 4:
‘TIL DEATH DO US PART: F. ALOCIS EFFECT ON NEUTROPHIL LIFESPAN.

Introduction:

Neutrophils are generated in the bone marrow at a rate of 1011 cells/day, and in the
bloodstream they are the most abundant leukocyte in circulation [386, 387]. To maintain
homeostasis, this large-scale production must be counteracted by efficient removal since
dysregulated neutrophil presence leads to profound and devastating conditions ranging
from neurologic defects to increased susceptibility to infections [76, 93, 388]. One of the
most successful mechanisms for the normal turnover of neutrophils is programmed cell
death, or apoptosis, which occurs in circulating neutrophils after 24 hours [389]. Apoptosis
is a non-inflammatory process, and in neutrophils it is characterized by membrane
blebbing, cell body shrinkage, cytoplasmic vacuolation, condensation of DNA, and
changes in the nuclear morphology from multi-lobulated to a round, dense shape [389391]. Neutrophils that have become apoptotic can be detected by using end-point
measurements like changes in nuclear morphology, DNA fragmentation, and accumulation
of phosphatidylserine (PS) in the outer membrane leaflet.
The molecular regulation of neutrophil apoptosis is a sophisticated process, but
generally, whether a neutrophil lives or dies is determined by the ratio of pro-survival or
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pro-apoptotic regulatory factors [392]. This ratio can change when apoptosis is activated
through one of three main pathways: intrinsic, extrinsic, or phagocytosis-induced cell death
(PICD). Both the intrinsic and extrinsic apoptosis pathways are mediated through the
actions of a family of cysteine proteases called caspases. The initiator caspases, caspase 8
(extrinsic pathway) and caspase 9 (intrinsic pathway), both converge at the activation of
caspase 3, which is called the executioner caspase. Caspase 3 activation is essential for
programmed cell death because its activation is required to initiate the defining
biochemical and biophysical changes that occur during apoptosis. In healthy cells, caspases
are in the cytosol as pro-enzymes that further stay in their inactive state through association
with proteins of the inhibitor of apoptosis (IAP) family (such as XIAP, cIAP, cIAP2). For
example, XIAP binds directly to caspases 9 and 3 and inhibits their processing and
activation [393, 394]. Once the pro-caspases are cleaved into their active form, their
protease activity will organize and set apoptosis processes in motion.
The intrinsic pathway is activated for both constitutive and stimulated apoptosis
and is regulated at the level of the mitochondria. The key step in this pathway is the
permeabilization of the mitochondrial outer membrane (MOMP) by pro-death proteins Bax
and Bak, which oligomerize and are inserted into the membrane. This disrupts the
organelle’s membrane potential and causes cytochrome C, Smac/DIABLO, and Htra2/Omi
to be released from the intermembrane space into the cell’s cytosol [395-397]. The released
cytochrome C will bind to apoptosis protease activating factor (APAF) to form a complex
that recruits and cleaves inactive procaspase-9 into its active form. The other mitochondriaderived proteins will also augment the cell death signal by directly inactivating pro-survival
factors [397]. Bax and Bak are pro-apoptotic members of the BCL-2 family, but within the
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same family of proteins are Myeloid Leukemia Cell Differentiation Protein (MCL)1 and
BCL2-Related Protein A1 (A1, also known as Bfl-1), which have pro-survival effects.
MCL-1 and A1 have short half-lives and require continuous synthesis to carry out their
pro-survival effects, whereas Bax and Bak have long half-lives [398-400]. Consistent with
this, the mRNA and protein expression of MCL-1 and A1 is high in healthy neutrophils to
prevent the disruption of the mitochondrial membrane, but as neutrophils age, levels of
MCL-1 and A1 decline while pro-death factors remain, initiating spontaneous apoptosis
[401-404].
The extrinsic apoptotic pathway is activated by the ligation of surface death
receptors that recognize Fas ligand, TRAIL, or TNF. Upon ligation, the receptors will
oligomerize and form a complex that recruits and activates caspase 8. In neutrophils the
extrinsic pathway is not sufficient to induce cell death [405]. In fact, the signal has to also
be amplified by the intrinsic pathway through Bid, a pro-apoptotic protein that links both
pathways together. Caspase 8 activation by the extrinsic pathway will activate Bid, which
will translocate to the mitochondria and activate Bax and Bak to initiate the intrinsic
pathway [406]. Finally, literature suggests that the extrinsic pathway does not appear to
play a role in the constitutive apoptosis pathways, but has a more important role in
neutrophil apoptosis during infection and inflammation [405, 407-410].
The third pathway that induces apoptosis is phagocytosis-induced cell death
(PICD), which was first described in 1992 [411]. While the mechanism is still poorly
understood, PICD requires the production of ROS, and is independent of death receptor
ligation [107, 412, 413]. Phagocytosis of bacterial pathogens, including Burkholderia
cepacia, Borrelia hermsii, Staphylococcus aureus, Streptoccocus pyogenes, and Listeria
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monocytogenes, is followed by global changes in neutrophil gene expression [109]. Cells
undergoing PICD have differentially affected pathways related to metabolism, cytokine
production, receptors, signal transduction, transcription, and host defense. As a
consequence of the changes in gene expression, cells undergoing PICD have a restricted
proinflammatory capacity via a general impairment in chemotaxis, phagocytosis and
degranulation [392]. Thus, in the context of infection, PICD represents a non-inflammatory
mechanism to clear tissues of effete neutrophils that contain non-viable or partially
degraded microbes.
When neutrophils migrate into sites of tissue inflammation, they display a
prolonged lifespan and become resistant to FAS- and TNF- induced apoptosis, likely to
promote a robust early response to infection [263]. This phenotype can be due to hypoxia
in inflamed tissues [414, 415], or cues at the site of infection, since both host and microbederived factors can increase neutrophil lifespan. For example, the same cytokines (IL-1,
TNF, GM-CSF, G-CSF, and IFN) that can recruit neutrophils to a site of infection will
also delay their apoptosis [127, 416-419]. Similarly, the anaphylatoxin C5a, LPS, and
lipoteichoic acid (LTA) are powerful chemotactic agents for neutrophils and protects them
from apoptosis [416, 420]. In the context of infection, PICD is desirable for the resolution
of inflammation, but many pathogens have evolved means to disrupt normal apoptotic
processes to promote pathogenesis [421, 422]. Generally, intracellular pathogens like
Anaplasma phagocytophilum, Chlamydia pneumoniae, and Francisella tularensis promote
neutrophil viability to protect their replicative niche whereas extracellular microbes like S.
pyogenes, S. aureus, and Pseudomonas aeruginosa accelerate apoptosis, trigger neutrophil
lysis, or redirect cell death towards necrosis to evade intracellular killing [89]. All of these
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outcomes can delay resolution of inflammation because (1) prolonged neutrophil lifespan
results in the accumulation of cells with increased pro-inflammatory potential, (2)
accelerated neutrophil lifespan promotes bacterial colonization or dissemination, and (3)
necrosis or lysis of neutrophils results in the release of toxic neutrophil components and
other DAMPS that exacerbate inflammation. Therefore, precise regulation of neutrophil
cell death is essential for curbing inflammatory responses.
In the context of periodontitis, not much is known about how periodontal pathogens
affect neutrophil lifespan. Most of the published data on apoptosis of neutrophils with
periodontal pathogens has been limited to very short timepoints (less than 3 hours), where
the full extent of neutrophil survival cannot be gauged. Moreover, defects in apoptosis
could be contributing to the progression of periodontitis, but this possibility has not been
explored much.
In this chapter, I demonstrate that contact of neutrophils with F. alocis results in an
upregulation of anti-apoptotic proteins, dampening of caspase activity, and delay of
neutrophil apoptosis. The F. alocis cultured neutrophils retained their pro-inflammatory
effector functions at longer timepoints as compared to untreated neutrophils.

Materials & Methods:

Neutrophil isolation: Human donor recruitment, blood draws, and materials required for
this procedure were in accordance with the guidelines approved by the Institutional Review
Board of the University of Louisville. Neutrophils were isolated from venous blood of
healthy donors using plasma‐Percoll gradients, as described previously [297].
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Bacterial strains and growth conditions: F. alocis ATCC 38596 was cultured in brain heart
infusion (BHI) broth supplemented 5 mg/mL yeast extract, L-cysteine (0.05%) and
arginine (0.05%) for 7 days anaerobically at 37 °C as previously described [275, 276].
Serum opsonization was performed by incubating F. alocis at 37°C for 20 min in 10%
normal human serum (Complement Technology, Inc., Tyler, TX, USA). F. alocis was heatkilled by incubation at 90 °C for 60 min. Non-viability was confirmed by incubation in
culture media at same conditions used for the live organism. After opsonization, F.
alocis was labeled with carboxyfluorescein succinimidyl ester (CFSE; 40 ng/μl) for 30 min
at room temperature in the dark and washed 3 times with PBS prior to use.
Cell culture and infection: Neutrophils (4 × 106 cells/mL) were cultured at 37°C, 5%CO2
in RPMI-1640 with L-glutamine or with cycloheximide (1 nM, Sigma), opsonized F. alocis
(multiplicity of infection (MOI) 10, 50, 100), or opsonized heat-killed F. alocis (MOI 10).
After 24 hours of culture, cells were split and processed as cytospins and stained with
HEMA or stained for Annexin V/7-AAD testing using the commercially available APC
Annexin V Apoptosis Detection Kit with 7-AAD (BioLegend, San Diego, CA, USA).
Samples were read on a BD FACSCelesta flow cytometer and analyzed using the FlowJo
software (Ashland, OR, USA). In experiments using neutralizing antibodies, neutrophils
were pre-treated with TLR6 neutralizing antibody (50 ug/mL, Invivogen) or isotype control
(Rat IgG,50 ug/mL, Invivogen) for 60 minutes and/or TLR2 neutralizing antibody (50
g/ml; clone TL2.1; BioLegend) or isotype control IgG2a kappa (50 g/ml; clone MOPC173; BioLegend) for 30 minutes.
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Neutrophil Western Blotting: Neutrophils (10 × 106 cells/mL) were cultured at 37°C,
5%CO2 in RPMI-1640 and left unstimulated, stimulated with soluble FasL (500 ng/mL,
BioLegend), or challenged with live opsonized F. alocis for 3, 6, 12, or 24 hours. Then,
cells were centrifuged at 6,000 ×g for 30 s and lysed for 30 min on ice in ice-cold lysis
buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% [vol/vol] Triton X-100, 0.5%
[vol/vol] Nonidet P-40, 20 mM NaF, 20 mM NaVO3, 1 mM EDTA, 1 mM EGTA, 5 mM
phenylmethylsulfonyl fluoride [PMSF], 21 μg/ml aprotinin, 5 μg/ml leupeptin, and 4mM
Diisopropyl fluorophosphates [DFP]). After protein estimation using the Pierce BCA
protein assay kit (Thermo Scientific, Waltham, MA, USA), samples were adjusted to a
concentration of 2 µg/µL. Unless otherwise noted, 10-20 µg/µL of total cell lysates were
separated by 12% SDS-PAGE and immunoblotted with antibodies for MCL-1 (1:500,
Proteintech, Rosemont, IL), XIAP, Caspase 3 and −actin (1:1000, Cell Signaling,
Danvers, MA, USA. The appropriate secondary antibodies were used at 1:2000 dilution
(Cell Signaling, Danvers, MA, USA). The ECL system (Amersham Pharmacia Biotech,
Little Chalfont, United Kingdom) or the SuperSignal West Femto Maximum Sensitivity
Substrate (Thermo Scientific,Waltham, MA, USA) was used to visualize antigen-antibody
reactions. Densitometric values of each band were calculated using Image Lab software
(BioRad, Hercules, CA, USA).

Luminescent Caspase Activity Assays: Neutrophils were left untreated or treated with
staurosporine (1 M), Fas L (500 ng/mL), or opsonized F. alocis ( MOI 10:1) for 0, 3, 6,
12, 24 hours at 37 °C, 5%CO2 in RPMI-1640. The activity of caspase 3/7, 8, and 9 was
assayed using manufacturer’s protocol from the Caspase-Glo assay kits from Promega

161

(Madison, WI). Briefly, 100 L aliquots containing 5 × 104 neutrophils were transferred to
white, flat bottomed 96-well plates in triplicates. Equal volume of the Caspase Glo-reagent
was mixed into each well and left to incubate at room temperature for 45 minutes. Activity
was assessed as by an end-point measurement of the luminescence generated from the
cleavage of the Caspase-Glo reagent.

Fluorescence Caspase 3/7 Activity Assay: Neutrophils (1 × 106 cells in 500 L) were left
to adhere to serum-covered coverslips in 24 well plates for 30 minutes before they were
untreated or stimulated opsonized F. alocis ( MOI 10:1). The infection was “synchronized”
by a centrifugation step (4 min, 600g, 14 °C) and the cells were cultured for 6, 12, 24 hours
at 37°C, 5%CO2 in RPMI-1640. At the indicated timepoints, 1 drop of CellEvent™
Caspase-3/7 Green ReadyProbes™ Reagent (Invitrogen) was added per well (each
containing 500 uL) and left to incubate at room temperature for 30 minutes. The wells were
washed 3x with sterile PBS and the cells fixed with 4% paraformaldehyde for 10 min at
room temperature. After once more wash with PBS, the coverslips were mounted onto
glass slides and imaged with a confocal microscope. 100 cells from throughout the
coverslip were counted and evaluated for expression of GFP.

Assessment of DNA fragmentation: Neutrophils (4 × 106 cells/mL) were stimulated with
viable opsonized F. alocis (MOI 10:1) or were left untreated for 0, 3, 6, 12, 24, or 48 hours
at 37 °C, 5%CO2 in RPMI-1640. DNA fragmentation was determined using the ApoBRDU
apoptosis detection kit (BD Biosciences), a modified TUNEL assay. Samples were labeled
according to the manufacturer’s instructions with minor modifications. PMNs were fixed

162

with 4% paraformaldehyde for 60 min at 4 ˚C, washed, and stained for 90 min. Samples
were read on a BD FACSCelesta flow cytometer and analyzed using the FlowJo software
(Ashland, OR, USA).

Transwell experiments: Neutrophils (2 × 106 cells in 600 L of RPMI) were added to the
wells of a 24 well plate with transwells containing a 0.4 M filter in duplicates. In the top
chamber, 100 L of either media or the opsonized F. alocis inoculum was added. A
separate well received F. alocis into the well with the neutrophils for the “same” control.
Then, the plate was cultured in an incubator at 37 °C, 5%CO2. After 24 hours of culture,
the duplicates were combined and stained for Annexin V and 7AAD as previously
described.

Generation of Conditioned Media: Neutrophils from the percoll gradient separation were
further enriched to obtain highly pure cells (>99%) by negative magnetic selection using
the Easy Eights EasySep Magnet and human neutrophil enrichment kit (Stemcell
Technologies, Vancouver, BC, Canada), as previously described [298]. Cell purity was
assessed by simultaneously staining with FITC‐conjugated anti‐CD66b (clone G10F5;
BioLegend, San Diego, CA, USA) and APC‐conjugated anti‐CD16 (clone CB16;
eBioscience, San Diego, CA, USA) antibodies and determining the percentage of
CD66b+CD16+ cells using BD Celesta flow cytometer (BD Biosciences, San Jose, CA,
USA). After purification, cells were resuspended the cells in clear RPMI medium
supplemented with 5% heat inactivated human serum (Atlanta Biologicals, Flowery
Branch, GA, USA) for a concentration of 4 × 106 cells/mL. Neutrophils were distributed
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into 12 well plates in triplicates. If needed, neutralizing antibodies were added for 30-60
minutes as listed above. Then, opsonized F. alocis (MOI 10) was added and phagocytosis
synchronized (600g for 4 min at 14°C). After incubation for 24 hours in 37 °C incubator,
5% CO2, supernatants were collected, centrifuged at 6000g for 30 sec at room temperature,
and triplicate conditions combined. Finally, supernatants were filtered by passing them
through 0.22 m filter, aliquoted and stored at -80 0C until use.

Imagestream Assays: A stock of neutrophils (10 × 106 cells/mL) was cultured at 37 °C,
5%CO2 in media (RPMI-1640 with L-glutamine), or with opsonized F. alocis (MOI 10)
for 1, 18, or 24 hours.
For phagocytic experiments, 4 × 106 neutrophils/mL from the aged neutrophil stocks
were challenged with human serum opsonized Alexa Fluor 488 heat-killed S.
aureus (Invitrogen; MOI 10) in a shaking water bath at 37 °C for 30 min. After this
timepoint, neutrophils were pelleted at 6000g for 30 seconds followed by fixing in the dark
with 4% paraformaldehyde for 10 min. After washing the cells with PBS, the membranes
of neutrophils were stained for 10 minutes with Alexa Flour 647-conjugated wheat germ
agglutinin (2 µg/mL, WGA, Molecular probes). Excess WGA was washed off with PBS
and the cells were read on the imaging flow cytometer. Phagocytosis was determined using
the internalization wizard from the IDEAS software.
For ROS production assays, 4 × 106 neutrophils/mL from the aged neutrophil stocks
were put into clean microcentrifuge tubes and 2′, 7′-dichlorofluorescein (DCF, 5 μM) was
added to each tube for 10 minutes in a shaking water bath at 37 °C. Half of the volume
from each tube was aliquoted into a new microcentrifuge tube: one was used to measure
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basal ROS production and the other one was further challenged with human serum
opsonized Alexa Fluor 488 heat-killed S. aureus (Invitrogen; MOI 10) for 30 min. After
30 minutes, the cells were washed with 0.05% sodium azide and fixed with 1%
paraformaldehyde. Samples were read on the imaging flow cytometer and analysis
completed on the IDEAS software. First, the percentage of cells that were positive for S.
aureus was determined. Next, the mean fluorescence intensity of DCF was quantified for
these S. aureus positive cells.

Statistical Analysis: Statistical differences among experimental conditions and time points
were analyzed using GraphPad Prism Software (Graphpad San Diego, CA, USA).
Differences were considered significant at the level P < 0.05. The specific statistical test
for each experiment is listed in their respective figure legend. If results represent data from
multiple experiments, mean values ± standard error of mean (SEM) are shown.

Results:
F. alocis extends neutrophil lifespan
One of the distinguishing features of neutrophils is their unique nuclear
morphology. In viable neutrophils, the nucleus is a multi-lobular structure that resembles
flower petals, but as the cells age and undergo constitutive apoptosis, their nucleus will
condense into a dense, round shape; therefore, I tested if opsonized F. alocis affects nuclear
morphology as a way to asses viability (Figure 4.1A). Cytospins of freshly isolated cells
showed the distinctive multi-lobular nuclear structure of neutrophils, and culture of
neutrophils in media with no serum for 24 hours resulted in the condensation of nuclei in
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the majority of cells. Similarly, addition of the pro-apoptotic translation inhibitor,
cycloheximide (CHX), resulted in the majority of neutrophils undergoing changes in
nuclear morphology. However, neutrophils co-cultured with F. alocis at a multiplicity of
infection (MOI) of 10 bacteria per neutrophil resulted in the retention of nuclear shape after
24 hours.
This finding was confirmed by measuring via flow cytometry the cell surface
expression of phosphotidyl serine (PS) and nuclear membrane permeabilization using
Annexin V and 7-AAD, respectively (Figure 4.1B). Flow cytometry dot plots show that
freshly isolated cells are negative for both 7-AAD and Annexin V (Q4: Annexin V-, 7AAD). However, as cells enter early apoptosis, they will become positive for Annexin V (Q3:
Annexin V+, 7AAD-) followed by becoming double positive for both stains (Q2: Annexin
V+, 7AAD+) during the late stages of apoptosis. Necrotic cells would only be positive for
7-AAD staining (Q1: Annexin V-, 7AAD+). When neutrophils are cultured in media for 24
hours, few cells are in the viable double negative quadrant, the majority of neutrophils
became Annexin V positive, and a few cells advanced further into the double positive
quadrant, indicating that a large proportion of neutrophils became apoptotic. The CHXtreated cells almost entirely advanced into the apoptotic quadrants, but in F. alocis-treated
cells, a large fraction of cells remained viable (Q4: Annexin V-, 7AAD-). Moreover, almost
no cells were in the late apoptosis quadrant (Q2: Annexin V+, 7AAD+) or the necrotic cell
quadrant (Q1: Annexin V-, 7AAD+; Fig. 4.1.B). When the percentages of cells in the viable
(Q4: Annexin V-, 7AAD-) quadrant were combined from 4-6 independent experiments,
there was a significantly larger percentage of F. alocis- stimulated cells that remained
viable as compared to their media cultured-counterparts (Figure 4.1C).
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Furthermore, by cytospin (Figure 4.1D) and flow cytometry (Figure 4.1E), the F.
alocis-dependent prolonged viability of neutrophils appears to be dose dependent, since
using a larger MOI of 50 increased the percentage of cells that retained their nuclear
morphology and stained negative for Annexin V and 7-AAD. At a MOI of 100, there was
still a significant percentage of viable cells compared to media-treated cells, but not larger
than a MOI of 50 (Figure 4.1 D-E). To continue the characterization of this response, I
sought to determine if extending neutrophil lifespan was an active process by F. alocis.
Thus, neutrophils were cultured in media alone or media with CHX, F. alocis, or heatkilled F. alocis for 24 hours followed by assessment of apoptosis by cytospin (Figure 4.1F)
and flow cytometry (Figure 4.1G). Based on nuclear morphology, heat-killed F. alocis can
delay apoptosis as well as the viable bacterium (Figure 4.1F). By flow cytometry, culture
of neutrophils with heat-killed F. alocis elevated the percentage of cells that were viable,
but this number was slightly less than viable F. alocis (Figure 4.1G). Together, this data
indicates that whether its viable or not, F. alocis can induce a dose-dependent delay in the
constitutive apoptosis of neutrophils.

F. alocis induces changes in the transcriptome to extend neutrophil lifespan
Based on the analysis of the RNAseq data, 11% of differentially expressed genes
are functionally categorized under the cellular process of apoptosis (Figure 2.2). For this
chapter, these genes were pooled for a heatmap to assess global changes in their expression
(Figure 4.2). The expression of several members of the inhibitor of apoptosis (IAP) family
like BIRC8, XIAP, cIAP1/2, Livin, NAIP was differentially regulated. Moreover, members
of the extrinsic pathway of apoptosis were downregulated, including caspase 8 and FADD.
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Notably, caspase 9 of the intrinsic pathway was also downregulated. Together, this data
indicates that F. alocis may be acting on multiple branches of apoptosis.
From the pathogens that can extend neutrophil lifespan, only Anaplasma
phagocytophilum can exert anti-apoptotic effects when it is viable and heat-killed [294].
Borjesson et. al published a microarray study of human neutrophils that were challenged
with A. phagocytophilum for 1, 3, 6, 9, 12, and 24 hours [294]. Based on the microarray
data, they compiled a list of genes upregulated and dowregulated by A. phagocytophilum
that relate to apoptosis and cell fate. Using that list, I built a heatmap to assess whether
these genes were also differentially expressed in our dataset (Figure 4.3). From our dataset,
the genes upregulated by A. phagocytophilum were also upregulated by F. alocis and the
genes downregulated by A. phagocytophilum were also downregulated by F. alocis,
suggesting F. alocis may be inducing a similar mechanism to extend neutrophil lifespan.

F. alocis induces changes in the expression of pro-survival proteins
Neutrophil survival relies heavily on the expression of the MCL-1, an antiapoptotic member of the Bcl-2 family [423]. MCL-1 has a short half-life and requires
continuous synthesis to carry out its pro-survival effects; however, based on the RNAseq
data, the gene expression of MCL1 is significantly decreased in F. alocis stimulated cells
(Figure 4.4A). Next, whole lysates from neutrophils cultured in media, with the extrinsic
apoptosis inducer Fas ligand (FasL) or with F. alocis for 0, 3, 6, 12, or 24 hours were run
on western blots, probed for MCL-1, and the intensity of the band quantified by
densitometric analysis (Figure 4.4B-C). Media-cultured cells had a steady, time-dependent
decrease in MCL-1protein levels, while treating the cells with FasL accelerated the
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degradation of MCL-1. However, despite not showing statistical significance, cells treated
with F. alocis had a milder decrease in the expression of MCL-1. These results suggest that
while F. alocis may not be increasing the expression of MCL-1 at the level of transcription,
it protects the anti-apoptotic protein from degradation to retain a pro-survival phenotype.
Another important pro-survival protein in neutrophils is XIAP, which binds to
caspase 3 to inhibit its activation. Gene expression data from the RNAseq dataset showed
that after 3 and 6 hours of challenge, F. alocis induces the upregulation of XIAP in human
neutrophils (Figure 4.5A). The gene expression was matched at the protein level where
XIAP was more abundant in cells that were challenged with F. alocis that those cultured
in media alone (Figure 4.5B-C). The increased XIAP protein expression was detectable as
early as 3 hours and remained significantly elevated until 12 hours. Due to the augmented
expression of XIAP, I hypothesized that the activation of the executioner protease, caspase
3 may be impaired in F. alocis-treated cells.

F. alocis dampens Caspase 3 activation
To determine activation of the executioner caspase, western blotting was used to
measure the amount of inactive zymogen pro-caspase 3 and active cleaved caspase 3 forms
in neutrophils cultured in media or stimulated with FasL or F. alocis during a time course
of 3, 6, 12, 24 hours (Figure 4.6A-B). Media treated cells showed a time-dependent
decrease in pro-caspase 3 and an increase in the expression of the cleaved caspase 3
fragment, which was faintly detectable at 6 hours. FasL treatment accelerated the
accumulation of cleaved caspase 3, which was detectable as early as 3 hours of stimulation.
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On the other hand, F. alocis-challenged neutrophils had dimly detectable cleaved caspase
3 only until 12 hours, which suggests that F. alocis delays caspase 3 cleavage.
While processing of procaspases into their mature forms is essential for their
activation, it not sufficient to induce maximal activity because their enzymatic function is
further modulated through association of cytoplasmic regulatory factors [424]. Thus, the
direct activity of caspase 3 was tested in the same experimental conditions by two different
assays: one with a chemiluminescent output and the other with a fluorescence output. The
theory behind both is similar in that at each timepoint desired, neutrophils will be incubated
with a probe that contains a specific cleavage site for active caspase 3. When caspase 3
cleaves the probe, luminescence or fluorescence will be emitted, and thus the intensity of
the signal can be correlated to enzyme activity. Like all previous experiments in this
chapter, the stimulation of neutrophils with F. alocis was done in suspension for the
chemiluminescence-based assay (Figure 4. 6C). The kinetics of cleavage of caspase 3
correlated closely with enzyme activity, since FasL-induced activation of caspase 3 had
measurable enzyme activity between 3 and 6 hours, with a steep incline in activity after
that. Media-cultured cells had caspase 3 cleavage as early as 6 hours and in the activity
assay, caspase 3 produced the first increase in light production between 6 and 12 hours. On
the other hand, F. alocis induced mild caspase 3 cleavage that resulted in significantly
diminished protease activity as compared to media or FasL stimulated cells at 12 and 24
hours (Fig 4.6 C).
When infections are carried out in suspension, the output is an average of the
responses of neutrophils at different stages in their bacterial interaction kinetics: some may
have not interacted with bacteria yet, others may be in the process of phagocytosis, and
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other may have already engulfed and degraded their cargo. Therefore, for the fluorescencebased assay, the neutrophils were attached on glass coverslips and the infection with F.
alocis was synchronized through a centrifugation step (Figure 4. 6D-E). Overall, the trend
of caspase activity was similar to the chemiluminescence assay, where F. alocis induced
decreased caspase 3 activity. However, it is important to note that adhesion in itself
prolongs the lifespan of neutrophils [425], so the timing of caspase 3 activation is delayed
in all conditions, and why I assessed caspase 3 activity as late as 48 hours. In conclusion,
F. alocis delays the cleavage and activation of procaspase 3, followed by a decrease in
caspase 3 activity that ultimately results in prolonged neutrophil survival.

F. alocis delays DNA fragmentation
The final outcome of caspase 3 activation is the destruction of cellular structures
like cytoskeletal protein degradation or DNA fragmentation [426]. Specifically, during the
final stages of apoptosis, caspase3-activated DNAses cleave nuclear DNA, which can be
detected experimentally through terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) staining. TUNEL staining will fluorescently label exposed 3’hydroxyl
ends that occur as a result of DNA strand cleavage, and the increase in fluorescence can be
detected via flow cytometry. Using this technique, I tested DNA fragmentation in our
experimental conditions (Figure 4.7A-B). Representative flow cytometry histograms from
each condition were superimposed to show differences in DNA fragmentation at 6-24
hours of culture (Figure 4.7A). At 6 hours, the majority of untreated and F. alocis
stimulated neutrophils were negative for DNA fragmentation like freshly isolated cells.
However, as the timecourse progressed, a larger population (~40%) of media-cultured
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neutrophils became positive for the TUNEL probe at 12 hours, whereas only ~20% of F.
alocis treated neutrophils had detectable DNA fragmentation (Figure 4.7B). The difference
in these values increased to statistical significance at 24 hours, where ~60% of media
neutrophils became positive for TUNEL while only ~40% F. alocis stimulated cells were
TUNEL positive. By 48 hours of ex-vivo culture, all cells became TUNEL +. Collectively,
this data supports the idea that relative to untreated cells, F. alocis markedly delayed DNA
fragmentation to retain neutrophil viability.

F. alocis meekly activates initiator caspases
Caspase 8 is the initiator caspase of the extrinsic apoptosis pathway that is initiated
upon ligation of surface death receptors and caspase 9 is the driver of the intrinsic pathway
that is activated through the release of mitochondrial factors into the cytoplasm [392].
Having established that caspase 3 activation is delayed in neutrophils stimulated with F.
alocis, I sought to determine which pathway is triggered upstream of caspase 3 activation
through the same chemiluminescence-based activity assays employed to detect caspase 3
activation. In untreated cells, caspase 8 (Figure 4.8A) and caspase 9 (Figure 4.8B) activity
peaked between 12 and 24 hours. Fas L was used as an extrinsic apoptosis pathway
activator and staurosporine was used as an inducer of the intrinsic apoptotic pathway. Both
of these positive controls induced activity of caspase 8 and -9, respectively, at earlier
timepoints than untreated cells. Contrastingly, neutrophils treated with F. alocis had a
gradual minimal increase in the activity of both caspases. Overall, the activity of caspases
8 and 9 was markedly lower in F. alocis treated cells as compared to untreated cells, which
suggests that the oral pathogen may be influencing the apoptotic cascade at multiple points.
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Furthermore, since caspase 3 activation and DNA fragmentation is detected at 24 hours of
culture with F. alocis, it is possible that caspase 3 is being activated through an alternative,
initiator caspase independent mechanism.

F. alocis pro-survival effect depends on contact with neutrophils through TLR2/6
Since neutrophil programmed cell death can be delayed by host derived factors like
DAMPS and pro-inflammatory cytokines or bacteria-derived components, I tested whether
contact with the bacterium is necessary to induce the prolonged lifespan of neutrophils.
First, I conducted a crude flow cytometry Annexin V/7-AAD assay where neutrophils were
stimulated with CFSE-labeled F. alocis. This allowed for an initial gate where neutrophils
were separated by their CFSE intensity as a measure of association with F. alocis (Figure
4.9A). Here, the neutrophils were divided into two populations: F. alocis negative (low
CFSE) or F. alocis positive (high CFSE), which were roughly the same size. Then, these
two populations were plotted in a traditional Annexin V/7-AAD quadrant to assess their
apoptotic state. It is possible to see from the flow cytometry dot plots that F. alocis (-)
neutrophils progressed into early apoptosis (Q3: Annexin V+, 7-AAD-) at a higher
percentage than F. alocis (+) cells, and that a larger portion of F. alocis (+) cells remained
in the viable quadrant (Q4: Annexin V-, 7-AAD-). This viability trend reached statistical
significance when two independent experiments were combined (Figure 4. 9B), suggesting
that association with F. alocis directly enhances neutrophil viability.
To determine if manipulation of the neutrophil phenotype required the binding or
phagocytosis of F. alocis, I used transwells with a pore size of 0. 4 m to quarantine the
neutrophils (PMN) from the bacteria (Figure 4. 9C). When neutrophils and F. alocis were
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in the same compartment, the viability of neutrophils increased as previously shown.
However, this effect was reversed when the oral pathogen and neutrophils were separated
by the transwell’s filter, confirming that contact between both parties is essential to induce
the pro-survival phenotype.
Since F. alocis is recognized by TLR2/6 receptors to initiate numerous neutrophil
effector functions, I assessed if the apoptosis delay was also mediated through TLR2/6
(Figure 4.9D). For these experiments, neutrophils were pre-treated with neutralizing
antibodies against TLR2 and TLR6 or corresponding isotype controls prior to stimulation
with F. alocis for 24 hours. As expected, CHX treatment decreased neutrophil viability and
F. alocis increased it. Blocking access to TLR2/6 decreased viability comparable to basal
levels, while the isotype control did not affect the F. alocis driven survival effect.
Combined, this data demonstrated that F. alocis contact with neutrophils through TLR2/6
ligation is responsible for the prolonged neutrophil lifespan.

Factors released during F. alocis & neutrophil interaction are pro-survival
Although contact of neutrophils with F. alocis through TLR2/6 is essential to
initiate neutrophil survival, the pro-survival response could be due to a paracrine effect
from cytokines or other pro-survival factors released by neutrophils downstream of TLR2/6
ligation. Therefore, to test this possibility, the supernatants of neutrophils cultured in media
or stimulated with F. alocis for 24 hours were collected and sterile filtered to generate
conditioned media (Figure 4.10A). Then, naïve neutrophils were cultured in fresh or
conditioned media for 24 hours and their apoptosis status assessed by cytospin (Figure
4.10B). Neutrophils cultured in conditioned media from untreated cells developed nuclear
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condensation whereas the multi-lobulated nuclear morphology was retained in neutrophils
cultured in the conditioned media from F. alocis-stimulated cells. This was confirmed by
flow cytometry where the progression into apoptosis of cells in the conditioned media
versus direct stimulation in fresh media was compared (Figure 4.10C). Both sets on
untreated cells, cultured in fresh or conditioned media, had the same percentage of viable
cells. When neutrophils were cultured with F. alocis-conditioned media, there was an
increase in the number of viable cells as compared to untreated cells, which indicates that
the interaction between F. alocis and neutrophils generates pro-survival factors. However,
this percentage of viable cells was not as robust as when neutrophils are stimulated with F.
alocis in fresh media, suggesting that both the bacteria-neutrophil interaction and the
secreted pro-survival factors are necessary to induce maximal neutrophil survival.
To determine the contribution of TLR2/6 signaling to the generation of these prosurvival factors, a new set of conditioned media was collected where neutrophils were pretreated with neutralizing antibodies against TLR2/6 or isotype controls prior to stimulation
with F. alocis for 24 hours. The supernatants were collected, sterile filtered, and used to
culture naïve neutrophils for 24 hours (Figure 4.10D). Assessment of apoptosis via flow
cytometry determined that while culturing cells in the F. alocis-conditioned media is not
as potent as stimulation with F. alocis, when neutrophils are pre-treated with inhibitors for
TLR2/6, the pro-survival effect is lost completely. Therefore, I conclude that the contact
between neutrophils and F. alocis through TLR2/6 initiates a signaling cascade that
produces pro-survival factors with paracrine effects on non-infected cells. However, this
pro-survival soup is not sufficient to elicit the maximal neutrophil survival possible in this
context and requires the presence of the bacterium.
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Neutrophils with F. alocis-mediated survival retain their functional capacity
As a non-inflammatory type of cell death, cells undergoing apoptosis have
restricted proinflammatory capacities like an impairment in chemotaxis, phagocytosis and
degranulation [392]. Since neutrophils challenged with F. alocis remain viable for longer
periods of time, I sought to determine whether they were also still capable of performing
their effector functions. Neutrophils were aged in media or media with opsonized F. alocis
for 18 or 24 hours, followed by the addition of non-viable, fluorescent S. aureus at a MOI
of 10 bacteria per neutrophil. These S. aureus particles are known to be ingested easily and
induce a robust ROS generation. The phagocytic capacity of these aged cells was tested via
imaging flow cytometry after fluorescently labeling the neutrophil membrane. Fig. 4.11A
shows representative neutrophils that were classified as S. aureus negative and S. aureus
positive. At 18 hours of culture, F. alocis-challenged neutrophils were significantly more
efficient at phagocytizing the opsonized S. aureus (Figure 4.11B). The neutrophils from
the same donors were also tested after 24 hours, and while the trend was the same, there
was no statistical significance between media-aged neutrophils and their F. alocischallenged counterparts.
Using imaging flow cytometry, the ability of aged neutrophils to produce ROS was
also assessed. The culture protocol was the same as above, but this time, aged neutrophils
were incubated with 2’,7’-dichlorodihydrofluorescein diacetate (DCF) prior to S. aureus
challenge. The ROS-reduced form of DCF will emit fluorescence, so increases in the
intensity of fluorescence can be attributed to ROS production, which is demonstrated in
the representative images (Figure 4.11C). By comparing the mean fluorescence intensity
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(MFI) of DCF at 1 hour, there is no significant difference between media or F. alocis
cultured neutrophils. However, as the cells age for 18 hours, the untreated cells lose some
of their capacity to produce ROS against S. aureus whereas F. alocis stimulated cells
produced a significantly higher amount of ROS (Fig 4.11 C-D). This difference was lost at
24 hours, where F. alocis cultured cells also begin to lose their functional capacity. Thus,
it becomes clear that F. alocis-challenged neutrophils were able to also retain their ability
to produce ROS for longer timepoints than media treated cells. Ultimately, this prolonged
lifespan and functional capacity could result in increased neutrophil-driven inflammation,
which is a hallmark of periodontal disease.

Discussion:
Despite their reputation as “pathogen busters,” neutrophil functions extend beyond
eliminating invading bacteria. Neutrophils will undergo controlled cell death through
apoptosis to diminish their pro-inflammatory potential and become targets for efferocytic
clearance by macrophages. The clearing of spent neutrophils initiates inflammation
resolution protocols and tissue repair; in fact, neutrophil apoptosis at sites of infection is a
characteristic of effective immune response [427]. In periodontitis, there is an extensive
accumulation of neutrophils, which are found at different stages of cell death [210, 264,
428]. This suggests that there is modulation of neutrophil lifespan and/or a defect in the
efficient clearing of dying neutrophils. However, there are only a few publications that
have addressed neutrophil viability after encounters with oral bacteria, and they have
focused on extremely short timepoints (three hours or less). Since the majority of studies
on cell death after interaction with periodontal pathogens have been done on epithelial cells
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and macrophages, this work fills an important gap in the knowledge of the scientific
community. To this point, F. alocis challenge induces apoptosis in normal oral
keratinocytes and epithelial cells [67, 73].
To assess apoptosis in neutrophils, I chose to use serum-free media in our
experimental design to eliminate the confounding effects of growth factors and serum
components as previously described [407, 429]. Even in these limiting conditions, F. alocis
was able to delay neutrophil constitutive apoptosis pathways. Specifically, our results show
that relative to control cells, neutrophils challenged with F. alocis retained their nuclear
morphology, showed decreased phosphatidylserine externalization by Annexin V staining,
and had diminished DNA fragmentation as tested by TUNEL. This phenotype could be
explained by a marked delay in the processing and subsequent activity of the executioner
caspase, caspase 3; an effect that has been previously observed for other intracellular
pathogenic bacteria like Francisella tularensis [407]. It is likely that in the case of F. alocis
challenged neutrophils, the delayed processing of caspase 3 is partially linked to the
increased gene and protein expression of XIAP, a protein that physically binds to Caspase
3 and prevents its activation. This is similar to the mechanism deployed by Neisseria
gonorrhoeae, which transiently delays the onset of apoptosis in parallel to the upregulation
of cIAP2 and XIAP [430]. Compounding on this inhibitory effect was a defect in the
activity of initiator caspases 8 and 9, suggesting that F. alocis is able to modulate the
activation of the intrinsic and extrinsic pathways. It would be important to also test the
processing of both these caspases via western blotting, as was done with Caspase 3 to
determine where F. alocis is impacting the activity of these caspases.
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Of note, all of these apoptosis assays were conducted under aerobic conditions,
where the presence of oxygen inactivates the majority of F. alocis in the culture between
4 and 10 hours (Shown in Chapter 6). Incidentally, after 6 hours of culture, the levels of
XIAP begin to decrease, procaspase 3 is cleaved, and DNA fragmentation becomes
detectable. While this suggests that viable F. alocis may be actively inducing XIAP
expression, heat-killed F. alocis also had a net pro-survival phenotype. This was surprising
given the fact that heat-killed F. alocis results in efficient phagosome maturation and
induces robust ROS production, which is an initiating factor in the phagocytosis-induced
cell death program. Our results also demonstrated that contact with F. alocis is required for
the pro-survival effect to take place. Both viable and heat-killed F. alocis activate TLR2/6,
which was necessary to induce neutrophil survival. Furthermore, the conditioned media
from neutrophils stimulated with F. alocis had pro-survival effects on naïve neutrophils,
likely through the release of pro-inflammatory cytokines that extend paracrine neutrophil
survival effects. Other than IL-8 production, the differences in cytokine output after
challenge with viable or heat-killed F. alocis has not been assessed. Changes in neutrophil
signaling between viable and heat-killed F. alocis may be responsible for these differences
and is an ongoing area of research in our laboratory.
Interaction with intracellular microbes can extend neutrophil lifespan, sometimes
to the advantage of the microbial agenda. For example, Chlamydia pneumoniae and the
fungal pathogen, Paracocciodes brasiliensis, that delay apoptosis by stimulating
neutrophil secretion of IL-8 [431, 432]. The Gram-negative Anaplasma phagocytophilum
also delays apoptosis for up to 90 hours [294, 433, 434], and shares similarities with F.
alocis. Much like F. alocis, A. phagocytophilum reduces proinflammatory cytokine release,

179

fails to induce ROS production, and delays apoptosis whether the bacterium is viable or
not [435-440]. Additionally, when the differential apoptosis gene expression profile from
A. phagocytophilum was assessed in our transcriptome data, the F. alocis-induced pattern
of gene expression generally mirrored the one from A. phagocytophilum, suggesting the
bacteria may have overlapping virulence strategies against neutrophils. It is known that A.
phagocytophilum inhibits cell apoptosis through the activation of the Janus kinase/signal
transducers and activators of transcription (JAK/STAT) pathway and type IV secretion
system (T4SS)-secreted proteins [441]; but I have not assessed whether F. alocis activates
these pathways and it is unknown whether the oral pathogen has a secretion system that is
relevant to human infection.
In conclusion, this is the first report to do an in-depth characterization of the
apoptotic effect the emerging oral pathogen, F. alocis has on human neutrophils. Although
more work will be needed to establish the in vivo relevance of this data, I speculate that the
extended neutrophil lifespan will have serious implications in disease progression by
extending the window of time where neutrophils can promote dysbiotic inflammation in
the oral cavity.
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Figure 4.1: F. alocis delays neutrophil apoptosis.

181

Figure 4.1: (A, D, F) Nuclear morphology changes were assessed by light microscopy
using images of HEMA-stained cytospins from freshly isolated neutrophils, neutrophils
cultured in media, or neutrophils stimulated with cycloheximide (CHX), F. alocis (MOI
10, 50 or 100), or heat-killed (HK) F. alocis for 24 hours. (B) Flow cytometry dot plot and
gating strategy of AnnexinV/7AAD stained neutrophils treated with the same conditions
as A. (C, E, G) Plots shows the % viable (Q4: Annexin V-, 7AAD-) neutrophils ± SEM
from 2-7 independent experiments. A one-way ANOVA with Tukey post-hoc tests was
performed on graphs C, E, and G. * p > 0.05, **p > 0.01, ***p > 0.001.
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Figure 4.2: F. alocis induces changes in gene expression of apoptotic genes.
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Figure 4.2: Heatmap shows the differential expression of genes in the apoptosis process
cluster from MetaCore. Gene expression data was generated from Illumina RNA
sequencing performed on human neutrophils from 4 individual healthy donors that were
either left unstimulated or challenged with F. alocis for 1, 3 or 6 hours.
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Figure 4.3: F. alocis induces a pattern of apoptosis gene expression like Anaplasma
phagocytophilum. A list of upregulated and downregulated genes related to apoptosis was
acquired from a microarray study by Borjesson et. al. The expression of these genes was
assessed in our data set. The heat map depicts our data from neutrophils challenged with
F. alocis for 1, 3 or 6 hours, but the genes are clustered based on whether they were
upregulated or downregulated by A. phagocytophilum.
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Figure 4.4: F. alocis upregulates gene expression of anti-apoptotic MCL-1 and delays
its degradation. Line graphs show the average Fragments Per Kilobase of transcript per
Million mapped reads (FPKM) of the gene for MCL-1 (A) in unstimulated (Basal)
neutrophils and F. alocis challenged neutrophils from 4 healthy donors. Representative
images show the western blots of whole cell lysates from media-cultured cells or cells
stimulated with Fas L or F. alocis that were probed for MCL-1 (B). Normalized western
blot densitometries are summarized from 4 and 7 independent experiments, respectively,
and plotted ± SEM (C). Two-way ANOVAs with Bonferroni post-hoc testing was
performed on all graphs. * = p > 0.05, **=p > 0.01, ***= p > 0.001
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Figure 4.5: F. alocis upregulates genes & protein expression of XIAP. Line graphs
show the average Fragments Per Kilobase of transcript per Million mapped reads (FPKM)
of the gene for XIAP (A) in unstimulated (Basal) neutrophils and F. alocis challenged
neutrophils from 4 healthy donors. Representative images show the western blots of whole
cell lysates from media-cultured cells or cells stimulated with Fas L or F. alocis that were
probed for XIAP (B). Normalized western blot densitometries are summarized from 4 and
7 independent experiments, respectively, and plotted ± SEM (C). Two-way ANOVAs with
Bonferroni post-hoc testing was performed on all graphs. * = p > 0.05, **=p > 0.01, ***=
p > 0.001
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Figure 4.6: F. alocis delays Caspase 3 activation.
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Figure 4.6: (A) Representative blot of time-dependent Caspase 3 processing from whole
cell lysates of untreated (media), Fas L or F. alocis treated neutrophils. (B) Data are plotted
as the mean ± SEM of the normalized densitometry of cleaved caspase 3 from 8
independent experiments. Asterisk denotes statistical significance in comparison to both F.
alocis and Fas L. (C) Caspase 3 activity was tested in suspension using a chemiluminescent
assay on neutrophils that were untreated (Media) or stimulated with Fas L or F. alocis
(MOI 10) for 3, 6, 12 or 24 hours. Data are plotted as the mean ± SEM of the luminescence
produced for each condition from 4 independent experiments. (D) Attached neutrophils in
media or challenged with F. alocis for 0, 6, 24, or 48 hours were examined for caspase
activity by a fluorescence-based assay and imaged using confocal microscopy. Cells that
express green fluorescence have active caspase 3 activity. (E) 100 cells were counted from
each condition and qualified on whether they became fluorescence as a measure of caspase
activity. Data are plotted as the percent ± SEM of neutrophils that became Caspase 3
positive at each timepoint from 5 independent experiments. Asterisk denotes statistical
significance between media and F. alocis conditions. A two-way ANOVA with Bonferroni
post-hoc testing was performed on all graphs. * = p > 0.05, **=p > 0.01, ***= p > 0.001
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Figure 4.7: F. alocis delays DNA fragmentation. A flow cytometry based TUNEL assay
was conducted on neutrophils cultured in media or with F. alocis (MOI 10) for 3, 6, 12,
24, and 48 hours. DNA fragmentation was detected as an increase in fluorescence by the
BrdU-FITC antibody. (A) Shows flow cytometry histograms of freshly isolated
neutrophils, media cultured neutrophils, or neutrophils challenged with F. alocis after 6,
12, and 24 hours. Gating was made to delineate the rightward shift in the populations that
became BrdU positive due to DNA fractionation. (B) The percent of TUNEL+ neutrophils
represents the number of cells ± SEM that migrated into the right gate in 4 independent
experiments. A two-way ANOVA with Bonferroni post-hoc testing was performed where
* = p > 0.05, **=p > 0.01, ***= p > 0.001.
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Figure 4.8: F. alocis minimally activates the initiator caspases, 8 and 9. Caspase 8 (A)
and Caspase 9 (B) activity was tested in suspension using a chemiluminescent assay on
neutrophils that were untreated (Media), stimulated with positive controls Fas L or
staurosporine, or F. alocis (MOI 10) for 3, 6, 12 or 24 hours. Data are plotted as the mean
± SEM of the luminescence produced for each condition from 4 independent experiments.
A two-way ANOVA with Bonferroni post-hoc testing was performed on A and B where *
= p > 0.05, **=p > 0.01, ***= p > 0.001.

191

Figure 4.9: Contact with F. alocis through TLR2/6 is necessary for prolonged
neutrophil lifespan.
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Figure 4.9:Annexin V/7AAD staining was performed on neutrophils that were challenged
with CFSE-expressing F. alocis for 24 hours. (A) Shows the flow cytometry gating strategy
employed. First the neutrophils were first sorted into F. alocis negative or positive based
on their CFSE intensity, followed by classical Annexin V/7AAD gating. (B) Shows the
mean percent viable (Q4: Annexin V-, 7AAD-) neutrophils ± SEM from the F. alocis
negative or positive cells from two independent experiments. A two-tailed student T-test
was performed to determine statistical significance. (C) Neutrophils (PMN) were cultured
in transwells as depicted with or without F. alocis for 24 hours followed by Annexin
V/7AAD staining. Data are plotted as the mean percent viable (Q4: Annexin V-, 7AAD-)
neutrophils ± SEM from two independent experiments. (D) Neutrophils were untreated
(Basal) or stimulated with F. alocis after pre-treatment with media, neutralizing TLR2/6
antibodies or isotype controls. Data are plotted as the mean percent viable (Q4: Annexin
V-, 7AAD-) neutrophils ± SEM from 6 independent experiments. A one-way ANOVA
with Tukey post-hoc testing was performed on C & D to determine statistical significance.
* = p > 0.05, **=p > 0.01, ***= p > 0.001.
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Figure 4.10: Factors released during F. alocis & neutrophil interaction are prosurvival.
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Figure 4.10: (A) Graphic depicting how conditioned media was generated. (B) HEMAstained cytospins of naïve neutrophils cultured in the conditioned media from untreated
cells or F. alocis treated cells. (C) Neutrophils were cultured in fresh media (blue dots) and
left untreated (UT) or stimulated with F. alocis, or cultured in the conditioned media
(orange dots) of untreated (UT) of F. alocis-stimulated cells for 24 hours followed by
staining for Annexin V and 7AAD. Data are plotted as the mean percent viable (Q4:
Annexin V-, 7AAD-) neutrophils ± SEM from 5-10 independent experiments. (D) Naïve
neutrophils were cultured in fresh media and left untreated (UT) or stimulated with F.
alocis, or they were cultured in the conditioned media from untreated cells or cells
stimulated with F. alocis after pre-treatment with media, neutralizing TLR2/6 antibodies
or isotype controls. After culture for 24 hours, the cells were stained for Annexin V and
7AAD. Data are plotted as the mean percent viable (Q4: Annexin V-, 7AAD-) neutrophils
± SEM from five independent experiments. One-way ANOVAs with Tukey post-hoc
testing was performed on C & D to determine statistical significance. * = p > 0.05, **=p >
0.01, ***= p > 0.001.
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Figure 4.11: F. alocis-challenged neutrophils retain functional capacity for longer
timepoints.
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Figure 4.11: Neutrophils were aged for 18 or 24 hours in media or stimulation with F.
alocis followed by a 30-minute challenge with S. aureus. First, the phagocytic capacity of
these cells was tested via imaging flow cytometer. (A) Images from the imaging flow
cytometer depict neutrophils that did or did not internalize S. aureus. (B) Summary from 3
independent experiments shows the mean percentage of neutrophils that phagocytosed S.
aureus. (C) Representative images from the imaging flow cytometer show the ROS
production in response to S. aureus challenge by cells aged for 18 hours with media or F.
alocis. (D) Represents the average mean fluorescence intensity ± SEM from media-aged
cells or F. alocis-aged cells that internalized S. aureus from 3 independent experiments.
Two-way ANOVAs with Bonferroni post-hoc testing was performed on B & D to
determine statistical significance. * = p > 0.05, **=p > 0.01, ***= p > 0.001.
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CHAPTER 5:
THE FINAL FRONTIER: CLEARANCE OF NEUTROPHILS AFTER F. ALOCIS
CHALLENGE

Introduction:
After the activation of a local inflammatory response due to infection, the proper
termination of the inflammatory cascade is important because it initiates a phase of tissue
repair and resolution responses. Improper resolution of inflammation results in excessive
scarring, organ damage, chronic inflammation, and loss of self-tolerance, which
contributes to multiple pathologies like cardiovascular disease, auto-immunity, and cancer
[442-444]. An important initiating step in this pathway is the clearing of dead or spent cells
through a process called efferocytosis.
In vivo, efferocytosis of apoptotic cell corpses occurs extremely quickly; for
example, when six million apoptotic cells are injected into the peritoneum of mice, the cells
are taken up by phagocytes within 15-30 min [445]. However, in a number of nonresolving, chronic inflammatory diseases, defects in efferocytosis develop and result in an
accumulation of dead cells [443]. When cells undergo apoptosis, they undergo a noninflammatory cell death because the cells maintain their membrane integrity for a limited
period of time. Nevertheless, they need to be cleared quickly to prevent secondary necrosis,
which will release their cytotoxic molecules into the extracellular space.
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In order to orchestrate efferocytosis, four main steps must take place. First,
chemotactic “find-me” signals are produced by dying neutrophils to attract efferocytic
cells. These signals include the nucleotides ATP and UTP, the chemokine fractalkine
(CX3CL1), and the lipids lysophosphatidylcholine (LPC) and sphingosine-1-phosphate
(S1P) [446]. Next, “eat-me” signals on the surface of the apoptotic cell mediate recognition
by macrophages. To distinguish them from viable cells, apoptotic cells downregulate
expression of “don’t eat me” signals like CD47, CD61, CD46 and CD31 and upregulate
expression of lipids (phosphatidylserine), proteins (ICAM-3), or modified carbohydrates
[442]. The third step involves the uptake and degradation of the apoptotic body in the
phagolysosomal compartment by proteases, DNAses and lipases. Finally, efferocytic
phagocytes release a number of anti-inflammatory mediators including PGE2, TGF-, IL10, and lactate, among others to initiate the resolution of inflammation [445].
In the context of periodontitis, not much was known about how periodontal
pathogens affect efferocytosis. However, pervasive defects in efferocytosis could be
contributing to the progression of periodontitis and the chronicity of inflammation in the
oral cavity. In chapter 2, I observed that F. alocis challenge induces significant differential
expression of pathways related to apoptosis and in chapter 4 our results demonstrated that
F. alocis prolongs the functional lifespan of neutrophils. Therefore, I hypothesized that F.
alocis interferes with efferocytosis to inhibit resolution of inflammation. Paradoxically,
neutrophils that were cultured with F. alocis were efferocytosed with greater frequency
than untreated neutrophils. However, once internalized, the F. alocis-challenged
neutrophils were not degraded as quickly as efferocytosed untreated neutrophils.
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Ultimately, I believe that under the right conditions, F. alocis could be using neutrophils
as “trojan horses” to gain access into a longer-lived host cell.

Materials & Methods:
Neutrophil isolation: Human donor recruitment, blood draws, and materials required for
this procedure were in accordance with the guidelines approved by the Institutional Review
Board of the University of Louisville. Neutrophils were isolated from venous blood of
healthy donors using plasma‐Percoll gradients, as described previously [297].

Bacterial strains and growth conditions: F. alocis ATCC 38596 was cultured in brain heart
infusion (BHI) broth supplemented 5 mg/mL yeast extract, L-cysteine (0.05%) and
arginine (0.05%) for 7 days anaerobically at 37 °C as previously described [275, 276].
Serum opsonization was performed by incubating F. alocis at 37°C for 20 min in 10%
normal human serum (Complement Technology, Inc., Tyler, TX, USA). Heat killed F.
alocis was generated by incubation at 90 °C for 60 min. Non-viability was confirmed by
incubation in culture media at same conditions used for the live organism. After
opsonization, F. alocis was labeled with carboxyfluorescein succinimidyl ester (CFSE; 40
ng/μl) for 30 min at room temperature in the dark and washed 3 times with PBS prior to
use.

Aging and staining of neutrophils: The membranes of neutrophils were stained with PKH26 using the manufacturer’s protocol (Sigma). After several washes with PBS to remove
excess dye, neutrophils were cultured in clear RPMI-1640 with L-glutamine and 5% heat
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inactivated human serum with or without opsonized F. alocis (MOI 10) at 37 °C, 5%CO2
for 18 hours. After 18 hours of culture neutrophils were stained for CD47 and CD31
(Biolegend, Carlsbad, CA, USA). Aged neutrophils were washed before adding to cultured
macrophages.

Mice and peritoneal macrophage extraction: All experiments were completed on male and
female C57Bl/6 wild-type mice between 8 to 12 weeks of age. The institutional animal
care and use committees at University of Louisville approved all animal experiments. As
previously described, mice were injected with 5 mM sodium periodate, sacrificed after 72
to 96 hours, and peritoneal cavities lavaged with phosphate-buffered saline containing 2
mM EDTA [447, 448]. Total lavage cells were plated in tissue-culture plates or chamber
slides in Iscove modified Dulbecco medium with 10% heat-inactivated fetal bovine serum
for 2 hours. Nonadherent cells were removed, and adherent macrophages cultured
overnight before use in experiments.

Human Macrophage culture: The mononuclear cell layer fraction from peripheral blood of
healthy donors was washed thrice using Krebs buffer. Then, the cells were plated in 6 well
plates at density of 2 million cells per well in krebs buffer containing 2mM HEPES and
allow to settle for 2 hours. The unsettled cells were removed and settled cells were washed
with krebs buffer. Next, the settled cells were gently scraped, plated on 6 well low
attachment plate in RPMI with 20% FBS, and incubated at 37 oC in a 5% CO2 incubator.
On the fourth day, the number of big cells was counted followed by plating the cells at the
density of 0.2 million cells on coverslips in 24 well in RPMI with 10% FBS. The media
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was changed in the wells on day sixth to RPMI with 5% FBS and on day seventh to RPMI
with 1% FBS. The human monocytes derived macrophages were used for experiment on
eighth day, when 60% or more of the cells were expressing CD68, a marker for
differentiated macrophages.

Macrophage phagocytosis assays: Macrophages that were seeded overnight onto on 8-well
glass chamber slides or 12 well plates were pulse fed (centrifuged 1 min, 800g, 25 °C)
neutrophils incubated in media for 18 hours or opsonized F. alocis-cultured neutrophils at
a MOI of 10 neutrophils per macrophage for 30 or 60 minutes at 37 °C. The slides or wells
were then washed 3 times with sterile PBS, which removed any uningested neutrophils.
For myeloperoxidase (MPO) staining, the 8-well chamber slides were fixed using
4% paraformaldehyde. Then, macrophages were stained for MPO by adding 3,3′diaminobenzidine (DAB) as previously shown [447, 448]. 100 cells were counted for each
experimental condition and qualified based on whether they were positive for MPO from
phagocytized neutrophils.
For flow cytometry experiments, antibodies for F4/80 (Mouse, BioLegend, #123118)
and CD16 (Human, BioLegend, #302012) were added to the wells to stain the cells on ice
for 20 minutes. Cells were then scraped and 20,000 cells were collected on a on a BD
FACSCelesta flow cytometer and analyzed using the FlowJo software (Ashland, OR,
USA). To obtain the % ingestion figure, the percentage of F4/80+, CD16+ cells (which
represents macrophages with attached neutrophils) was subtracted from the percentage of
F4/80+, PKH-26+ cells.
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For confocal imaging, macrophages were seeded overnight onto on 8-well glass
chamber slides and then fed aged PKH-26-labeled neutrophils that had been challenged
with CFSE-labeled, opsonized F. alocis. After feeding for an hour, the neutrophils were
washed off and the macrophages were processed for confocal staining or left for another
23 hours of culture. Upon completion of each timepoint, the cells were stained with
antibodies against F4/80. The cells were fixed with 4% paraformaldehyde and imaged by
confocal microscopy to assess whether the neutrophils and/or F. alocis ingested by the
macrophages had been degraded.

Macrophage Supernatant and Lysate Collection: Macrophages that were seeded overnight
on 12 well plates in duplicates were left untreated or fed neutrophils for an hour as
previously described. The washes to remove uningested neutrophils were pooled, pelleted
and lysed on ice for 30 minutes in the lysis buffer described above. Fresh, warmed media
was added to the wells with macrophages, and the cells were incubated for an additional
hour (for total of 2 hours with PMN) or 23 hours (for a total of 24 hours with PMN). At
each indicated timepoint, 25 L of lysis buffer was added to each well. Then, the cells were
scraped into the lysis buffer, the duplicates were combined and placed on ice for 30
minutes. The lysates and their respective western blots were generated as described for
neutrophils above, with the exception that 20 µg of the cell lysates were separated by 12%
SDS-PAGE and immunoblotted with antibodies for F. alocis (1:2000, generated by Pocono
using UV killed F. alocis), elastase (1 µg/ml, Abcam), or -actin (1:1000, Cell Signaling).
Additionally, at the completion of the 24-hour timepoint, the supernatants were saved from
the wells, centrifuged to remove any cell debris and 1% protease and phosphatase inhibitors
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were added to the supernatants to protect them from degradation. These supernatants were
run on a 32-analyte multiplex assay to determine the cytokine profile.

F. alocis Colony Forming Units: For each timepoint tested, three culture tubes were
generated. The first one contained the F. alocis inoculum in the neutrophil culture media,
the other two tubes had the F. alocis inoculum co-cultured with human neutrophils. At the
end of each timepoint, the F. alocis inoculum tube and one of the tubes with F. alocis and
neutrophils were placed on ice while the second tube containing F. alocis and neutrophils
was centrifuged (300g, 5 min, 4 °C) and washed 3 times to remove extracellular bacteria.
During the final wash of the intracellular bacteria condition, the F. alocis inoculum tube
and the tube with the total F. alocis and neutrophils were centrifuged (6000g, 2 min, 4 °C)
to pellet all bacteria and immune cells. The pellets from the inoculum, the total F. alocis
and neutrophils, and the intracellular F. alocis were lysed for 1 minute in 0.02% saponin
and serially diluted in sterile PBS. These dilutions were sterilely plated in duplicate 10 µL
drop aliquots on anaerobic BHI plates (BHI media (7.4g/200ml), L-cysteine (0.1g/ 200ml),
yeast extract (1g/200ml), agar powder (3g/200ml), 0.05% arginine and 5% sheep blood).
The plates were transferred into an anaerobic chamber and allowed to grow for 72 hours.
Colonies that grew were counted and Gram stained. In experiments where anaerobic and
aerobic conditions were tested in parallel, the anaerobic neutrophil media was put into the
anaerobic chamber and the aerobic media was left in an aerobic incubator the night before
performing the assay.
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Statistical Analysis: Statistical differences among experimental conditions and time points
were analyzed using GraphPad Prism Software (Graphpad San Diego, CA, USA).
Differences were considered significant at the level P < 0.05. The specific statistical test
for each experiment is listed in their respective figure legend. If results represent data from
multiple experiments, mean values ± standard error of mean (SEM) are shown.

Results:
Efferocytosis of neutrophils aged with F. alocis
Since F. alocis-challenged neutrophils have extended survival and retain their
functional capabilities, I hypothesized that efferocytosis of these F. alocis neutrophils
would be hampered. To test this, I acquired mouse macrophages by inducing sterile
peritonitis in wild-type mice. These peritoneal macrophages were pulse fed for 30-60
minutes with 18 hours aged human neutrophils that were either untreated (media) or
challenged with F. alocis (MOI; 10 bacteria per neutrophil); the feeding ratio used was of
10 neutrophils per macrophage. After 30 or 60 minutes, uningested neutrophils were
washed off and the macrophages were stained for myeloperoxidase (MPO) as a way to
visualize internalized neutrophils, which can be appreciated in the representative images
(Figure 5.1A). 100 macrophages from each condition were tallied based on whether they
ingested neutrophils, and at both 30 and 60 minutes, neutrophils challenged with F. alocis
were efferocytosed by more macrophages compared to the untreated neutrophils (Figure
5.1B). Ultimately, I chose to use the mouse macrophage/human neutrophil model for the
rest of the efferocytosis experiments; however, I wanted to determine if the pattern of
ingestion was the same in human monocyte derived macrophages (HMDM) (Figure 5.1C).
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Only one replicate with one donor was conducted, but in HMDM, F. alocis-stimulated
neutrophils were also efferocytosed more readily at both timepoints tested.
To confirm the MPO imaging data, I used flow cytometry as a high-throughput
technique to evaluate the internalization of PKH-26 labeled neutrophils by F4/80
expressing macrophages. Figure 5.1D depicts representative flow cytometry dot plots that
show the gating strategy employed to determine uptake. The untreated macrophage control
only stained positive for F4/80, but when macrophages were fed untreated neutrophils,
there was a shift to the right, indicating neutrophil uptake. This shift was even more
pronounced in macrophages that were fed F. alocis-stimulated neutrophils (Figure 5.1D).
When the population of macrophages that ingested neutrophils was combined from several
mice, ~20% of macrophages engulfed untreated neutrophils after 30 minutes and this value
doubled when the ingestion time was increased to 60 minutes (Figure 5.1E). In the case of
F. alocis-stimulated neutrophils, 40% of macrophages had ingested neutrophils at 30 min,
and at 60 minutes this value rose to 80% of macrophages. Thus, the enhanced ingestion of
F. alocis-treated neutrophils observed by microscopy was also mirrored in the more robust
flow cytometry approach (Figure 5.1E).

Expression of “Don’t eat me” signals on F. alocis-stimulated neutrophils
The best characterized “eat me” signal on apoptotic cells is the expression of
phosphatidyl serine (PS) on the cell surface. However, F. alocis stimulation results in
decreased externalization of PS as compared to unstimulated cells (Chapter 4). Therefore,
I hypothesized that instead of expressing more “eat me” signals than untreated controls,
perhaps F. alocis neutrophils express fewer “don’t eat me” signals like CD47 (Figure 5.2A)
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and CD31 (Figure 5.2B). Both CD47 and CD31 are shed naturally as neutrophils age,
which is why there is a decrease in the expression of both of these markers between freshly
isolated neutrophils and neutrophils aged for 18 hours. Concomitantly, stimulating the
neutrophils with pro-apoptotic Fas L resulted in decreased expression of both CD47 and
CD31 as compared to neutrophils cultured in media for 18 hours. In the case of CD47, F.
alocis-stimulated cells expressed significantly more CD47 than untreated cells (Figure
5.2A). On the other hand, F. alocis stimulated cells expressed significantly less CD31 than
media-cultured cells (Figure5.2B). In fact, the expression of CD31 on F. alocis stimulated
neutrophils was comparable to that of the pro-apoptotic stimulant, Fas L.
Previous reports have shown that the secreted proteases of oral bacteria like P.
gingivalis can cleave CD31 to induce the efferocytosis of viable cells [449, 450]. To assess
if viable F. alocis is producing a protease that is cleaving of CD31 on viable cells,
neutrophils were stimulated with heat-killed F. alocis. In terms of CD47 expression, both
heat-killed and viable F. alocis resulted in comparable CD47 expression (Figure 5.2A).
However, although it did not reach significance, treating the neutrophils with HK F. alocis
resulted in a partial rescue of the CD31 expression (Figure 5.2B). Together, this suggests
that the decreased expression of CD31 may be due to released F. alocis proteases.
Additionally, neutrophils can release their own proteases through granule exocytosis that
can also cleave off neutrophil membrane receptors [449]. To confirm the decreased CD31
expression was due to the action of proteases, I cultured neutrophils with media or F. alocis
in the presence of protease inhibitors (PI) and then quantified the expression of CD47 and
CD31 (Figure 5.2C-D). The presence of PI restored CD47 expression to fresh cells levels
for both untreated and F. alocis-stimulated neutrophils, indicating that proteases are part
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of the cells normal CD47 downregulation, regardless of infection (Figure 5.2D). However,
in the case of CD31, the inhibitors did not restore CD31 of any of the conditions to the
level of fresh cells (Figure 5.2D). In media-cultured cells, the expression of CD31 was the
same whether or not the inhibitors were present. In F. alocis stimulated cells, protease
inhibitors restored CD31 levels to the media-cultured cells, suggesting that in F. alocis
infection, proteases are responsible for the added shedding of CD31. Taken together, this
data suggests that macrophages are able to engulf viable, F. alocis-challenged cells more
than apoptotic untreated cells because F. alocis causes a decrease in expression of CD31
through proteases.

Macrophage degradation of F. alocis-cultured neutrophils
After recognizing dead cells, the efferocytic macrophages begin to digest the
phagocytized cargo. In our system, I examined the digestion of neutrophils by confocal
microscopy (Figure 5.3A-B). After feeding membrane-labeled neutrophils for an hour, the
uningested granulocytes were washed off and the macrophages were either fixed for
imaging or left to digest their neutrophil cargo for an additional 23 hours. Consistent with
our previous results, after 1 hour of feeding, F. alocis-neutrophils were ingested more than
media-cultured cells (Figure 5.1A). Notably, CFSE-labeled F. alocis could still be detected
within neutrophils that were efferocytosed. Then, after 24 hours of culture between the
neutrophils and the macrophages, the ingested media-cultured neutrophils had been almost
entirely degraded whereas the F. alocis-stimulated neutrophils remained more intact, with
F. alocis still detectable intracellularly. Figure 5.3B shows a zoomed portion of the merged
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images shown in panel A, to better appreciate the architecture of the neutrophils within the
macrophages.
To quantify this phenomenon, the same experiments were conducted, but this time,
instead of viewing the cells on the confocal microscope, whole cell extracts were collected
and western blots of these lysates were probed with polyclonal antibodies against F. alocis
as a measure of bacterial proliferation or probed for elastase as a measure of neutrophil
presence within the macrophage (Figure 5.4A). On the representative western blot shown,
the first thing to appreciate is that the F. alocis antibody recognizes proteins from
neutrophils (UT PMN) and macrophages (Mo) even when the bacterium is not present.
Thus, quantification of these blots was done on the most prominent F. alocis protein band
that could be detected, which is the one delineated by the blue box. Quantification that
focused on this band showed an incremental decrease, but not a complete degradation, of
F. alocis proteins within macrophages (Figure 5.4B). Next, the blots were probed for
elastase as a measure of neutrophil presence. The first two lanes, which represent the
lysates of neutrophils washed off the macrophages that were not ingested, the amount of
elastase was less in the F. alocis-stimulated neutrophils, suggesting that more neutrophils
were ingested by the macrophages, as has been shown previously. Unlike the elastase from
untreated neutrophils inside the macrophages, the elastase from F. alocis-stimulated
neutrophils could still be detected after 24 hours of culture, indicating that the efferosome
is not as efficient at degrading F. alocis-stimulated neutrophils (Figure 5.4C).

Neutrophils as “trojan horses” for F. alocis
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While some pathogens delay neutrophil death to maintain viability of their
replicative niche and others will accelerate apoptosis or trigger PMN lysis to evade
intracellular killing. Another proposed mechanism is the use of infected neutrophils as
“Trojan horses” for infection of macrophages. Since F. alocis extends neutrophil lifespan
and delays the degradation of neutrophils inside macrophages, I tested the possibility that
F. alocis was using neutrophils to create another niche inside the longer-lived
macrophages.
First, I assessed by flow cytometry how many macrophages internalized
neutrophils that contained F. alocis to see if macrophages preferentially engulfed cells
harboring bacteria. To accomplish this, PKH-26 labeled neutrophils were co-cultured with
CFSE-labeled F. alocis for 18 hours followed by feeding of macrophages for 1 hour. Using
the same gating strategy as Figure 5.1D, the population of macrophages that efferocytosed
neutrophils was determined (Figure 5.5A). These PKH-26 positive macrophages (Q2:
F4/80+, PKH+) were further characterized based on their intensity of CFSE as a measure
of the percent of neutrophil+ macrophages that also contained F. alocis (Figure 5.5A). The
summary figure of these experiments shows that as expected, 100% of the macrophages
that phagocytized media-cultured neutrophils did not contain any F. alocis (CFSE negative
(-)). However, when macrophages were fed F. alocis-stimulated neutrophils, 50% of the
macrophages internalized F. alocis-containing neutrophils (Figure 5.5B). In the condition
where macrophaes were fed F. alocis-stimulated neutrophils, there was a small (5-10%)
difference between the CFSE(-) and the CFSE (+) macrophages; however, despite reaching
statistical significance, is likely not biologically relevant. Together, this data demonstrates
that macrophages are not preferentially efferocytosing F. alocis infected neutrophils.
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The basis behind cellular “trojan horses” is that a viable microbe drives the uptake
of their cell host by another cell that will provide a longer-lived or more permissive
replicative niche. However, the viability of F. alocis in culture with neutrophils had only
been tested up to 4 hours [284]. Therefore, the survival of F. alocis with neutrophils was
tested for longer timepoints (Figure 5.5C). At 1 and 4 hours of culture, neutrophils were
responsible for an overall reduction of viable F. alocis as compared to the inoculum alone.
However, at 10 hours both the inoculum and the neutrophil-cultured F. alocis were
markedly affected in their CFU counts. Parallel to these experiments, extracellular F. alocis
was extensively washed off and intracellular F. alocis was plated (Figure 5.5D). Data
shows that neutrophils do not reduce F. alocis numbers within the first 4 hours of challenge.
However, by 10 hours of culture the quantity of CFU dramatically decreased, same as the
inoculum and the total culture of F. alocis with neutrophils. Since F. alocis is a strict
anaerobe, I hypothesized that by 10 hours, the aerobic environment was inactivating the
oral pathogen.
Due to their limited oxygen diffusion capacity, normal tissues are considered
physiologically hypoxic [451]. Tissues can become increasingly hypoxic during infection
through the activation of the NADPH oxidase complex [452], and as the depth of the
periodontal pocket increases, the oxygen tension also decreases [453]. Neutrophils are
likely exposed to profound levels of hypoxia as they are largely recruited to periodontal
disease-associated tissues or trapped in areas of microcirculatory impairment. As a crude
method to mimic the environment where neutrophils are exposed to F. alocis in vivo,
neutrophils ± F. alocis were cultured in anaerobic media in an anaerobic chamber or in
aerobic media in an incubator. First, the apoptotic status of these neutrophils was tested
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after 24 hours (Figure 5.5E). Culturing neutrophils anaerobically results in enhanced
neutrophil viability in untreated cells, but in both sets of cells, F. alocis extended the
leukocytes’ survival even further.
Then, the ability of these cells to kill F. alocis was tested (Figure 5.5F). At 1 and 4
hours of culture, there was no difference in the killing efficiency of neutrophils cultured
aerobically or anaerobically. After 10 hours and overnight incubations, F. alocis was
eliminated in aerobic culture conditions as previously shown. Interestingly, under
anaerobic conditions, only the F. alocis cultured with neutrophils at both of these
timepoints produced CFUs, indicating that F. alocis lifespan is extended in the presence of
neutrophils. F. alocis did not proliferate more than the inoculum at any timepoint tested.
When the intracellular bacteria were plated, aerobically cultured bacteria perished by 10
hours, but anaerobically cultured bacteria could form colonies even after overnight culture
with neutrophils (Figure 5.5G). There was also no significant difference between the CFUs
counts at 1, 4, and 10 hours, indicating that under anaerobic conditions, F. alocis is able to
dampen neutrophil microbicidal mechanisms for long periods of time. Taken together, this
data shows that under anaerobic conditions, F. alocis requires the presence of neutrophils
to survive for extended periods of time, and also that the bacterium is able to remain viable
within neutrophils for long periods of time. These findings are particularly exciting because
they could mean that under hypoxic conditions, F. alocis could be using neutrophils as
vehicles to enter macrophages as another niche.

Efferocytosis of F. alocis-cultured neutrophils induces a pro-inflammatory environment
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The final step in efferocytosis is the release of anti-inflammatory mediators that
will tip the scale towards the resolution of inflammation. To determine if this was the case,
I collected supernatants for cytokine analysis from untreated macrophages or macrophages
that efferocytosed untreated neutrophils or neutrophils exposed to F. alocis. The cytokine
multiplex data showed that efferocytosing F. alocis-neutrophils results in macrophages
releasing a significant amount of pro-inflammatory cytokines like G-CSF, IL-1, IL1 TNF, and IL-6 (Figure 5.6). There was also an upward trend in the release of the proinflammatory cytokine IFN but this did not reach significance. Furthermore, the
generation of chemokines like RANTES (CCL5), KC (CXCL1), IP-10 (CXCL10), LIX
(CXCL5), MCP1 (CCL2), and MIP2 (CXCL2) was also amplified compared to
macrophages alone or macrophages that received untreated neutrophils (Figure 5.7).
Paradoxically, macrophages that internalized F. alocis-stimulated-neutrophils produced
significant amounts of the anti-inflammatory cytokine, IL-10. Other cytokines like IL-17,
MIG (CXCL9), MIP-1 (CCL3), and MIP-1 (CCL4), were not significant. Overall, the
cytokine data shown here suggests that the resolution function of efferocytosis is corrupted
when the macrophages ingest F. alocis challenged neutrophils. These efferocytosing cells
will produce pro-inflammatory cytokines and chemokines that will recruit more immune
cells. Together, this response will feed into the dysregulated chronic inflammation cycle of
periodontal disease and prevent the resolution.

Discussion
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Since challenge with F. alocis delayed the externalization of phosphatidyl serine
(PS), and the cells retained their functional capacity after 18 hours of challenge, I
hypothesized that efferocytosis would also be defective. Surprisingly, this was not the case,
since F. alocis challenged neutrophils were efferocytosed by macrophages significantly
more than control cells. It has been previously demonstrated that PS expression is not
absolutely necessary for the uptake of neutrophils by macrophages [449]. Thus, when the
expression of “don’t eat me” signals was tested, F. alocis-neutrophils showed enhanced
membrane expression of CD47 but decreased expression of CD31. CD47 on viable
neutrophil membranes will be recognized by the macrophage receptor SIRPα (signal
regulatory protein α) that activates inhibitory phosphatases (SHP-1 and SHP-2) via ITIMs
(immunoreceptor tyrosine-based inhibition motifs) in SIRPα. Overall, this results in the
inhibition of macrophage efferocytosis [454]. CD31 expression prevents phagocyte
ingestion of viable cells by transmitting ‘detachment’ signals to the macrophage [455]. It
is possible that despite the high expression of CD47 in F. alocis-neutrophils, this is not
enough to overcome the lack of repulsive signaling from the diminished expression of
CD31. In fact, when CD31 was cleaved off of freshly isolated neutrophils by P. gingivalis
gingipains, the neutrophils were efficiently engulfed by macrophages [449].
In our system, HK F. alocis induced a milder reduction in CD31, suggesting that
like P. gingivalis, viable F. alocis is actively inducing the proteolytic cleavage of CD31. It
will be interesting to test whether HK F. alocis-stimulated neutrophils are efferocytosed to
similar levels as untreated cells, since they display comparable levels of CD31. Other
proteinase activity sources that should be considered are elastase and cathepsin G, two
neutrophil-derived proteases typically found in azurophilic granules and on the surface of
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neutrophils when they are primed [456]. Previous results from our laboratory show that
azurophilic granules are not released at early timepoints (30 min) [284], but the release of
azurophilic granule content during longer challenge periods has not been determined.
Importantly, both of these proteases have been linked to modifications that modulate
efferocytosis. Elastase cleaves the phosphatidyl serine receptor on phagocytes, leading to
defective apoptotic cell clearance [457] and cathepsin G cleaves CD31 on neutrophils to
hinder uptake by macrophages [449]. Our studies used a pan-protease inhibitor cocktail,
but it may be valuable to use specific inhibitors for each of the proteases to determine if
they play a role in the CD31 shedding.
In our experimental set up, F. alocis was cultured aerobically with neutrophils,
meaning that by 10 hours most of the strictly anaerobic bacteria was no longer viable.
Regardless of this, bacteria could still be visualized within neutrophils that were engulfed
by macrophages up to 24 hours after efferocytosis. This brings up several important
questions that revolve around the possibility of neutrophils as “trojan horses” for the
infection of macrophages. After culture of neutrophils with F. alocis, how early can the
neutrophils be internalized by efferocytes? If F. alocis is viable within the apoptotic cells,
can the bacterium survive and/or proliferate within the apoptotic cell phagosome?
As a crude way to determine the role of atmospheric oxygen on the neutrophil-F.
alocis interaction, I performed the infection under aerobic or anaerobic conditions. The
basal length of neutrophil lifespan was prolonged, but F. alocis challenge increased the
number of viable neutrophils even further. Of course, longer timepoints and more precise
environmental oxygen controls will be necessary to assess the full impact of F. alocismediated survival under hypoxic conditions. It was not surprising that anaerobic conditions
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prolonged the survival of F. alocis, but it was unexpected that in the 10 hour and overnight
timepoints, only the F. alocis conditions that received neutrophils had CFU formation,
suggesting that the bacteria are able to survive better in the presence of neutrophil-driven
inflammation. Intracellular CFU could be detected in the overnight cultures, but since these
assays were done in suspension it is not possible to guarantee the intracellular bacteria
detected were present in neutrophils the entire culture period. While it will need to be tested
in our system, I believe that the decreased bacterial killing under anaerobic conditions
cannot be attributed to defects in neutrophil functions because of decreased availability of
oxygen. Studies that have specifically tested neutrophil functionality describe that hypoxia
does not affect phagocytosis, but enhances neutrophil degranulation, the autophagic
capacity of neutrophils, and the killing of some microbes like Escherichia coli and S.
aureus [451, 458]. The only function that was impaired seemed to be the production of
ROS, but in the case of F. alocis, the bacterium is able to grow better in the presence of
hydrogen peroxide and at least aerobically, induces minimal ROS generation from
neutrophils [58, 284].
The fate of the pathogen and the immune cell in which it resides in will highly
depend on the type of efferocyte, host factors like genetic polymorphisms, and the type of
cell death the immune cell containing the bacterium underwent [443]. For example, low
virulence strains of Mycobacterium tuberculosis induce apoptosis in cells and when
macrophages engulf these cells, the lysosomal fusion with the apoptotic cell phagosomes
promotes bacterial killing [459]. However, virulent M. tuberculosis strains induce necrosis
in neutrophils and when the necrotic neutrophils are internalized by macrophages, M.
tuberculosis intracellular growth is promoted [460]. Thus, it is possible that despite
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efficiently engulfing F. alocis-challenged neutrophils, macrophages are not able to digest
the cargo because the viable neutrophils did not trigger the signaling needed for full
phagosome maturation and subsequent degradative capacity. To prove this, more studies
are needed to characterize the macrophage phagosome that contains F. alocis-stimulated
neutrophils. One of the first things to test would be ROS production and phagosome
acidification, since they are essential for efficient proteolysis of apoptotic cells within
efferosomes [447].
Instead of initiating a pro-resolution phenotype, the macrophages that ingested the
F. alocis-laden neutrophils secrete a number of pro-inflammatory cytokines and
chemokines that will likely contribute to drive the chronicity of periodontal inflammation.
Another indirect consequence of defective efferocytosis is the development of autoimmune
responses. Normally, efferocytosis helps mount an adaptive immune response against
bacteria through the process of antigen cross-presentation [443]. However, when there is
limited proteolysis of phagosomal cargo, there is enhanced presentation of antigens and
increased potential for excessive activation of adaptive immune responses [443, 447]. To
address this point, it will be interesting to see if the cross-presentation is different between
macrophages that ingested untreated or F. alocis stimulated neutrophils.
Efferocytosis in the oral cavity has also been ill-defined, especially when it comes
to the contribution of emerging oral pathogens. Despite being functional and viable,
neutrophils that interact with F. alocis will be efficiently ingested by efferocytic
macrophages. However, instead of initiating the resolution of inflammation, the
macrophages will add to the pro-inflammatory milieu by secreting more cytokines and
chemokines. Ultimately, these result begin to delineate how engulfing F. alocis-stimulated
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neutrophils can influence the action of efferocytic macrophages and how F. alocis may be
contributing to the chronic dysregulated inflammation observed in periodontitis.
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Figure 5.1: Efferocytosis of F. alocis-challenged neutrophils is more efficient than
media-cultured neutrophils.
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Figure 5.1: Neutrophils were aged for 18 hours in media or with F. alocis followed by a
30- or 60-minute pulse feeding of macrophages. (A) Representative images show MPO
staining of mouse peritoneal macrophages after neutrophil feeding. Arrows indicate
engulfed neutrophils. (B) 100 macrophages from each condition were qualified based on
whether they had efferocytosed neutrophils. The percentage of myeloperoxidase (MPO)
positive macrophages were plotted ± SEM where each dot represents the macrophages
from one mouse, conducted over 3 experimental replicates. A two-tailed student T-test was
performed to determine statistical significance at each timepoint. (C) The efferocytosis
assay and MPO staining was completed for one replicate using human neutrophils and
human macrophages. Data are plotted as in B. (D) Flow cytometry dot plots show the
gating strategy to determine the uptake of PKH-26 labeled neutrophils by F4/80 labeled
macrophages. (E) Summarizes the % macrophages that internalized neutrophils ± SEM
where each dot represents the macrophages from one mouse, conducted over 2
experimental replicates. A two-tailed student T-test was performed to determine statistical
significance at each timepoint. * = p > 0.05, **=p > 0.01, ***= p > 0.001.
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Figure 5.2: F. alocis-challenged human neutrophils expression of “don’t eat me”
signals. Fresh neutrophils or cells aged for 18 hours in media or with FasL, F. alocis or
heat killed (HK) F. alocis (MOI 10) were stained for (A) CD47 or (B) CD31 expression.
Data show the mean channel fluorescence of expression ± SEM from 3-10 independent
experiments. Then, In addition to the conditions from A and B, some neutrophils were also
pre-treated with protease inhibitors (PI) followed by culture for 18 hours in media or with
F. alocis and staining for (C) CD47 or (D) CD31 expression. One-way ANOVAs with
Tukey post-hoc testing was performed on all plots to determine statistical significance. * =
p > 0.05, **=p > 0.01, ***= p > 0.001.
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Figure 5.3: F. alocis-challenged human neutrophils persist in macrophages after 24
hours.
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Figure 5.3: PKH-26 labeled neutrophils (Red) were aged for 18 hours in media or with
CFSE F. alocis (Green) and then fed to macrophages for 1 hour. After washing off noningested neutrophils, the cells were left to culture for an additional 23 hours or fixed and
macrophages stained for F4/80 (Blue). (A) Shows representative Z-stack images of
macrophages from these conditions. (B) Shows zoomed sections from the merged images
in A.
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Figure 5.4: F. alocis challenged human neutrophils are not efficiently degraded by
macrophages.
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Figure 5.4: Neutrophils (PMN) were aged for 18 hours in media (UT) or with F. alocis
(Fa), and then fed to macrophages (Mo) for 1 hour. After washing off non-ingested
neutrophils, the cells were left to culture for 1 or 23 more hours. (A) Whole cell lysates
were probed for F. alocis, Elastase, or β actin. Lysates are from the non-ingested
neutrophils aged for 18 hours in media or with F. alocis, unchallenged macrophages (Mo),
macrophages fed media-cultured neutrophils (Mo + UT PMN), or macrophages fed F.
alocis-cultured neutrophils (Fa + UT PMN). Box highlights unique F. alocis protein used
for blot quantification as region of interest (ROI). Data are plotted as the mean ± SEM of
the normalized densitometry of (B) the boxed F. alocis protein or (C) elastase. Each dot
represents a mouse and data was collected from 2 experimental replicates. One-way
ANOVAs with Tukey post-hoc testing were performed on B & C to determine statistical
significance.
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Figure 5.5: F. alocis neutrophils as “trojan horses”.
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Figure 5.5: (A) Dot plots show gating strategy to determine the percent population of
macrophages that engulfed neutrophils (F4/80+, PKH-26+, Q2). Q2 macrophages from
both the media-treated neutrophils condition and CFSE-labeled F. alocis-treated neutrophil
condition, were plotted by their CFSE intensity in a histogram. Two gates differentiate
macrophages that ingested neutrophils that did not contain bacteria (CFSE(-)) and
macrophages that ingested neutrophils that contained F. alocis (CFSE(+)). (B) Shows the
% of Q2 macrophages ± SEM that ingested F. alocis negative CFSE(-) or F. alocis positive
CFSE(+) neutrophils from both conditions. Each dot (N=6) represents a mouse from 2
experimental replicates. (C) Data show the total colony forming units (CFU) from the
aerobic culture of F. alocis inoculum and F. alocis cultured with neutrophils for 1, 4, 10
hours and overnight. (D) Shows CFUs recovered from F. alocis cultured with neutrophils
where extracellular bacteria was washed off. C and D show average CFUs ± SEM from 3
independent experiments. (E) Neutrophil viability was assessed after 24 hours of aerobic
or anaerobic culture in media or with F. alocis by Annexin V/7AAD staining. Data are
plotted as the mean percent viable (Q4: Annexin V-, 7AAD-) neutrophils ± SEM from two
independent experiments. (F) Shows total colony forming units (CFU) from the culture of
F. alocis inoculum and F. alocis cultured with neutrophils under aerobic and anaerobic
conditions for the times shown. (G) Shows intracellular CFUs recovered after aerobic and
anaerobic culture. Both F and G represent the average CFUs ± SEM from 2 independent
experiments. One-way ANOVAs with Tukey post-hoc testing was performed on B, D, and
E to determine statistical significance. A two-way ANOVA with Bonferroni post-hoc
testing was performed on C, F and G to determine statistical significance. * = p > 0.05,
**=p > 0.01, ***= p > 0.001.
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Figure 5.6: Cytokine profile of efferocytic macrophages after ingestion of F. alocis
neutrophils. Neutrophils (PMN) were aged for 18 hours in media (UT) or with F. alocis
(Fa), and then fed to macrophages (Mo) for 1 hour. After washing off non-ingested
neutrophils, the cells were left to culture for 23 more hours. The supernatants were
collected from 7 mice over 2 independent experiments and tested using a 32-analyte
multiplex array. The targets that could be detected are shown here. One-way ANOVAs
with Tukey post-hoc testing were performed to determine statistical significance. * = p >
0.05, **=p > 0.01, ***= p > 0.001.
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Figure 5.7: Chemokine profile of efferocytic macrophages after ingestion of F. alocis
neutrophils. Neutrophils (PMN) were aged for 18 hours in media (UT) or with F. alocis
(Fa), and then fed to macrophages (Mo) for 1 hour. After washing off non-ingested
neutrophils, the cells were left to culture for 23 more hours. The supernatants were
collected from 7 mice over 2 independent experiments and tested using a 32-analyte
multiplex array. The targets that could be detected are shown here. One-way ANOVAs
with Tukey post-hoc testing were performed to determine statistical significance. * = p >
0.05, **=p > 0.01, ***= p > 0.001.
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CHAPTER 6:
DISCUSSION AND FUTURE DIRECTIONS

Periodontitis is an irreversible, bacteria-induced, chronic inflammatory disease that
compromises the integrity of tooth-supporting tissues and adversely impacts systemic
health. Neutrophils are the immune system’s first line of defense against bacteria in the
oral cavity, where their microbicidal functions typically protect the host against periodontal
disease. However, periodontal pathogens have evolved mechanisms to resist neutrophil
microbicidal mechanisms while still propagating inflammation, which provides essential
nutrients for the bacteria to proliferate and cause disease. Advances in sequencing
technologies have recognized several newly appreciated bacteria associated with
periodontal lesions, like the Gram-positive anaerobic rod, Filifactor alocis.
With the discovery of these emerging oral bacterial species, there is also a growing
need to (1) assess their pathogenic potential and (2) determine their contribution to disease
progression in order to develop adequate therapies against periodontal disease and its
associated comorbidities. Previous research from our laboratory initially characterized
some of the pathogenic behaviors of F. alocis toward neutrophils. The work from this
dissertation is an extension of this goal and was also aimed at understanding how the
neutrophil functions were modulated. To get a global picture of changes in neutrophils
during F. alocis challenge, I conducted a time course transcriptome study. Analysis of this
dataset demonstrated that F. alocis has a pervasive effect on neutrophil gene expression.
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By combining results from the transcriptome and F. alocis-modulated neutrophil effector
functions, here I will discuss our working model of how F. alocis may be contributing to
the chronic inflammation and the progression of periodontal disease (Figure 6.1).
First of all, F. alocis is recognized by human neutrophils through ligation of TLR2/6.
The resultant signaling modulates neutrophil migration patterns [275] and induces granule
exocytosis. Both of these functions have implications for tissue destruction in the
periodontium. Compounding the inflammatory response is the fact that previous work
showed that F. alocis could survive within neutrophils up to 4 hours [284]. Using colony
forming units, I confirmed these findings and found that under anaerobic conditions, viable
F. alocis can be recovered after 24 hours of culture with human neutrophils. Additionally,
the bacteria’s survival is extended when neutrophils are present, suggesting that neutrophils
contribute to favorable conditions for the bacterium and/or act as a niche for persistence.
The intracellular persistence of F. alocis in human neutrophils has been attributed to
minimal ROS production and a delay in phagosome maturation [284]. Both of these
phenotypes were confirmed in murine neutrophils, which is an important detail for when
studies progress into the animal models of periodontitis. Regardless of defective TLR2 or
MyD88 signaling, ROS production was not restored nor further dampened. However,
granule fusion with the phagosome showed some interesting differences. Compared to
wild-type neutrophils, the maturation of the phagosome was accelerated in F. alocis
phagosomes from TLR2 deficient mice, whereas neutrophils from MyD88-/- mice were not
able to digest viable F. alocis after 24 hours. For optimal antimicrobial capacity, it is critical
that both the NADPH oxidase is activated and neutrophil granules fuse with the phagosome
[321]. Thus, more studies will be needed to tease apart the signaling cascades that lead to
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minimal ROS generation and a delay in granule fusion with the phagosome. Of note, the
data from the transcriptome shows that F. alocis challenge significantly downregulates the
expression of genes in the vesicle-mediated transport, regulated exocytosis and neutrophil
degranulation. For example, multiple members of the Rab and Syntaxin families were
differentially expressed, but it will be necessary to determine if their functions are
impaired. Together with the measured decrease in granule mobilization due to F. alocis
infection, this is a promising area that merits more research.
One of the top hits from the transcriptome was inflammation, which is expected in
the context of a chronic inflammatory bacterial infection. Amongst the significant
upregulated pathways was NFκB signaling. Experimentally, I determined that NFκB is
activated very quickly after F. alocis challenge, and that TLR2 and MyD88 signaling is
critical for the production of cytokines and chemokines. These pro-inflammatory mediators
are especially important in the context of periodontitis because the chemokines will recruit
more inflammatory cells to the oral cavity, and the pro-inflammatory cytokines will prime
incoming cells, further enhancing their capacity to drive tissue destruction. Additionally, I
found that the interaction between neutrophils and F. alocis produces pro-survival soluble
factors that extend the neutrophil lifespan, which also extends the time they can drive the
dysregulated inflammatory environment.
Despite driving a pro-inflammatory program, F. alocis also seems to be striking a
balance between pro- and anti-inflammatory responses. For example, in comparison to
other oral pathogens, F. alocis does not induce NETs production and inhibits the release
of NETs by the potent neutrophil activator, PMA [276]. Neutrophils stimulated with the
oral pathogen also produced a significant amount of the anti-inflammatory cytokine, IL-
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10. Similarly, in the transcriptome data, the upregulated inflammatory pathways from early
timepoints became significantly downregulated during the later time points, suggesting that
F. alocis may be gaining control of the cell and dampening inflammatory processes at later
timepoints. Data from this dissertation exemplified this concept further by showing that F.
alocis dampened the activation of TNF-mediated MAPK signaling and as a result, limited
the production of IL-8. At later timepoints, F. alocis challenge resulted in the significant
downregulation of signal transduction pathways like MAPK, GPCR, Rho GTPases, PI3K,
PTEN, AKT, and PKA, which could have significant impacts on neutrophil functions
towards secondary stimuli.
I found that neutrophils stimulated with F. alocis for up to 18 hours retain their
phagocytic capacity and their ability to generate ROS in response to secondary stimuli, like
S. aureus. However, there are other neutrophil functions I have not assessed downstream
of F. alocis stimulation. Furthermore, it would be interesting to assess whether neutrophil
negative feedback loops are activated with different kinetics or to different magnitudes
during F. alocis stimulation to enact the changes in responsiveness of these neutrophils.
The microbiota associated with disease is influenced by the virulent traits of specialized
microorganisms that raise the pathogenicity and survival of the entire community. While
it has been shown that F. alocis can protect other species from complement killing [64],
one of the aspects of F. alocis infection I have not addressed in depth is the bystander
effects of F. alocis-influenced neutrophil functions. Are F. alocis-controlled neutrophils
defective at eliminating other oral bacteria? At early timepoints, the dampened ROS
response is limited to F. alocis phagosomes [284], but is the thwarted granule movement
wide-spread in the cell and could it protect other internalized bacteria?
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Neutrophils that encounter F. alocis have prolonged lifespans and retain their
functional capabilities for a longer time than unstimulated cells. The next step in the
apoptosis story is to determine how/where the apoptotic pathways are specifically targeted
by F. alocis, since caspase 3, 8, and 9 were minimally activated in F. alocis treated
neutrophils. Furthermore, can F. alocis pre-treatment of the neutrophils prevent activation
of apoptotic pathways by known cell death agonists? The effect on neutrophil survival was
even more pronounced in anaerobic conditions. Since neutrophils encounter hypoxic
conditions as periodontitis develops and the periodontal pocket deepens, more work to
elucidate their responses in this environment will give a better picture of neutrophils
behavior in the progression of the disease. Despite the extended lifespan and functional
capacity of neutrophils when challenged with F. alocis, to our surprise, the infected
neutrophils were more avidly engulfed by macrophages compared to media-cultured
neutrophils. I now believe this effect is due to the loss of CD31 expression on the surface
of F. alocis-challenged neutrophils, which is driven by an F. alocis-derived protease. More
experiments are needed to prove our hypothesis, as well as characterize this protease.
The progression of neutrophil cell death into apoptosis and subsequent efferocytosis
is supposed to be a non-inflammatory process. However, macrophages that engulfed F.
alocis-challenged neutrophils produced a robust pro-inflammatory cytokine and
chemokine response. Additionally, F. alocis-neutrophils were degraded to a lesser extent
than media-cultured neutrophils. The differences in cargo degradation within efferosomes
between untreated or F. alocis treated neutrophils is an area that warrants more
characterization. Several markers are available to track the maturation of efferosomes like
LC3, LAMP1, and lysotracker, so the presence of these should be assessed in our system.
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Decreased efferosome maturation has two important implications that should also be
tested. The first is that under the correct oxygen conditions, F. alocis may be using
neutrophils as “trojan horses” to enter a longer-lived host. Corroborating this hypothesis is
unpublished data from our laboratory shows that F. alocis can also establish a niche within
human macrophages. The second implication is that if dysregulated clearance of apoptotic
cells can accelerate the progression of autoimmune disorders [427]. There is a strong
correlation between limited proteolysis of phagosomal cargo and cross-presentation of
antigenic peptides by major histocompatibility complex proteins that activate adaptive
immune responses [447, 461]. Pathways for autoinflammatory diseases like rheumatoid
arthritis were significant hits in the transcriptome of F. alocis-challenged neutrophils.
In conclusion, the data from this dissertation asserts that F. alocis manipulates
neutrophil gene expression profiles, signaling cascades and antimicrobial mechanisms to
survive intracellularly, extend neutrophil lifespan, and cause the release of proinflammatory cytokines. The nefarious effects of F. alocis on neutrophils also trickle down
to efferocytic macrophages and potentiate more inflammation in the oral cavity. Finally,
our results are the first to delineate the F. alocis strategies to control neutrophil effector
functions by interrupting intracellular signaling and will enhance our understanding of how
oral bacteria undermine the innate immune system.
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Figure 6.1 Working model of F. alocis effects on neutrophils.
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